The role of macrophage insulin receptor substrate 2 signaling In the regulation of energy homeostasis by Rached, Marie Therese
1 
 
 
 
 
The Role of Macrophage Insulin Receptor Substrate 2 
Signaling In the Regulation of Energy Homeostasis.  
 
                                        Marie Therese Rached 
               Imperial College, Faculty of Medicine, Clinical Science Centre 
                                          Doctor of Philosophy
2 
 
 
Declaration of originality 
The work presented in this PhD thesis is my own. Contributions and 
collaborations made by other people are referenced in the methods section 
(chapter 2) of this thesis. 
3 
 
Copyright Declaration 
‘The copyright of this thesis rests with the author and is made available under a 
Creative Commons Attribution Non-Commercial No Derivatives licence. 
Researchers are free to copy, distribute or transmit the thesis on the condition 
that they attribute it, that they do not use it for commercial purposes and that they 
do not alter, transform or build upon it. For any reuse or redistribution, 
researchers must make clear to others the licence terms of this work’.
4 
 
 
Abstract 
 
The development of obesity, an imbalance between energy intake and energy 
expenditure, is associated with disordered cross-talk between the metabolic and 
immune systems. Insulin resistance, a hallmark of the obese state, is in part a 
consequence of increased adipose tissue inflammation and is characterized by 
increased classical macrophage (CAM) infiltration. Yet the genes and molecular 
mechanism(s) underlying these processes remain poorly understood. Insulin 
receptor substrate 2 (Irs2) is a critical signaling node through which both insulin 
and cytokines act to regulate cellular function and may therefore influence 
macrophage function. To understand the importance of Irs2 in both macrophage 
biology and energy homeostasis, we have generated mice lacking Irs2 in 
macrophages (Irs2lysozymeM-/-). When challenged with high fat diet, Irs2lysozymeM-/- 
mice were resistant to weight gain and fat accumulation in part due to increased 
energy expenditure. Moreover, they displayed improved glucose homeostasis.  
At the molecular level, there was decreased adipose tissue expression of 
inflammatory markers (CAM) that might explain the improved insulin sensitivity. 
Additionally, there was increased brown adipose tissue expression of 
thermogenic markers which may underpin the increased energy expenditure. 
mRNA sequencing analysis of bone marrow-derived macrophages (BMDM) 
treated with lipopolysaccharides (LPS) revealed that inflammatory signaling 
pathways, including the nucleotide-binding-oligomerization domain (NOD)-like 
receptor and the toll-like receptor signaling pathways were down-regulated in the 
Irs2lysozymeM-/- BMDM compared to control BMDM. This analysis also revealed that 
targets of Krüppel-like factor 4 (KLF4), a transcription factor implicated in 
macrophage polarization, were up-regulated in LPS-treated Irs2lysozymeM-/- BMDM. 
Unbiased metabolomics approach also revealed that the levels of secreted 
citrulline, a by-product of nitric oxide synthesis and a CAM marker, are reduced 
in LPS- treated Irs2lysozymeM-/- BMDM.  
These studies implicate a novel role for macrophage Irs2 in energy homeostasis 
regulation and identify potential inflammatory processes that can be targeted to 
treat obesity and insulin resistance.  
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Chapter 1: Introduction 
 
1.1 Energy homeostasis and its regulation 
Homeostasis is the ability of an organism to maintain a constant internal environment including 
such properties as a constant pH and a constant body temperature. As first described by Claude 
Bernard in 1865 and further conceptualized by Walter Cannon in 1932, homeostasis involves 
both retaining the body’s internal equilibrium as well as making adjustments to environmental or 
physiological changes in order to keep this internal equilibrium (Keesey and Powley, 2008). 
These adjustments consist of a series of reactions that work together to oppose the actions that 
are induced by these disturbances. They can be either voluntary like eating in response to hunger 
or involuntary like shivering in response to cold.  
Body energy stores are under tight regulation whereby energy input usually equates to 
the energy output. Thus for energy homeostasis to occur both food intake (input) and energy 
expenditure (output) need to be coordinated. For instance, weight loss under physiological 
conditions is usually associated with increased food intake and decreased energy expenditure, 
whereas overfeeding resulting in weight gain will lead to a suppression of food intake and favor 
energy expenditure.   
The homeostatic adjustments to maintain an equilibrated energy balance are in part 
regulated by the release of hormones into the bloodstream. The word hormone and the endocrine 
concept were first suggested in 1902 by two British physiologists Maddox Bayliss and Ernest 
Henry Starling who demonstrated the role of the gut as an endocrine organ producing and 
secreting the hormone secretin. In the process of their experiments, they discovered that the 
pancreas produces various substances following the release of secretin from the gut and this was 
independent of the nervous system. Since then a diverse range of hormones have been 
identified. These include steroid hormones synthesized and secreted by the adrenal glands 
(glucocorticoids such as cortisol) and by the gonads (sex hormones) as well as hormones of the 
gastrointestinal tract such as ghrelin and peptide tyrosine tyrosine (PYY) and insulin from the beta 
cells of the pancreas (Rehfeld, 1998). In fact it has subsequently been recognized that the 
gastrointestinal tract is the largest endocrine organ followed by the adipose tissue which is also 
considered as a source of humoral secretion.   
The central nervous system (CNS) and in particular the hypothalamus has been shown to 
play an essential role in the regulation of body weight, integrating nutrient sensing mechanisms 
critical for the maintenance of energy homeostasis. For example, among the early experiments to 
demonstrate this were performed in rats that underwent lesioning of their lateral hypothalamus 
and as a consequence they became hypophagic or aphagic and displayed reduced energy 
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expenditure (Corbett et al., 1985). These animals maintained reduced body weight even after 
they resumed feeding, and were unable to restore their normal body weight despite the fact their 
food intake returned to normal. Interestingly, rats whose body weight was reduced by partial 
starvation before the hypothalamic lesions (HL) did overeat to restore their initial body weight and 
were able to overcome the anorexia observed in the HL rats. These results imply that the set 
points of body weight regulation are under control of the lateral hypothalamus (Powley and 
Keesey, 1970; Keesey et al., 1979). More recent studies have started to identify the molecular 
components of these hypothalamic mechanisms. For example, melanin concentrating hormone 
(MCH), a neuropeptide expressed in the lateral hypothalamus plays a role in the regulation of 
energy homeostasis. Ablation of MCH neurons in mice causes reduced body weight, fat and lean 
mass. Reduced food intake and increased energy expenditure accounted for the lean phenotype 
observed in these mice (Alon and Friedman, 2006). 
In addition to the LH, the ventro-medial hypothalamus (VMH) is also involved in the regulation of 
food intake. Contrary to the role played by LH, lesioning of the VMH results in hyperphagia and 
obesity (Rothwell and Stock, 1982). Both LH and VMH are also involved in the regulation of 
energy expenditure which will be emphasized in section 1.5.1.1. 
Likewise, the arcuate nucleus in the mediobasal hypothalamus has an important role in the 
regulation of energy homeostasis (Thaler et al., 2012). 
1.2 Changes in adipose tissue physiology in health and disease. 
The adipose tissue (AT) is the second largest endocrine organ after the GI tract. The major form 
of adipose tissue is the white adipose tissue (WAT) which is primarily involved in energy storage 
and also plays a complex role in energy homeostasis due to its varied endocrine and metabolic 
functions. White adipose tissue is distributed in several anatomical locations in mice and humans. 
The most studied WAT depots in rodents are the visceral or abdominal fat that comprises four 
specific depots: the mesenteric fat that surrounds the intestine, the retroperitoneal depots found 
along the dorsal abdomen and the kidney, the omental fat that covers the stomach and spleen 
and the perigonadal fat attached to the gonads. Another form of adipose tissue is brown adipose 
tissue (BAT). This type of AT is involved in adaptive thermogenesis and heat dissipation rather 
than energy storage (Bjørndal et al., 2011). In humans, BAT is present at very small amounts at 
the back of the neck and along the spinal cord. Despite its low abundance, it is extremely 
metabolically active and has been implicated in the regulation of energy homeostasis (Himms-
hagen, 1985).  In addition to these two well established forms of adipocytes, recent studies have 
indicated the presence of a third form called beige AT. The beige AT consists of brown-like 
adipocytes inside some depots of WAT, mainly the subcutaneous and perigonadal WAT. These 
brown-like adipocytes, unlike the classical brown adipocytes, are not derived from the same 
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cellular lineage and differ functionally from the brown cells (Wu et al., 2012). Beige AT is able to 
expand when physiologically appropriate in a process that has been termed “browning”.  
As discussed in 1.1, energy balance is maintained when food intake and energy 
expenditure are balanced. Any excess fuel is stored in the form of triglycerides in the adipocytes 
present primarily in the WAT and constitutes a source of energy when food availability is limited. 
Mature adipocytes constitute 35 to 70% of the total WAT, while the remaining cells are composed 
of pre-adipocytes, fibroblasts, endothelial cells and leucocytes. This multicellularity of WAT 
contributes to the large number of proteins synthesized and secreted from WAT under various 
physiological conditions. For instance, mature adipocytes synthesize and secrete numerous 
hormones, growth factors and cytokines that are involved in overall energy homeostasis including 
those implicated in the regulation of lipid metabolism, glucose homeostasis, inflammation, 
angiogenesis and blood pressure (Blüher et al., 2002; Unger and Elmquist, 2006). 
1.2.1 Obesity 
An imbalance in WAT homeostasis and function caused by dysregulated energy consumption or 
expenditure results in the development of obesity, a leading cause of mortality and morbidity 
worldwide. People are considered obese when their body mass index (BMI), the ratio of body 
weight over the square of the height, exceeds 30 kg/m
2
. Obesity rates in the UK are amongst the 
highest in Europe with around 24% of men and 25% of women being obese according to the HSE 
(Health Survey for England) 2012 data.  
As mentioned by Hippocrates “Corpulence is not only a disease itself, but the harbinger of 
others”. Subsequently it has been established that obesity is a risk factor for diseases such as 
cardiovascular disease, non-alcoholic fatty liver disease (NAFLD), type-2 diabetes and cancer, all 
of which may lead to premature death (Figure 1.1). Some of the co-morbidities associated with 
obesity are components of “syndrome X”, also known as the “metabolic syndrome”, which was 
first proposed by Reavan in 1988. The metabolic syndrome was defined by the World Health 
Organization on the basis of insulin resistance and type-2 diabetes. The National Institute of 
Health–(USA) later proposed that three of the following five parameters are required to diagnose 
the metabolic syndrome in adults: large waist circumference, hypertension, high concentrations of 
triglycerides and fasting blood glucose levels as well as decreased high-density lipoprotein 
cholesterol levels. 
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Figure 1.1 Consequences of obesity 
Adapted from  (Hotamisligil, 2006). 
 
 
1.3 Insulin resistance in type-2 diabetes 
1.3.1 Metabolic role of insulin 
At the metabolic level, insulin action plays a key role in integrating mechanisms that allow the 
organism to equilibrate energy supplies and demands in both fed and fasted states. Insulin 
regulates pathways that affect carbohydrate, lipid and protein metabolism. In the fed state, dietary 
intake of carbohydrates increases blood glucose levels and consequently leads to insulin 
secretion from the  cells of the pancreas. In the skeletal muscle and liver, insulin promotes 
glucose uptake and glycogen synthesis. It inhibits hepatic production of glucose 
(gluconeogenesis), and increases lipogenesis in the liver. In the adipose tissue, insulin increases 
lipogenesis and inhibits lipolysis. In the fasted state, however, when blood glucose levels 
decrease, insulin production is reduced. This triggers increased gluconeogenesis and 
glycogenolysis (breaking down of glycogen into glucose) in the liver. These two metabolic 
pathways are facilitated by glucagon, another hormone secreted from the α cells of the pancreas 
when blood glucose levels are low (Quesada et al., 2008). 
Insulin resistance (often associated with obesity) is generally characterized by a failure of 
adipocytes, muscle and liver cells to respond to insulin (Matsumoto et al., 2006; DeFronzo and 
Tripathy, 2009; Arner, 2003). Defective insulin signaling in other non-classical insulin target 
24 
 
tissues such as the brain and β cells may also contribute to the pathophysiology of insulin 
resistance (Kasuga, 2006). Altered adipocyte metabolism, failure of the liver to suppress glucose 
production and impairment in muscle glucose uptake following a meal are all key components of 
the insulin resistance usually observed in type-2 diabetes (Groop et al., 1989). As a 
compensatory mechanism, pancreatic islets increase their production of insulin leading to 
hyperinsulinemia while maintaining normal blood glucose levels. The lack of anti-lipolytic function 
of insulin in adipose tissue results in a chronic elevation of circulating free fatty acids (FFAs) 
which may lead to an increase in hepatic gluconeogenesis, and contribute to both muscle insulin 
resistance and pancreatic  cell dysfunction. Increased serum FFAs inhibit glucose transport in 
skeletal muscle and as a consequence glycogen synthesis, as a result of decreased levels of 
glucose-6-phosphate (Roden et al., 1996). Similarly, prolonged elevations of FFAs impair glucose 
stimulated insulin secretion by  cells (Carpentier et al., 2000). This in turn leads to a failure of 
normal insulin-stimulated glucose uptake by tissues and therefore hyperglycemia, the hallmark of 
diabetes. Hyperinsulinemia and hyperglycemia are therefore central to the pathophysiology of 
type-2 diabetes, and also contribute to lipid disorders and cardiovascular diseases as well as their 
complications and other associated diseases (DeFronzo, 2009). 
1.3.2 Molecular mechanisms of insulin resistance 
Following a meal, the rise of insulin favors the uptake of carbohydrates and proteins into the sites 
of storage and their conversion into triglycerides, a more compact way to store energy than 
carbohydrates. However, abnormal lipid accumulation alters insulin signaling leading to insulin 
resistance. For instance, excess of fatty acids in the heart of rats impairs insulin-stimulated 
glucose uptake by these cells, and results in the accumulation of glycolytic intermediates and the 
inhibition of glucose oxidation (RANDLE, 1962; Hue and Taegtmeyer, 2009). The accumulation of 
lipids in the muscle is associated with the activation of members of the protein kinase C (PKC) 
family and this is mediated by the build-up of diacylglycerols (DAGs) and ceramides. These are 
products of triacylglycerol (TAG) hydrolysis by the rate limiting enzyme adipose triglyceride lipase 
(ATGL). They are thought to alter insulin signaling by several mechanisms mediated by PKC 
activation including serine/threonine phosphorylation of insulin receptor substrate proteins and 
decreased Glut4 translocation. In the liver, the associated abnormal lipid accumulation is at the 
basis of NAFLD which itself is associated with liver insulin resistance (Kienesberger et al., 2009; 
Samuel and Shulman, 2012).  
Endoplasmic reticulum (ER) stress, which involves the activation of the unfolded protein response 
(UPR), is another mechanism that contributes to insulin resistance, mainly in the liver in 
association with NAFLD. It is initiated by the accumulation of unfolded proteins in the ER lumen. 
The immunoglobulin-binding protein (BiP) is a molecular chaperone that initiates the UPR by 
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binding to the exposed hydrophobic regions of these unfolded proteins, allowing the activation of 
three transmembrane proteins that work together to reduce the ER stress response: the inositol 
requiring enzyme-1 (IRE1α), the PKR-like ER kinase (PERK) and the activating transcription 
factor-6 (ATF6) (Samuel and Shulman, 2012). 
1.4 Inflammation: a key player in metabolic disorders 
With human evolution the two dominant traits associated with human survival are: 1) a strong 
immune system and 2) the ability to store energy and use it when food supplies are scarce. 
These two characteristics are mutually linked and have been highly conserved across species 
from Caenorhabditis elegans (C.elegans) and Drosophila to mammals. At the molecular level, 
cytokines, hormones, signaling proteins and transcription factors have multiple overlapping roles 
that involve both the regulation of energy homeostasis and immune function. A striking example 
is insulin which initiates the insulin signaling pathway and overlaps with multiple inflammatory 
signal transduction pathways as well as being a key metabolic signal (Wellen and Hotamisligil, 
2005).  
It has now become widely appreciated that dysregulation of the immune system plays an 
important role in the development of obesity. While malnutrition is associated with reduced 
immunity and a risk for infection, excess nutrient intake and storage leading to obesity is 
associated with inflammatory diseases, including atherosclerosis, lipid disorders and diabetes. 
Several cells of both the adaptive and innate immune system act as mediators in the abnormal 
metabolic processes that occur during the development of obesity and its associated 
abnormalities. Thus, while the involvement of the immune system in the pathophysiology of type-
1 diabetes has long been recognized (Hassan et al., 2012), more recently immune dysfunction 
has been implicated in the pathogenesis of type-2 diabetes (Mathis, 2013). 
1.4.1 Chronic inflammation as a link between obesity and metabolic disorders 
The first clear link between obesity and inflammation was the observation that tumor necrosis 
factor-α (TNFα) is highly expressed in the adipose tissue of four rodent models of obesity and 
diabetes (Hotamisligil et al., 1993) as well as the adipose tissue and muscle of obese humans 
(Hotamisligil et al., 1995; Saghizadeh et al., 1996). In these studies it was shown that intravenous 
infusion of recombinant TNFα receptor-Immunoglobulin G (IgG) protein into obese fa/fa rats for 3 
days to neutralize TNFα caused an improvement in glucose homeostasis and in particular insulin 
sensitivity in clamp studies (Hotamisligil et al., 1993).  In addition, deletion of  TNFR1 and TNFR2, 
the two main receptors of TNFα, in mouse models of obesity such as leptin-deficient mice (ob/ob) 
resulted in improved insulin sensitivity. This was associated with decreased circulating levels of 
FFAs and improved insulin signaling in both fat and liver tissues (Uysal et al., 1997).  
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A large number of follow-up studies have strongly established inflammation as a key component 
of obesity and its associated co-morbidities. Obesity is associated with increased circulating 
levels of inflammatory cytokines, in particular interleukin-1 β (IL-1β) and interleukin-6 (IL-6), which 
induce a chronic low-grade inflammation manifested by increased levels of C-reactive protein 
levels (CRP)  (Bunout et al., 1996; Visser et al., 1999). CRP is a systemic marker of inflammation 
and its concentrations predict cardiovascular diseases via increased production of nitric oxide 
(Clapp et al., 2005). High IL-6 levels are seen in type-2 diabetic patients and result in high blood 
levels of acute phase markers such as serum amyloid A (SAA) that are associated with 
dyslipidemia (Pickup and Crook, 1998). Similarly, in patients with coronary heart disease (CHD), 
IL-6 plays a critical role in the induction of the acute phase response, marked by high levels of 
SAA and CRP. IL-6 increases lipid uptake by macrophages and the formation of foam-cell 
macrophages. Along with other inflammatory cytokines such as IL-1 and TNFα, IL-6 is produced 
by macrophage foam cells in the arterial wall and contributes to the pathogenesis of 
atherosclerosis (Yudkin et al., 2000). At the molecular level, inflammatory signaling pathways 
inhibit insulin signaling and induce a state of insulin resistance in peripheral tissues mainly 
through the effects upon insulin receptor substrate signaling. For instance, activation of TNFα 
activates stress kinases such as c-Jun N-terminal kinase (JNK) and IB-kinase (IKK)- nuclear 
factor kappa-light-chain-enhancer of activated B cells (NF-B) signaling pathways which inhibit 
insulin signaling by inducing serine/threonine phosphorylation of insulin receptor substrate (IRS) 
proteins. This uncoupling of insulin signaling is due to the inability of the IRS proteins to interact 
with the juxtamembrane domain of the insulin receptor (IR). In fact, the serine/threonine 
phosphorylation of the IRS proteins disables their tyrosine phosphorylation and therefore the 
propagation of the insulin signaling (Hotamisligil et al., 1996; Paz et al., 1997). In the three main 
classical insulin target tissues, adipose tissue, liver and skeletal muscle, these two transduction 
pathways account for most of the inflammatory signals that converge with the insulin signaling 
pathway.   
1.4.2 The white adipose tissue: a new environment for immune cells.  
In addition to its role in the storage of excess energy in the form of triacylglycerols, white adipose 
tissue (WAT) fulfills many biological and physiological functions including the regulation of lipid 
metabolism and glucose homeostasis, the production of adipokines and chemokines and the 
secretion of inflammatory cytokines. A list of some of these secreted factors and their functions is 
presented in table 1.1. 
As discussed earlier in 1.2, WAT is deposited in different fat depots that fulfill different functions. 
These include two major sites: the visceral WAT (VAT) and the subcutaneous WAT (SAT). VAT 
has a greater effect on insulin action than SAT because VAT is more likely linked to insulin 
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resistance and has a highest percentage of inflammatory cells. Moreover, VAT lipolysis results in 
excess FFA delivered to the liver through the portal vein which in turn results in increased 
gluconeogenesis (Nielsen et al., 2004; Chu et al., 2002; Lebovitz and Banerji, 2005). As a result 
increased visceral adiposity as opposed to excess subcutaneous adiposity is more associated 
with hepatic insulin resistance (Nielsen et al., 2004). The role of SAT has in fact been suggested 
to be beneficial in some studies but its precise contribution to insulin sensitivity has yet to be 
determined (Tran et al., 2008).  
In addition to its role in energy storage and metabolic homeostasis, WAT has emerged as a key 
site for the role of immune cells in metabolism. Immune cells are divided into innate (non-specific) 
and adaptive (specific or acquired) immune cells. The innate immune system includes 
macrophages, granulocytes and mast cells and represents the immediate line of defense to 
combat some microorganisms such as bacteria. The adaptive immune system comprises 
lymphocytes and is so called because it is acquired upon exposure to certain pathogens and it 
defends the organism from a second reinfection with the same pathogen. Despite their functional 
differences, both immune systems communicate to protect the body from infectious agents. 
Interestingly, innate immune cells initiate and direct adaptive immune responses and are able to 
clear pathogens that have been targeted by the adaptive immune system (Janeway et al., 2001). 
These cells will be discussed in details in sections 1.6 and 1.7. 
Adipocytes and immune cells share similar features which further reinforces the concept of a 
mutual functionality between metabolism and inflammation. These features include production of 
cytokines (IL-6 and TNFα) and chemokines such as chemokine (C-C motif) ligand 2 (CCL2) also 
known as monocyte chemoattractant protein 1 (MCP1), and lipid accumulation, for instance in the 
case of macrophages that form foam-like cells. They express common factors including nuclear 
hormone receptors such as the peroxisome proliferator activator receptor gamma (PPARγ) and 
the liver X receptor (LXR), in addition to fatty acid binding proteins (FABP) like the adipocyte 
protein 2 (Ap2) (Wellen and Hotamisligil, 2005).  
An important feature of obesity and its metabolic complications is the infiltration of immune cells 
into the VAT. Even though macrophages have been considered to be functionally and numerically 
the most abundant in the AT, recent reports have implicated the role of additional components of 
the innate and adaptive immune system in obesity-induced inflammation (Mathis, 2013; Mathis 
and Shoelson, 2011). Another connection between immunity and metabolism comes from studies 
on the hormone leptin, an adipose-tissue-derived hormone. Leptin is an appetite hormone 
normally high in obese people with high appetite. In additon, mice deficient in leptin or its receptor 
are obese. These studies show that leptin is crucial in maintaining the proliferation and survival of 
T cells (Howard et al., 1999) and favors the development of T helper 1 (Th1) over T helper 2 
(Th2) cells (Lord et al., 1998).  
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Molecule Function 
Adiponectin Anti-inflammatory hormone, protective role in 
type-2 diabetes and cardiovascular diseases, 
insulin sensitizing 
Leptin Control of appetite and energy expenditure via 
signaling to the hypothalamus 
CCL2 (MCP1)  Regulates leukocyte migration into sites of 
inflammation and tissue damage 
Chemokine (C-C motif) ligand 3 (CCL3) also 
known as macrophage inflammatory protein-1 
α (MIP1α) 
Regulates leukocyte migration in inflammatory 
processes 
Resistin Role in insulin resistance and may play a role 
in inflammation 
TNFα Inhibits insulin signaling in cells and contributes 
to the development of insulin resistance during 
inflammation.  
 
Table 1.1: Molecules secreted by the WAT to the bloodstream. 
Adapted from (Yang, 2008)  
 
 
 
1.5 Brown adipose tissue 
The brown adipose tissue (BAT) is specialized in the dissipation of energy in the form of heat in a 
process termed non-shivering thermogenesis. BAT owes its name to the high number of 
mitochondria and the high number of capillaries in these adipocytes that give BAT depots a 
“brown” macroscopic appearance. These mitochondria have high concentrations of a protein 
called uncoupling protein 1 (UCP1) which uncouples ATP synthesis from respiration, generating 
heat. BAT is mostly abundant in human and mice neonates at a time when non-shivering 
thermogenesis is a very important source of heat generation and its amount decreases gradually 
with age. Even though it is present at low abundance in adult animals, it plays a potentially 
important role in energy expenditure as it has been estimated that as little as 50 g of BAT can 
contribute to 20% of daily energy expenditure in humans (Rothwell and Stock, 1982). 
However, the presence of significant BAT depots in adult humans remained a controversial area 
until recently when positron emission tomography (PET) scanning with 2-[fluorine18]-fluoro-2-
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deoxy-d-glucose (
18
F-FDG) along with computer tomography (CT), revealed glucose uptake in 
what has been identified as BAT in several areas of the adult human body including the cervical, 
supraclavicular and to a lesser extent the paravertebral region. These are located in different 
regions to the ones present in mice, the latter being mainly interscapular (Nedergaard et al., 
2007; Gesta et al., 2007). This increased glucose uptake coincides with increased BAT metabolic 
activity. In mice, this activity increases upon cold exposure and high fat feeding while it 
diminishes in a warm environment and upon fasting (Nedergaard et al., 2007).  
There remain some controversies regarding the contribution of metabolically active BAT in 
regulating energy homeostasis. Studies in mice and human have indicated a positive correlation 
between active BAT and a lean phenotype as well as insulin sensitivity (Lee et al., 2013; Lowell et 
al., 1993), while others have not found such a correlation (Sturkenboom et al., 2004; Enerbäck et 
al., 1997). One explanation behind these contradictions is that in both circumstances, mice and 
humans were not maintained at conditions that raise their BAT activity. 
The importance of BAT in the regulation of glucose metabolism has been recently emphasized in 
BAT transplantation experiments in mice. Recipient mice manifest an improved glucose 
homeostasis phenotype, reduced body weight and adiposity and they are protected from obesity-
induced insulin resistance, via an IL-6 dependent mechanisms (Stanford et al., 2013).  
  
1.5.1 Energy expenditure and non-shivering thermogenesis 
1.5.1.1 Control of thermogenesis 
Energy expenditure is mainly physiologically regulated by two basic metabolic mechanisms in 
mice; first, shivering thermogenesis that occurs upon cold exposure in un-acclimatized mice and 
uses skeletal muscle contraction to generate heat; secondly, non-shivering thermogenesis (also 
known as adaptive thermogenesis), as described above, in which heat is generated in BAT and 
which occurs upon longer term exposure to cold. Non-shivering thermogenesis is generally under 
the control of the sympathetic nervous system (Himms-hagen, 1984) but can also be regulated by 
the thyroid hormone triiodothyronine (T3) which is produced and secreted by the thyroid gland 
(Cannon and Nedergaard, 2004). When the hypothalamus senses cold temperatures, it triggers 
the release of catecholamines, mainly norepinephrine from the sympathetic fibers and the adrenal 
gland that act on the adrenergic receptors (α1, α2 and β) within BAT. Concerning β receptors, β3-
adrenergic receptors are the most significant ones in BAT as they are not subject to 
desensitization like β1 and β2 receptors. Likewise, β3 receptors are the only subtype expressed 
in mature brown adipocytes in mice, whereas β1 and β2 are mostly abundant in humans (Blaak 
et al., 1993). The neural pathways involved in cold-induced non-shivering thermogenesis include 
sensory afferents innervating the skin, the preoptic area of the anterior hypothalamus (POAH) 
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and the spinal cord (Himms-hagen, 1984). The neural pathway from the POAH is mediated by the 
neurotransmitter gamma aminobutyric-acid (GABA) which signals to the ventromedial nucleus 
(VMN) in the hypothalamus. GABA induces the release of glutamate that reaches the 
preganglionic nerves. These nerves release acetylcholine in the sympathetic chain and 
subsequently the sympathetic nerves produce catecholamine in the brown adipocytes inducing 
thermogenesis (Cannon and Nedergaard, 2004).  
In addition to the role of VMH and LH in food intake (discussed in 1.1), they are also involved in 
the regulation of energy expenditure. VMH-lesioned rats develop obesity in the absence of 
hyperphagia, mainly due to a reduced energy expenditure manifested by atrophied BAT. 
Additionally, electrical stimulation of VMH increases BAT temperature, an effect similar to what is 
seen following noradrenergic stimulation. In contrast, LH-lesioned rats manifest increased heat 
production (Rothwell and Stock, 1982).  
In addition to the role of catecholamines and the thyroid hormone in the regulation of 
thermogenesis, other hormones including leptin may stimulate thermogenesis by activating the 
sympathetic nervous system at low temperatures. Ucp1-deficient mice (Ucp1-/-) and ob/ob mice 
can survive at 4°C when slowly adapted to low temperature. However, double knock-out 
ob/ob.Ucp1-/- mice can only survive at low temperatures when administered leptin which acts on 
the thyroid axis and increases circulating T3 levels to regulate thermogenesis and maintain body 
temperature (Ukropec et al., 2006). Additionally, insulin which rises following a meal induces diet-
induced thermogenesis and increases heat production in lean insulin sensitive individuals, 
whereas the increased heat production is significantly less in obese insulin resistant people (De 
Palo et al., 1989). 
1.5.1.2 Molecular changes in BAT during thermogenesis 
Marked morphological and molecular changes occur in the ATs following the release of 
catecholamines. In the WAT there is an increase in lipolysis and release of free fatty acids into 
the serum. In BAT, norepinephrine binding to its β3 adrenergic receptor activates adenylate 
cyclase which catalyzes the conversion of adenosine triphosphate (ATP) to 3, 5’-cyclic AMP 
(cAMP) which in turn activates protein kinase A (PKA) that phosphorylates several lipolytic 
proteins, the most predominant of which are ATGL and hormone sensitive lipase (HSL) (Pagnon 
et al., 2012). ATGL catalyzes the hydrolysis of triglycerides into diglycerides and HSL breaks 
down diglycerides into free fatty acids taken up by mitochondria (Zimmermann et al., 2004; 
Cannon and Nedergaard, 2004). This activates mitochondrial UCP1, mostly abundant in the inner 
membrane of the BAT mitochondria. UCP1 allows the leak of protons (H+) by transporting them 
into the mitochondrial matrix, therefore uncoupling protons from ATP synthesis which is the basis 
of the heat production and dissipation effect. Interestingly, α2 adrenergic receptors have an 
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opposite function to β3 adrenergic receptors as they inhibit adenylate cyclase activity (Nicholls 
and Locke, 1984; Aquila et al., 1985). 
Similar to cold exposure stress, dietary excess is sensed by the hypothalamus which in turn, in 
order to avoid excess weight gain, stimulates β-adrenergic sympathetic nerves to increase 
energy expenditure. Thus, increased weight gain in mice is associated with increased energy 
expenditure (Lowell and Bachman, 2003). In fact, mice on HFD show increased energy 
expenditure compared to mice on chow. However, it has been suggested that defective Ucp1-
mediated thermogenesis plays a role in diet-induced obesity. Although high Ucp1 mRNA and 
protein expression levels were found in BAT of high-fat diet (HFD) fed mice compared to mice on 
chow diet (Fromme and Klingenspor, 2011), other genetic models of obesity such as Irs2 Knock-
out mice (Irs2-/-) and ob/ob mice (Masaki et al., 2004; Commins et al., 1999) display low Ucp1 
levels in their BAT. The explanation for this is thought to be that Ucp1 expression increases 
during early weight gain such as in mild obesity for instance HFD-fed mice. However, with excess 
fat accumulation and in morbid obese mice such as ob/ob mice, the BAT becomes incapable of 
dissipating enough heat to lose weight, resulting in decreased Ucp1 expression. 
In addition to the increased Ucp1 gene expression following norepinephrine-increased cAMP 
production, there is also increased activity of the type-2 iodothyronine deiodinase (DIO2) which 
converts the pro-hormone thyroxine (T4) to T3 in the BAT (Williams and Bassett, 2011). The 
DIO2-dependent T3 activation involves its interaction with α and β receptors expressed in BAT. 
The T3/α receptor interaction increases adrenergic responsiveness, whereas T3 binding to β 
receptor induces Ucp1 expression (Ribeiro et al., 2001) (Figure1.2). 
In addition to the thermogenic effect of the mitochondrial protein UCP1, other proteins have also 
been involved in cold-induced thermogenesis, whereby some act in part through UCP1 but also 
other factors. Among these, the transcriptional co-activator peroxisome proliferator-activated 
receptor gamma coactivator 1-alpha (PPARGC1A or PGC1), an upstream regulator of Ucp1, is 
an example. PGC1 is a co-activator of transcription and therefore does not bind DNA directly 
but interacts with nuclear transcription factors such as PPAR that can interact with DNA. It is 
highly expressed in the nucleus of tissues where energy demand is high such BAT and skeletal 
muscle and has an important role in cold-induced thermogenesis.  Its expression is induced upon 
activation of the β3 adrenergic/cAMP pathway and its activation induces uncoupling of oxidative 
phosphorylation and mitochondrial biogenesis. In fact, PGC1 increases the transcriptional 
activity of PPAR and T3 thyroid hormone receptor on the Ucp1 promoter in BAT (Puigserver et 
al., 1998) (Figure1.2). 
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Figure 1.2 Mechanism for β-adrenergic stimulation of thermogenesis in a brown adipocyte 
cell 
-adrenergic receptor (-AR) agonists bind the -AR and increases cAMP production which in 
turn activates protein kinase A (PKA). PKA phosphorylates the cAMP-responsive element binding 
protein (CREB-P) which acts as a transcription factor and regulates expression of Pgc1α and 
Dio2. PGC1α is a co-activator of PPAR which binds Ucp1 enhancer and induces its expression. 
DIO2 converts T4 to T3 which binds the thyroid hormone receptor (TR) which also binds Ucp1 
enhancer (Lowell and Spiegelman, 2000). 
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1.5.1.3 Mechanism of norepinephrine synthesis 
 
As discussed above, catecholamines play a key role in thermogenesis by initiating a signaling 
cascade upon their binding to -adrenergic receptors and activating protein kinases and 
transcription factors leading to the induction of thermogenic gene expression such as Ucp1. The 
regulation of catecholamine biosynthesis is therefore crucial in this thermogenesis process. The 
three catecholamines dopamine, norepinephrine and epinephrine are derived from the non-
essential amino acid L-tyrosine following a sequence of biochemical reactions, that occur in the 
brain, adrenal medulla and tissues innervated by the sympathetic nervous system. Tyrosine 
hydroxylase (TH) is the rate limiting enzyme in the synthesis of these catecholamines and 
requires the cofactor tetrahydropteridine, Fe+ and oxygen for its enzymatic activity. It was first 
prepared from beef adrenal medulla extracts (Nagatsu et al., 1964). TH catalyzes the 
hydroxylation of tyrosine into dopa which is then decarboxylated into dopamine. Dopamine β 
hydroxylase converts dopamine to norepinephrine which is then converted to epinephrine via the 
enzyme phenyl-ethanolamine-N-methyl-transferase (PNMT) (Weiner, 1970; Pohorecky et al., 
1969).  
TH is encoded by the tyrosine hydroxylase gene and changes in Th mRNA levels can alter the 
enzyme abundance and therefore its activity. Physiological changes such as cold exposure 
(Stachowiak et al., 1985) drug administration (Leviel et al., 1991) and glucocorticoids (Lucas and 
Thoenen, 1977) have been shown to alter Th mRNA levels (Kumer and Vrana, 1996). Recent 
findings have implicated that some innate immune cells such as macrophages isolated from 
interleukin-4 (IL-4)-treated mice express high TH protein levels when these mice are caged at 
4°C after cold adaptation. Similarly, norepinephrine levels (pg/µg of protein) were increased in 
macrophages from the same mice (Nguyen et al., 2011).  
 
1.6 Innate immune cells in obesity-induced insulin resistance 
 
It has been suggested that innate immune cells contribute to obesity-induced insulin resistance. 
Macrophages are prime candidates due to their potent inflammatory properties in the AT of obese 
mice and humans. Clinical studies and experimental mice models of diet-induced, genetic and 
pharmacological manipulations have suggested a strong link between macrophages in the AT 
and the development of insulin resistance.   
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1.6.1 Macrophages 
1.6.1.1 Macrophage discovery and origin 
Macrophages are the largest mononuclear phagocytic cells present in tissues and were 
discovered based on their “phagocytic” property. It was Elie Metchnikoff who first discovered the 
concept of phagocytosis in 1866 when he observed nutrient uptake by some cells of the 
Turbelaria worm. He later confirmed and published his findings in 1880, when he discovered two 
types of cells of mesodermal and ectodermal origin with phagocytic capacity in the marine animal 
Coelenterata. In 1884, he published his landmark observation where mesodermic cells of the 
starfish larvae were capable of migrating and attacking foreign insults (reviewed by (Kaufmann, 
2008)). Macrophages can therefore be considered an “ancient” cell type in the metazoan 
kingdom. Indeed early life forms such as unicellular eukaryotic organisms known as protozoa 
share similar features to the mammalian macrophage. 
Macrophages have been classified as part of the mononuclear phagocyte system (MPS), a 
system that also comprises monocytes, the precursors of macrophages. The MPS has been 
proposed to arise from a succession of events that lead to the formation of resident 
macrophages. Hematopoietic stem cells in the bone marrow develop into progenitor cells that can 
commit to either a macrophage or a granulocyte depending on the stimulus. In the presence of 
macrophage colony-stimulating factor (M-CSF), the macrophage colony forming unit differentiates 
into monoblasts, pre-monocytes and monocytes before becoming a macrophage (Wynn et al., 
2013). However, this concept has been recently challenged. In fact, in mice, macrophages 
originate from the yolk sac ectoderm of day 8 embryos giving rise to macrophages that do not 
have an initial monocytic origin. Following this, fetal liver hematopoiesis takes place and 
generates circulating monocytes in the fetus. Post-natally, fetal liver hematopoiesis is replaced by 
bone marrow hematopoiesis giving rise to circulating monocytes, which were thought to be the 
origin of all tissue resident macrophages in the adult. Experiments using lineage tracing 
approaches and knock-out mouse models have confirmed that most tissue macrophages do not 
have a monocytic origin. Two transcription factors, the spleen focus forming virus proviral 
integration oncogene spi1 (Pu.1) and the myeloblastosis oncogene (Myb) are required for 
macrophage development. Pu.1 is essential for the formation of macrophages originating from 
the yolk sac but not those deriving from hematopoietic stem cells (HSCs). In contrast Myb is 
necessary for HSC-macrophage differentiation and is dispensable for yolk sac macrophages. 
Deletion of Pu.1 and Myb in mice therefore indicated that resident macrophages in most tissues 
are Pu.1 dependent, and therefore originate from the yolk sac not the bone marrow. These 
studies have therefore defined three different origins, at least, for macrophages: the yolk sac, the 
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fetal liver and the bone marrow which arise during development but persist until adulthood (Wynn 
et al., 2013; Schulz et al., 2012; Geissmann et al., 2010).  
These mice models also led to the definition of the origin of other specific tissue resident 
macrophages. For instance, microglial cells (macrophages of the brain) are primarily derived from 
the yolk sac progenitors whereas Langerhans cells, macrophages of the skin, are derived from 
both the yolk sac and the fetal liver. Additionally, most of the resident tissue macrophages such 
as those in the pancreas, liver, brain and spleen have a yolk sac origin. Lung and kidney 
macrophages have a chimeric mixture consisting of both bone marrow and yolk sac origins 
(Ginhoux et al., 2010; Hoeffel et al., 2012; Wynn et al., 2013). 
1.6.1.2 Macrophage polarization 
Macrophages are remarkably plastic cells as they express different markers in different tissues 
they host and can change their functional properties, a phenomenon known as polarization, 
depending on the environmental cues they are exposed to and the gene expression profile that 
characterize them. 
Macrophage plasticity is manifested by the acquisition of various polarized functional properties. 
Most importantly, their function and gene expression programs change when they come into 
contact with various micro-environmental stimuli including cytokines and bacterial products, 
therefore highlighting their remarkable diversity (Lawrence and Natoli, 2011). A detailed functional 
classification of macrophages partitions them into two well-established categories, which were 
developed on the basis of in vitro studies: classically activated macrophages (CAM) or M1 
macrophages and alternatively activated macrophages (AAM) known as M2 macrophages. 
Depending on the microenvironment and the triggering stimuli, macrophages polarize to either 
category. CAMs arise following stimulation with inflammatory signals whereas AAMs are induced 
by a variety of stimuli including anti-inflammatory signals. They are further subdivided into 
subgroups: AAMa, AAMb and AAMc based on the expression profile of cell surface ligands, 
receptors and secretory products (table 1.2) (Mantovani et al., 2004; Benoit et al., 2008; Hao et 
al., 2012). 
Despite the progress being made, the origins underlying macrophage polarization are poorly 
understood and it is also becoming clear that this classification may be an over-simplification. 
Therefore this CAM/AAM system must be considered carefully as it might overlook more complex 
functional networks such as those implicated in gene expression regulatory pathways in 
macrophages (Gautier et al., 2012).  
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To identify genes with the potential to direct macrophage polarization towards a CAM or AAM 
phenotype, in vitro assays and gene expression analysis in bone marrow-derived macrophages 
(BMDM) have been used. In addition, the use of genetically modified mice including those with 
macrophage-specific deletions of various genes has given useful insights into this process. For 
example, deletion of the transcription factor Krüppel-like factor 4 (KLF4) directs macrophages 
towards a CAM phenotype. Mechanistically, KLF4 cooperates with the signal transduction and 
transcription 6 (STAT6) to induce transcriptional activation of AAM markers following activation 
with IL-4. In KLF4-/- BMDM, there is 42 to 70% reduced expression of IL-4-induced AAM markers 
compared to that in control BMDM. On the other side, upon lipopolysaccharide (LPS) treatment of 
KLF4-/- BMDM, CAM markers are up-regulated compared to control BMDM through a 
mechanism involving co-activators of the NF-κB signaling pathway (Liao et al., 2011).   
1.6.1.2.1 Classically activated macrophages  
CAMs are generally induced following stimulation with inflammatory products such as LPS, INF 
or TNF. These macrophages express high levels of inflammatory cytokines such as TNFα, IL-6 
and IL-1β. LPS potently induces macrophage activity by acting through its main receptor the 
cluster of differentiation 14 (CD14) and triggering the Toll-like receptor 4 (TLR4) signaling. The 
mechanism of action of LPS signaling is discussed in section 1.15.  
Binding of TNF to its receptors (TNFR1 and TNFR2) activates many inflammatory signaling 
pathways in macrophages and induces gene expression changes mainly via two transcription 
factors: NF-κB and activator protein 1 (AP-1). Activation of TNFR1 induces a series of signaling 
cascades responsible for the activation of the NF-κB pathway mainly via two kinases belonging to 
the family of the mitogen-activated protein kinase 3 (MAPK3): the receptor interacting protein 1 
(RIP1)/ mitogen-activated protein/ ERK kinase kinase 3 (MEKK3) and the TGFβ activated kinase 
(TAK1) that induce phosphorylation of IKK. The activation of AP-1 is dependent on the activation 
of p38 mitogen activated protein kinase (MAPK) and JNK signaling pathways via the mitogen 
activated protein kinase kinase 4 and 6 (MEK4 and MEK6) (Parameswaran and Patial, 2011).  
INF binding to INFR activates the receptor associated tyrosine kinases Janus kinases 1 and 2 
(JAK1 and JAK2) which phosphorylate the cytoplasmic tail of the INFR. This recruits the signal 
transduction and transcription 1 (STAT1) to the activated receptor and its subsequent tyrosine 
phosphorylation. Upon phosphorylation, STAT1 translocates to the nucleus and binds the GAS 
(gamma activated site) present in the promoter of its target genes such as the interferon 
regulatory factor 1 (IRF1) (Lucas et al., 1998; Schroder et al., 2004). 
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1.6.1.2.2 Alternatively activated macrophages  
AAMs subgroup a (AAMa) are produced following stimulation with IL-4 or interleukin-13 (IL-13). 
IL-4 is a cytokine produced predominantly by eosinophils but also by the cluster of differentiation 
4 (CD) 4+ T helper cells and basophils. In vitro assays have shown that stimulation of BMDM with 
20 ng/ml of IL-4 and IL-13 for 30 minutes induces STAT6 tyrosine phosphorylation through JAKs 
1 and 3.  Following its phosphorylation, STAT6 dimerizes and migrates to the nucleus where it 
regulates expression of AAM markers.  
AAMa express several genes whose regulation is dependent on IL-4 signaling. These include, 
among others, arginase 1 (Arg1), chitinase 3 like 3 (Chi3l3) (Hebenstreit et al., 2006; Welch et al., 
2002) and “found in inflammatory zone 1” (Fizz1) (also known as resistin-like molecule alpha 
(Relmα) (Hebenstreit et al., 2006; Stütz et al., 2003)) which have the STAT6 consensus 
sequence in their promoters and are therefore direct targets of STAT6. The mannose receptor 
(MR) (also known as mannose receptor C type 1 (MRC1)) gene expression is also up-regulated 
upon IL-4 treatment but is not a direct target of STAT6 since the consensus sequence is absent 
in the IL-4 responsive element on the MR promoter. However, STAT6 is indirectly implicated in 
the regulation of IL-4-induced MR expression (Stein et al., 1992; Egan et al., 2004). Other genes 
have been implicated in the induction of AAM polarization. These include the jumonji domain 
containing 3 (jmjd3) (Satoh et al., 2010) and the nuclear hormone transcription factor peroxisome 
proliferator-activated receptor-ɣ (PPARɣ). Jmjd3 has been shown to regulate AAM polarization 
independently of STAT6. PPARɣ mRNA and protein expression are increased upon IL-4 
treatment in peritoneal macrophages (Huang JT et al 1999). Additionally, there is a physical 
interaction between STAT6 and PPARɣ upon IL-4 signaling that increases PPARɣ binding to the 
promoter of its target genes including the fatty acid binding protein 4 (FABP4).  
AAMb markers are induced by toll-like receptor and interleukin 1 receptor antagonist. They mainly 
include IL-6, IL-10 and CCL1. AAMc are polarized by IL-10 and express chemokine markers such 
as chemokine (C-X-C motif) ligand (CXCL)13  (Hao et al., 2012; Benoit et al., 2008). A more 
complete list of the most common genes and metabolites that are used to define the various 
macrophage polarization phenotypes is listed in table 1.2. Some of these macrophage markers, 
including cell surface receptors, enzymes, metabolites, cytokines and chemokines are described 
in more detail in the following paragraphs. 
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CAM AAMa AAMb AAMc 
Cell surface receptors: 
IL1RI, MHCII, CD80, 
CD86, TLR2, TLR4 
Cell surface receptors: 
MRC1, CD163, MHCII, 
CHI3L3, FIZZ1, JMJD3 
Cell surface 
receptors: 
MHCII, CD86 
Cell surface 
receptors: CCR2, 
CD163, TLR1, 
TLR8 
Enzymes: INOS Enzymes: Arginase 1   
Metabolites: NO, L-
citrulline 
Metabolites: Urea, L-
ornithine 
  
Cytokines: TNF, IL1, 
IL6, IL12, IL23 
Cytokines: IL1Rα, IL10, 
TGF 
Cytokines: 
TNF, IL1, IL6, 
IL10 
Cytokines: IL1Rα, 
IL10, TGF 
Ligands: CCL2, CCL3, 
CCL4, CCL5, CCL8, 
CCL9, CCL10, CCL11 
Ligands: CCL17, CCL18, 
CCL22, CCL24 
Ligands: CCL1 Ligands: CCL16, 
CCL18 
Chemokines: CXCL8, 
CXCL9, CXCL10, 
CXCL11, CXCL16 
  Chemokines: 
CXCL13 
 
Table 1.2 Summary of differentially expressed genes encoding growth factors, cytokines, 
surface receptors and chemokines as well as the final products of L-arginine metabolism 
of classically and alternatively activated macrophages. L-arginine is converted into nitric oxide 
(NO) and L-citrulline following digestion with INOS (inducible nitric oxide synthase) in CAMs and 
into urea and L-ornithine following its hydrolysis by arginase-1 in AAMa (Benoit et al., 2008; Hao et 
al., 2012). The full name of these abbreviations is presented in the list of abbreviation at the 
beginning of this thesis. 
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1.6.1.3 Macrophage surface receptors 
Macrophages are characterized by specific cell surface proteins that distinguish them from other 
cells of the immune system and therefore define their specific activities and role in the immune 
system. These cell surface receptors determine macrophage activities such as growth, 
differentiation, migration and secretion. The first receptors to be identified are the Fc receptors of 
Igs and the complement receptors. Additionally, macrophages possess G protein-coupled 
receptors and receptors for many cytokines and activation of these cytokines upon ligand binding 
induces intracellular signaling pathways that involve downstream activation of protein kinases and 
a subsequent phosphorylation of proteins. In this section, the function of some of these surface 
receptors will be addressed. 
The complement receptors are involved in opsonisation. Opsonisation is a process that 
involves the binding of an opsonin molecule such as an antibody to the epitope of an antigen. The 
opsonin-antigen complex is then recognized by a macrophage which will deposit complement 
components such as the complement component 3 b (C3bi) on the pathogen surface aiding in its 
destruction. These complement receptors include the clusters of differentiation (CD) 11b and 11c. 
CD11b: The complement receptor 3 or CR3 (CD11b/CD18), also known as Mac-1, is an α/ 
glycoprotein that belongs to the 2 integrin superfamily of cell surface receptors. It recognizes 
C3bi, mediates macrophage adhesion, aids macrophage migration to the site of inflammation and 
induces their phagocytic capacity (Springer et al., 1979; Rosen and Gordon, 1987; Arnaout, 
1990). CD11b is also present on granulocytes. 
CD11c: Another receptor of the integrin superfamily, also known as complement receptor 4 
(CR4), also recognizes C3bi. It is expressed in inflammatory macrophages but more abundantly 
in dendritic cells. Dendritic cells are innate immune cells with antigen presenting properties as 
they process antigens and present them on their cell surface to other cells of the immune system 
such as T cells (Hume, 2008).  
 
Adhesion G protein-coupled receptors include the F4/80 receptor. 
F4/80 antigen is a cell surface glycoprotein that belongs to a subtype of G-coupled protein 
receptors (Austyn and Gordon, 1981; McKnight et al., 1996).  It is involved in cell-cell interaction 
and transduction of extracellular stimuli including cytokines and hormones. F4/80 antigen is 
specific to macrophages and is absent in granulocytes and T cells.  EMR1 is the human homolog 
of F4/80. 
 
Cytokine receptors: The cytokine receptors found on macrophages include those for TNFα, 
INFγ, IL-4 and macrophage colony stimulating factor (M-CSF) receptors. These cytokines, albeit 
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not all produced by macrophages, bind to macrophages and affect their function. The IL-4 
receptor and its signaling pathway are discussed in section 1.13 of this chapter. 
 
M-CSF receptor (M-CSFR) (also known as CSF1R) belongs to the family of tyrosine kinase 
receptors. M-CSF is the ligand for M-CSF receptor and is produced by fibroblasts, osteoblasts 
and macrophages. It induces monocyte and macrophage growth and differentiation and is also 
implicated in macrophage chemotaxis and phagocytosis. It induces production of TNFα, INFγ and 
the inflammatory lipid prostaglandin E2 (PGE2) (Kawasaki and Ladner, 1990).  
The INFγ receptor belongs to the hematopoietic cytokine family of receptors. Its ligand INFγ is 
produced by natural killer cells and T cells and acts on macrophages to enhance the respiratory 
burst and major histocompatibility complex II (MHCII) expression (Schroder et al., 2004). 
The TNF receptor is composed of two receptors TNFR1 and TNFR2 which bind TNFα as 
discussed earlier in 1.6.1.2.1. TNFα is produced by inflammatory macrophages but also other 
cells of the innate immune system such as mast cells and lymphocytes. In macrophages, it 
induces chemotaxis and phagocytosis as well as release of PGE2. TNFα is produced in response 
to many stimuli including bacterial LPS, a wall component of the Gram-negative bacteria. 
Activation of TNFα receptors triggers activation of multiple inflammatory signaling pathways such 
as the JNK and the NF-κB signaling pathways (Parameswaran and Patial, 2011). The signaling 
mechanisms of these pathways are discussed in section 1.15. 
NF-κB activation occurs when the NF-κB inhibitor IκBα undergoes proteosomal degradation 
following its serine phosphorylation by the protein kinase IKK (Davis et al., 2005). NF-κB 
translocates to the nucleus where it acts as a transcription factor and regulates expression of 
many inflammatory genes including Tnfα and Inos. At the cellular level, both JNK and NF-κB 
pathways regulate expression of genes responsible for cell proliferation, differentiation and 
survival.  
 
Hormone receptors including those of the receptor tyrosine kinase family such as the insulin 
receptor are also present on the surface of macrophages. Insulin signaling in macrophages will 
be discussed in section 1.14 entitled “Insulin and IL-4 signaling in macrophages”. 
 
Lectin-like superfamily of receptors includes the MR and the macrophage C-type lectin domain 
family 10 member A (CLEC10a) known as CD301 or macrophage galactose N-acetyl-
galactosamine specific lectin 1 (MGL) that recognize oligosaccharides present on the surface of 
infectious agents such as microbes. These two surface receptors are specifically expressed on 
the surface of alternatively activated macrophages after IL-4 treatment (Nguyen et al., 2011). 
These interactions are important in mediating endocytosis and phagocytosis of the infectious 
agent (Chawla, 2010). 
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1.6.1.4 Secretory products of macrophages 
Macrophages play a crucial role in the regulation of immune responses and the development of 
inflammation by secreting multiple products including enzymes, cytokines, chemokines and 
metabolites. When they metabolize the amino acid arginine into ornithine they play a role in 
wound healing and repair and are AAMs. When arginine is metabolized into nitric oxide they are 
CAMs or killer macrophages and play a role in the destruction of foreign particles.    
1.6.1.4.1 Enzymes produced and secreted by macrophages 
Lysozymes  
Lysozymes belong to the glycoside hydrolase family of enzymes and mediate the hydrolysis of 
the cell wall of some bacteria especially Gram positive bacteria like Bacillus and Streptococcus. 
Unlike the human genome that encodes only one lysozyme gene, the murine genome encodes 
for two lysozyme genes, the lysozyme M gene expressed in macrophages and granulocytes and 
the lysozyme P gene expressed in Paneth cells of the intestine. Lysozyme M mRNA is most 
highly expressed in differentiated macrophages, and to a lesser extent in immature macrophages 
(Cross et al., 1988).  
 
Arginase 1 (ARG1) is an enzyme that belongs to the ureohydrolase superfamily of enzymes. It 
catalyzes the final step in the urea cycle where it converts the amino acid L-arginine into urea and 
ornithine through the following reaction: 
 
L- Arginine + H2O                Urea + Ornithine 
 
The urea cycle consists of a series of biochemical reactions with the final purpose of converting 
ammonia into urea, which is less toxic to the body. Any perturbations in the urea cycle causes 
increased ammonia levels which results in high toxicity in the body and can cause death (Morris, 
2002). This enzyme is encoded by the Arg1 gene. In addition to its abundant expression in the 
liver, ARG1 is expressed in other tissues and cells such as primary macrophages and 
macrophage cell lines upon inflammatory and anti-inflammatory stimuli. Unlike its high basal 
expression in liver, Arg1 expression in macrophages is low and only increases following external 
stimuli such as stimulation with the Th2 cytokine IL-4. This is dependent on the STAT6 
transcription factor that directly binds the Arg1 promoter. Therefore, its expression is a useful 
marker for alternatively activated macrophages. In addition to STAT6, the Arg1 promoter has 
binding sites for CCAAT-enhancer binding protein β (CEBPβ) (Gray et al., 2005) and KLF4 
transcription factors (Liao et al., 2011) which cooperate with STAT6 to induce Arg1 gene 
expression. Additionally, Arg1 expression increases in BMDM following LPS stimulation. The 
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increased Arg1 expression is accompanied by increased ARG1 activity and is maximal after 24 
hours of LPS treatment. The signaling mechanisms leading to increased Arg1 expression upon 
both stimuli are different. Treatment with LPS activates the TLR-Myd88 (myeloid differentiation 
primary response 88) signaling pathway, whereas IL-4 induced Arg1 expression is STAT6 
dependent. Nonetheless, both mechanisms activate CEBPβ to induce its expression (Menzies et 
al., 2010).   
Mice lacking Arg1 in myeloid cells show increased levels of tissue nitric oxide (NO) when infected 
with Myobacterium tuberculosis. In fact, ARG1 competes with INOS, an enzyme that uses 
arginine to produce nitric oxide (NO) (Luiking et al., 2012; Pesce et al., 2009; Morris, 2002). 
Macrophage secretion of ARG1 leads to suppression of L-arginine resulting in 
immunosuppression through inhibition of T cell proliferation.  It also increases the cytotoxic 
activity of macrophages against bacteria and viruses and tumor cells (Munder, 2009). 
 
Inducible nitric oxide synthase (INOS) is an enzyme that catalyzes the conversion of arginine 
into NO and citrulline via the following reaction:  
 
L-Arginine+ 3/2 NADPH +H
+
 +2O2   Citrulline +NO+ 3/2 NADP
+
 
 
INOS is encoded by the Inos gene which is highly expressed in macrophages upon inflammatory 
stimulation such as that seen with LPS, TNFα and INFɣ. It is therefore considered an 
inflammatory marker. Its promoter is a direct target for NF-κB transcription factor (Morris et al., 
2003; Davis et al., 2005).  
NO is a free radical and is an important signaling molecule as it regulates many physiological 
processes. High ARG1 levels inhibit nitric oxide production by macrophages and therefore the 
ability of the organism to fight some bacteria and parasites (Rosselli et al., 1998). 
1.6.1.4.2 Chemokine ligands produced by macrophages  
CCL2 is produced by monocytes, macrophages and dendritic cells during inflammation. It is the 
ligand for both chemokine receptors 2 and 4 (CCR2 and CCR4) present on the surface of 
monocytes, T cells and basophils. It plays a role in the pathogenesis of obesity including insulin 
resistance and atherosclerosis (Mita et al., 2011; Mauer et al., 2010).  
CCL3 is produced by inflammatory macrophages and plays a role in the recruitment of immune 
cells to sites of inflammation. It binds CCR1 and CCR5 present at the cell surface of 
macrophages (Kaufmann et al., 2001) and other immune cells including T cells. Mouse studies 
have implicated the role of this chemokine in the development of atherosclerotic lesions as well 
as adipose tissue expansion and the control of leptin and insulin levels (Kennedy et al., 2012). 
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The chemokine C-C ligand 8 (CCL8) also known as monocyte-chemoattractant protein 2 
(MCP2) is a chemokine produced by multiple cell types including fibroblasts and mononuclear 
cells of the circulation. It is secreted during allergic reactions by recruiting eosinophils and 
basophils and during inflammation by activating natural killer (NK) cells and T cells. Like CCL3, 
CCL8 binds to the chemokine receptors CCR1 (Gong et al., 1997).  
1.6.1.4.3 Cytokines produced and secreted by macrophages 
IL-6, IL-1β and TNFα belong to the same family of pro-inflammatory cytokines. They are all 
produced and secreted by macrophages in response to inflammatory signaling molecules that 
activate the toll-like receptor signaling cascades (discussed in section 1.15). Their gene 
promoters contain an NF-κB binding site and they are therefore direct targets for the transcription 
factor NF-κB (Libermann and Baltimore, 1990; Hiscott et al., 1993; Collart et al., 1990).  
In addition to the role of IL-6 in regulating inflammatory responses (van der Poll et al., 1997), its 
systemic levels in mice have been shown to directly contribute to the regulation of energy 
homeostasis. In fact, BAT transplantation into HFD-fed recipient mice improves their overall 
metabolic phenotype in an IL-6 dependent manner (Stanford et al., 2013).  
Transplantation experiments of mesenteric fat from IL-1β knock-out mice into recipient mice 
reduces glucose levels during a pyruvate challenge test compared to mice receiving fat from wild-
type (WT) donors. Additionally, HFD-fed IL-1β knock-out mice show decreased macrophage 
number in their epididymal adipose tissue compared to WT mice on HFD (Nov et al., 2013).  
TNFα is another inflammatory cytokine which expression levels are increased in the AT of obese 
rodents (Hotamisligil et al., 1993). In a transgenic mouse model of increased NF-κB p65 
transcriptional activity in adipose tissue (aP2-p65 mice), there was increased serum levels of 
TNFα, IL-6 and IL-1 associated with increased systemic inflammation, and increased 
macrophage infiltration in the adipose tissue (Tang et al., 2010).  
1.6.1.4.4 Metabolites produced by macrophages and implicated in their function  
Ornithine: As discussed above, ornithine is an amino acid that is a product of the conversion of 
L-arginine into urea via arginase 1. The production of ornithine is essential for the synthesis of 
polyamines and proline in the cytosol. The latter is essential for collagen synthesis and tissue 
regeneration. Ornithine crosses the mitochondrial membrane through the ornithine transporter 
(ORNT1) and induces the production of glutamate in the mitochondria (Luiking et al., 2012) 
(Figure 1.3). 
Citrulline: An amino-acid that can be synthesized from ornithine via ornithine transcarbamylase 
(OTC) as an intermediate product of the urea cycle or from L-arginine to produce NO via INOS 
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(Figure 1.3). Citrulline can lead to the formation of arginine in many cell types of the body via two 
main enzymes: arginosuccinate synthase (ASS) and arginosuccinate lyase  (ASL) (Morris, 2007). 
It is an essential intermediate in the urea cycle and participates in the detoxification process of 
ammonia. 
Arginine: Considered as a non-essential amino acid under basal conditions when it is sufficiently 
present in a healthy organism. However, under conditions of stress such as inflammation or 
infection, arginine levels become insufficient to meet metabolic demands and therefore arginine is 
classified as an essential amino acid. Decreased arginine levels have been shown to alter 
expression of INOS. This is a result of increased serine/threonine kinase activity of general 
control non repressed 2 (GCN2) and a consequent phosphorylation of the eukaryotic initiation 
factor 2 α (EIF2α) that inhibits the initiation of Inos mRNA translation into protein (Morris, 2007).   
Both ornithine and citrulline levels were found to be increased in the plasma of obese mice, while 
arginine bioavailability (arginine to ornithine plus citrulline ratio) was reduced (Sailer et al., 2013). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 Interaction between the urea cycle and the arginine-nitric oxide cycle 
Adapated from (Luiking et al., 2012) 
ARG: Arginine, ASL: Arginosuccinate Lyase, ASS: Arginosuccinate Synthase, ASP: Aspartate, CIT: 
Citrulline, GLU: Glutamate, GLN: Glutamine, ORN: Ornithine, ADMA: Asymetric dimethyl arginine, 
DDAH: Dimethylaminohydrolase, FAD: Flavin adenine dinucleotide; FMN: Flavin mononucleotide, 
OTC: Ornithine transcarbamylase. 
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1.6.1.5 Macrophage migration into the AT 
1.6.1.5.1 Cellular changes in the obese AT 
As the AT expands during the development of obesity, the individual adipocytes enlarge and 
become hypertrophic. This creates hypoxic sites in the AT and therefore the AT becomes poorly 
oxygenated. Hypoxia up-regulates the production of many inflammatory markers such as those 
involved in angiogenesis including vascular endothelial growth factor (VEGF) and the matrix 
metalloproteinases MMP2 and MMP9. With hypertrophy and hypoxia, the adipocyte also 
becomes necrotic and this in turns triggers the migration of macrophages as professional 
phagocytes into the AT. Macrophages accumulate around dead adipocytes and form crown-like 
structures. They then fuse with adipocyte lipid droplets and phagocytose them thus forming a 
multinucleated syncytia containing large lipid droplets, which are a hallmark of the chronic 
inflammation observed in late stages of obesity (Sun et al., 2011).   
1.6.1.5.2 Molecular and biochemical changes in the obese AT 
The migration of macrophages into AT is highly dependent on cross-talk between macrophages 
and adipocytes. Following hypoxia, cells of the AT (pre-adipocytes, adipocytes, endothelial cells 
and macrophages) secrete small inflammatory molecules such as chemokines that attract 
monocytes into the hypoxic sites. These monocytes migrate into the AT where they differentiate 
into macrophages. Among these chemokines, CCL2, CCL3 and CCL8 showed increased 
expression in the WAT of obese mice (Sun et al., 2011). Adipose tissue CCL2 plays a central role 
in the development of insulin resistance. It participates in the recruitment of monocytes into the 
adipose tissue during obesity. Initial studies showed that Ccl2 mRNA levels and CCL2 plasma 
concentration levels are increased in the AT of obese diabetic db/db mice as well as diet-induced 
obese mice. Mice that over-express CCL2 in their AT, showed increased fasted blood glucose 
levels and are more glucose intolerant and insulin resistant than control mice. In addition, CCL2 
knock-out mice are protected from HFD-induced insulin resistance and glucose intolerance 
without reduction in their body weight  (Kanda et al., 2006). However, another study conducted in 
2008 has challenged these findings. In this study, CCL2 knock-out mice fed a HFD gained 
significantly less body weight than control mice. However, they did not show any improvement in 
their glucose and insulin tolerance compared to the control mice on HFD (Kirk et al., 2008). 
These findings indicate complexity in the precise role of CCL2 in the pathophysiology of obesity 
and insulin resistance.  
CCL3 is secreted by macrophages and attracts neutrophils. Subcutaneous injection of high doses 
of CCL3 into mouse footpads induced inflammation characterized by neutrophil infiltration (Wolpe 
et al., 1988). However, a recent study indicated that while the expression levels of a macrophage 
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marker were increased in the WAT of western diet-fed mice, CCL3 expression levels were 
unchanged, dissociating CCL3 expression from macrophage accumulation (Surmi et al., 2010).  
Increased macrophage accumulation in the AT, as a consequence of a demand of the tissue to 
get rid of the excess dead adipocytes, is associated with a biological process called lipolysis 
(Kosteli et al., 2010). Lipolysis is the process by which triglycerides break down by hydrolysis into 
glycerol and free fatty acids and is the sum of basal lipolysis and demand lipolysis. Basal lipolysis 
is defined by the total amount of AT triglyceride content, whereas demand lipolysis is determined 
by the release of free fatty acids in response to certain stimuli, the most important of which are 
catecholamines. Obese mice with high basal lipolysis have increased adipose tissue macrophage 
(ATM) accumulation compared to lean mice. During weight loss, as basal lipolysis decreases 
macrophage content in the adipose tissue decreases too (Kosteli et al., 2010).  
1.6.1.5.3 Adipose tissue macrophages in the regulation of energy homeostasis 
ATMs are a very heterogeneous cell population because of their multiple origins. As the origin of 
tissue macrophages can be varied (fetal liver, yolk sac and bone marrow) as discussed 
previously, these macrophages can be resident cells or newly recruited from the bone marrow. 
Previously it was thought that the latter are the main ones implicated in adipose tissue 
inflammation since monocytes migrate from the circulation to the hypoxic site of the AT. However, 
recent studies have shed light on the role of resident macrophage in this process. More 
specifically, the in situ proliferation of resident macrophages has been associated with the 
inflammation setting of obesity and has emphasized an important role of CCL2 in this process 
(Amano et al., 2014). 
Despite the fact that CAM/AAM classification was established using large in vitro based 
characteristics, it is also used in vivo to characterize tissue macrophages and define their roles in 
disease states. CAMs and AAMs are characterized by different gene expression profiles following 
the nature of the external stimuli and therefore acquire various morphological and functional 
properties. 
CAMs are mainly present in AT of obese mice with insulin resistance. Mice fed a HFD for 20 
weeks and ob/ob mice manifest an increased population of F4/80 positive and
 
CD11c positive 
 
cells with increased expression of inflammatory markers including IL-6 and INOS (Lumeng et al., 
2007a; Lumeng et al., 2007b). AAMs are implicated in tissue repair and they are abundant in AT 
of lean mice. Interestingly, AAMs have been shown to play a crucial role in regulating energy 
homeostasis by promoting local and systemic insulin sensitivity and those are most likely to be 
resident macrophages (Chawla et al., 2011; Nguyen et al., 2011; Osborn and Olefsky, 2012; Wu 
et al., 2011). Recently a novel role for ATM in the regulation of energy homeostasis has been 
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proposed as it has been shown that acclimatisation of mice to cold increases the alternative 
macrophage signature in BAT and WAT depots. These AAMs in turn produce norepinephrine to 
sustain cold-induced thermogenesis. Macrophage norepinephrine account for 50% of total 
catecholamines content in WAT and BAT (Wynn et al., 2013). 
Cold-dependent-alternative activation of macrophages is triggered by the IL-4/STAT6 signaling 
cascade since STAT6 knock-out mice and mice lacking the IL-4Rα in macrophages have 
impaired thermogenesis upon cold exposure. This is primarily dependent on the expression of 
STAT6 target genes mainly Arg1, Mrc1 and Clec10A. Catecholamines released by macrophages 
increase lipolysis in WAT and the expression of thermogenic markers in the BAT.   
Additionally, TH, the key enzyme in the synthesis of catecholamines was found to be increased in 
peritoneal macrophages upon IL-4 treatment and in the ATM of mice exposed to cold. BMDM 
treated with IL-4 showed increased norepinephrine secretion in their media compared to non-
treated BMDM whereas the hormonal content in ATM of mice exposed to cold were not altered. 
LPS treatment induced a slight increase in norepinephrine levels in BMDM. In this study, the 
hormone levels were measured by enzyme linked immunosorbent assay (ELISA). ATM showed 
increased mRNA and protein levels of Arg1, Mrc1 and Clec10a upon cold exposure (Nguyen et 
al., 2011). 
An earlier study has demonstrated increased TH expression in alveolar macrophages following 4 
hours of stimulation with 30 ng/ml of LPS. Dopamine β hydroxylase mRNA expression levels 
were also found to be increased in these LPS-treated cells. Both epinephrine and norepinephrine 
were detected earlier in the secreted media following 15 minutes of LPS treatment  (Flierl et al., 
2007). 
These findings on the role of AAM in switching on the adaptive thermogenesis in BAT and the 
lipolysis of stored triglycerides in WAT add to the role of the hypothalamus in triggering cold-
induced thermogenesis. These findings suggest additional complexity in the role of macrophages 
in the regulation of energy homeostasis and provide a new mechanism by which macrophages 
may influence metabolism.   
The concept of ATM classification should be taken with caution specifically that some studies 
have revealed that AAM are correlated with obesity in humans. These studies were conducted on 
subcutaneous adipose tissue from obese healthy humans which revealed high mRNA expression 
of AAM and not CAM markers in these tissues. The differences in ATM signature between obese 
mice and humans might be explained by the development of insulin resistance which is a 
consequence of obesity in HFD-fed mice but absent in the healthy obese humans (Lee, 2013; 
Bourlier et al., 2008). 
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1.6.2 Role of other innate immune cells in metabolism 
In addition to macrophages, other innate immune cells, including mast cells and granulocytes 
have also been implicated in obesity-induced metabolic aberrancies although their precise roles 
remain to be defined. Similar to macrophages, mast cells and granulocytes also have 
inflammatory properties. 
1.6.2.1 Mast cells  
In addition to their main role in allergic response, the abundance of immunoglobulins E (IgE) on 
the cell surface of mast cells has broadened their function to cover diverse areas such as the 
regulation of metabolic diseases. The first observation suggesting a role of mast cells in obesity 
was made in 1963 when it was found that the number of mast cells increased by 4 fold in the 
obese adipose tissue compared to their lean counterparts (Hellman et al., 1963). This was 
recently confirmed in both humans and mice. In human WAT sections, immunostaining with mast 
cell tryptase revealed a higher number of mast cells in the obese WAT compared to the lean 
subjects (Zhang and Shi, 2012). Genetic evidence for a role of mast cells in metabolism has 
come from the study of mice deficient in mast cells. These mice harbor a mutation in the promoter 
region of the gene encoding C-KIT (also known as CD117), a receptor for C-KIT ligand required 
for mast cell proliferation, differentiation and survival. When fed a western diet these animals 
displayed an improvement of their glucose homeostasis accompanied with increased energy 
expenditure, reduced visceral and subcutaneous fat content as well as reduced body weight (Liu 
et al., 2009). 
1.6.2.2 Granulocytes 
Granulocytes constitute 60-70% of total white blood cells and there are three types; eosinophils, 
neutrophils and basophils.  
Eosinophils 
Similar to mast cells, the biological functions of eosinophils have been recognized to be much 
broader than their role in allergy and the response to parasitic infections such as intestinal 
helminths. In fact, in developed countries where the prevalence of the metabolic syndrome is high 
and helminth infection is low, the number of eosinophils is low. This observation further 
consolidated the relationship between immunity and metabolism and established a new role for 
eosinophils in the regulation of energy homeostasis. In WAT, eosinophils are the main cells 
producing the anti-inflammatory cytokine IL-4 and IL-13 which induce differentiation of ATM into 
AAMs. In mouse models with genetic deficiency of eosinophils, the number of AAMs is greatly 
reduced as shown by the reduced number of arginase-1-expressing macrophages. This is 
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accompanied with increased inflammation in their WAT resulting in insulin resistance when these 
mice are fed a high fat diet (Wu et al., 2011). 
Hypereosinophilic IL-5 transgenic mice have an increased number of eosinophils in their 
perigonadal WAT as observed by immunohistochemistry (IHC) of siglec-F, an eosinophil marker 
in WAT sections. As a consequence, these mice have reduced visceral WAT and better glucose 
tolerance compared to control mice on chow diet. In separate studies it has been shown that 
inducing an increased eosinophil count in HFD-fed mice by infecting them with the parasite 
Nippostrongylus brasiliensis led to a decreased number of CAMs. This was accompanied with 
reduced perigonadal WAT mass and body weight and an associated improvement in their 
glucose levels and insulin sensitivity (Wu et al., 2011).  
Neutrophils  
Neutrophils are the most abundant granulocytes (~90% of total granulocytes). As suggested by 
some studies (Elgazar-Carmon et al., 2008; Talukdar et al., 2012), neutrophils are the first 
immune cells to migrate into the AT when mice are fed a HFD since adipocytes produce 
cytokines such as interleukin-8 that attract neutrophils. Consequently, their numbers increase in 
the WAT as soon as three days of HFD feeding and remains high throughout the development of 
obesity. The increased number of neutrophils was determined by flow cytometry staining of the 
neutrophil markers the granulocyte differentiation antigen (Gr-1) and CD11b in the WAT stromal 
vascular fraction (SVF) from diet-induced obese mice. Staining for F4/80 and CD11c, two 
inflammatory macrophage markers was negative at this time point. 
Once in the AT, neutrophils produce chemokines and inflammatory cytokines that facilitate 
inflammatory macrophage migration which then contribute to insulin resistance. For example, 
neutrophil elastase is a protease produced by neutrophils and is a regulator of inflammation.  
Mice with genetic deletion of neutrophil elastase gained significantly less body weight, and had 
higher oxygen consumption and core body temperature when challenged with HFD compared to 
control mice. Additionally, they had improved glucose tolerance and insulin sensitivity. The 
improved insulin action was due to increased insulin-stimulated AKT phosphorylation in the liver 
and WAT of these mice. Consistently, IRS1 levels were higher in the liver of these mice 
compared to control mice as measured by western blotting (Talukdar et al., 2012).  
Basophils  
Basophils are the least abundant cells in the blood and they have been implicated in inflammatory 
and allergic reactions. Recent studies have found a positive correlation between basophil number 
and body mass index (BMI) in healthy subjects (Johannsen et al., 2010).  Nonetheless, there are 
no reports yet that indicate the role of adipose tissue basophils in obesity and insulin resistance 
(Johnson et al., 2013).  
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1.7 Adaptive immune cells in obesity-induced type-2 diabetes 
Early observations indicated that human BMI correlated with transcript levels of the cluster of 
differentiation 3 (CD3), an antigen specific to mature T cells. This occurred in their VAT 
suggesting T cell infiltration in obesity. In fact, several groups have demonstrated that T cells 
infiltrate into the fat several weeks before the ingress of macrophages. However, there are 
conflicting results regarding the kinetics of T cells enrichment in the AT of mice during the onset 
of HFD-induced obesity. Some studies have indicated that Th1 cells infiltrate the perigonadal 
WAT of mice on HFD before the accumulation of ATMs (Lumeng et al., 2009). However, this 
observation was contradicted by another study that suggested that a significant T cell enrichment 
is subsequent to ATM accumulation and occurs only after 20-22 weeks on HFD. In contrast, 
macrophages were enriched by week 8 (Strissel et al., 2010). Both studies used different 
approaches to quantify the number of T cells in the perigonadal AT. The first study stained for 
CD3 by immunohistochemistry in perigonadal AT sections whereas the second study used flow 
cytometry to quantify the number of CD3+ cells in the stromal vascular fraction of perigonadal 
WAT. Additionally, expression of the Th1 inflammatory marker INFγ was determined by real time-
polymerase chain reaction (RT-PCR). Both studies used C57Bl/6J male mice and the same fat 
content in their HFD (60% energy (Kcal) from fat) and yet they yielded different results. Perhaps 
the fact that two different techniques were used to quantify CD3+ cells explains the discrepancy 
in the time-course of T cell recruitment into the adipose tissue.   
Despite these controversies, increased numbers of Th1 cells in AT are detected in obese mice 
(Rocha et al., 2008) and humans as determined by increased numbers of Th1-INFγ-secreting 
cells. This proinflammatory Th1 signature coincides with insulin resistance. In addition to their 
function as inflammatory Th1 cells, CD4+ cells can be CD4+ T helper 2 (Th2) cells and T 
regulatory cells (Tregs) which produce anti-inflammatory cytokines. During obesity, there is an 
imbalance in the ratio of Th1 versus Th2 and Tregs cells. For instance, the number of CD4+ 
Foxp3+ Tregs cells is high in lean VAT but significantly decreased in insulin-resistant models of 
obesity. A linear correlation between the number of CD4+ Foxp3+ Tregs cells and the homeostasic 
model assessment for insulin resistance (HOMA-IR) has been described since ob/ob mice with 
the highest HOMA-IR showed a very small percentage of these cells compared to other mouse 
models of obesity. Gain of function experiments of Tregs cells in VAT by daily injection of an IL-2 
complex into mice on HFD rescued them from obesity-induced glucose intolerance (Feuerer et 
al., 2009). Grafts of CD4+ and CD8+ T cells into Rag1-null mice (mice with no mature T and B 
lymphocytes) on HFD results in an overall improvement of their glucose homeostasis associated 
with a drop in their body weight. These metabolic improvements were due to the activity of CD4+ 
T cells and suggest a cross-talk between these cells and some subsets of macrophages to 
control insulin sensitivity (Winer et al., 2009). Additionally, mice lacking the transcription factor T-
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bet, a master transcription factor that directs T cells into Th1 lineage, showed increased visceral 
adiposity, leptin levels and reduced energy expenditure yet they were more insulin sensitive on 
both chow and HFD. This uncoupling between adiposity and insulin action was accompanied by 
reduced numbers of CD3+CD4+ immune cells and molecules responsible in T cell trafficking as 
well as reduced secretion of adipose tissue INFγ (Stolarczyk et al., 2013). 
 
1.8 Mouse models with alterations in insulin and cytokine signaling 
pathways in myeloid lineages with a focus on macrophages. 
Despite the great efforts developed to elucidate the role of ATM in obesity-induced inflammatory 
changes and the regulation of energy homeostasis, a perfect model to target these cells has not 
been established and many questions remain unresolved. The use of genetic mouse models has 
some technical limitations although they provide useful information regarding the role of certain 
genes and their involvement in the regulation of multiple signaling pathways. For example, the 
use of global knock-out mouse models poses challenges in interpretation since they target every 
single cell in the body. Therefore, their use does not give insights into the role played by genes in 
specific cells or tissues at certain times during a mouse’s development and lifespan.  
Bone marrow transplantation strategies in chimeric mice have some advantages over knockout 
mice since they provide information on the role played by immune cells compared to other cells in 
the body. Nonetheless, this approach does not target a specific cell in the immune system so the 
contribution of multiple inflammatory immune cells cannot be distinguished, for example in the 
development of insulin resistance and energy homeostasis. The best approach to target specific 
cells and study their gene functions is based on the Cre-loxP technology. The lysozyme M Cre 
mouse model is the most successfully used to study macrophage function. In fact, as explained in 
detail in the methods section (chapter 2), the lysozyme M Cre driver deletes in myeloid lineages, 
specifically macrophages and granulocytes (Clausen et al., 1999). Since macrophages have 
been shown to play a significant role in metabolism compared to granulocytes, studies using this 
mouse model have focused on macrophages. 
    
Below is table 1.3 showing mouse models with conditional gene targeting in lysozyme M Cre 
mice, the phenotypic characteristics of these mice compared to control mice as well as the 
cellular and/or molecular mechanisms underlying these changes.  
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Gene name Phenotype Mechanism Reference 
Ikk-β, the 
activator of 
NF-κB 
Improved insulin 
sensitivity,  GIR 
and lower HGP on 
HFD, improved 
GTT and ITT upon 
LPS injection 
Decreased NF-κB 
signaling and IL-1 
production 
(Arkan et al., 2005) 
JNK Protected from 
obesity-induced 
insulin resistance 
but develop obesity 
Increased AKT 
phosphorylation in 
liver, muscle and 
WAT. Reduced 
macrophage 
infiltration in adipose 
tissue 
(Han et al., 2013) 
Insulin 
receptor 
Protected from 
obesity-induced 
insulin resistance 
but develop obesity 
Reduced JNK activity 
in skeletal muscle 
and reduced ATM 
number, reduced 
MMP9 expression 
(Mauer et al., 2010) 
IL4rα They do not 
manifest increased 
energy expenditure 
upon IL-4 
administration 
unlike control mice  
Reduced TH protein 
levels in both BAT & 
WAT upon 
exogenous IL-4 
treatment 
(Nguyen et al., 2011) 
53 
 
SOCS1 Glucose 
intolerance, 
hyperinsulinemia , 
increased HGP and 
increased serum 
concentrations of 
inflammatory 
cytokines 
Reduced IRS1 
tyrosine 
phosphorylation, and 
AKT phosphorylation 
in the liver 
(Sachithanandan et al., 
2011) 
PPARγ Glucose intolerance 
, insulin resistance 
and increased HGP 
Reduced IRS1 
tyrosine 
phosphorylation and 
AKT serine 
phosphorylation, 
increased IKKα/β 
serine and JNK 
threonine/tyrosine 
phosphorylation in 
liver and skeletal 
muscle 
 
(Hevener et al., 2007) 
ERα Glucose 
intolerance, insulin 
resistance, obesity 
and atherosclerotic 
lesions 
Reduced AKT 
phosphorylation in 
adipocytes, 
increased JNK 
phosphorylation in 
liver. Reduced 
macrophage LPS-
phagocytosis 
capacity  
(Ribas et al., 2011) 
PPARδ Obesity, insulin 
resistance, hepatic 
steatosis on HFD 
Reduced AKT and 
STAT6 activity in 
WAT. Increased 
CAM mRNA levels 
and reduced AAM 
mRNA in WAT and 
liver 
(Kang et al., 2009) 
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KLF4 Obese, insulin 
resistant and 
glucose intolerant 
on HFD 
Increased CAM 
markers and reduced 
AAM markers in the 
SVF and increased 
bactericidal activity 
(Liao et al., 2011) 
NCoR Improved GTT and 
reduced fasted 
insulin levels on 
HFD 
Reduced mRNA 
levels of F4/80, 
Cd11c and Il-6 in 
pWAT. Reduced 
macrophage 
infiltration in pWAT. 
(Li et al., 2013) 
 
Table 1.3: Mouse models with specific deletion of certain genes in lysozyme M Cre line, 
their metabolic phenotypes and mechanisms underlying these phenotypic changes.  GIR: 
glucose infusion rate; HGP: hepatic glucose production; GTT: glucose tolerance test; ITT: insulin 
tolerance test; IKKβ: IKβ kinase β; IL4rα: Interleukin-4 receptor alpha; SOCS1: Suppressor of 
cytokine signaling 1; ERα: estrogen receptor alpha; PPARδ: peroxisome-proliferator activated 
receptor delta; NCoR: nuclear receptor co-repressor 1. 
 
1.9 Insulin signaling 
 
The insulin receptor (IR) belongs to the family of receptor tyrosine kinases (RTK) that also 
includes the insulin-like growth factor (IGF)-I receptor. These receptors are transmembrane 
proteins composed of an extracellular domain ( subunit) that binds the ligand and an 
intracellular domain ( subunit) which is a tyrosine kinase. This kinase domain triggers 
phosphorylation of tyrosine residues on other signaling molecules as well as on the receptor 
itself. When insulin binds to the  subunits of the IR, it induces the tyrosine kinase activity of the  
subunit. Subsequently, the receptor is autophosphorylated followed by tyrosine phosphorylation 
of intracellular receptor substrates which allows insulin signaling to occur (White and Kahn, 
1994).  
Insulin signaling mediates its function through two main signaling pathways: the 
phosphatidylinositol 3-kinase (PI3K)- protein kinase B (PKB) axis responsible for regulating the 
metabolic actions of insulin including gluconeogenesis in the liver and glucose synthesis, and the 
rat sarcoma -mitogen-activated protein kinase (Ras/MAPK) pathway involved in the regulation of 
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the expression of specific genes (details in section 1.12). Both pathways cooperate together to 
regulate cellular growth and differentiation (Figure 1.4) (Taniguchi et al., 2006). 
The activation of these two signaling pathways is under the control of the IR and its substrates 
the IRS proteins. The IR and IRS proteins share similar features as they both triggered by 
tyrosine phosphorylation and inhibited by serine phosphorylation and protein tyrosine 
phosphatases (PTP) (Taniguchi et al., 2006).   
Understanding the molecular mechanisms of insulin signaling is crucial to understanding its 
pleotropic effects on insulin-target tissues and their links to non-classical targets such as the 
immune system. In turn this knowledge may lead to the design of effective interventions for the 
treatment of insulin resistance and type-2 diabetes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 Mechanism of insulin signaling in a cell  
Adapted from (Taniguchi et al., 2006) 
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1.10 Insulin receptor substrates 
1.10.1 History of IRS proteins 
There are four insulin receptor substrate proteins which have the predominant roles of mediating 
the various functions of insulin in mice. These are insulin receptor substrates 1 (IRS1), IRS2, 
IRS3 and IRS4. While IRS1 and IRS2 are ubiquitously expressed, IRS1 appears to mediate 
insulin function mostly in the skeletal muscle, while IRS2 is more important in the liver, adipose 
tissue and  cells of the pancreas. IRS1 was first detected in Fao hepatoma cells by 
immunoprecipitation using antiphosphotyrosine antibodies, and was termed pp185 based on its 
migration on a protein electrophoresis gel following insulin treatment (White MF et al 1994). In 
addition to IRS1, the immunoprecipitated product contained another phosphotyrosine-containing 
IR substrate which was termed IRS2 (Miralpeix et al., 1992). Tyrosine phosphorylated IRS2 
migrated slightly slower than IRS1 (Sun et al., 1995). In other cells and tissues, pp185 migrates 
between 165 and 195 kDa depending on its phosphorylation status. Before insulin stimulation, it 
migrates at a distance correlating to 165 kDa in Fao cells. Following insulin stimulation, it shifts to 
170 kDa after one minute treatment and to 180 kDa after one hour treatment (Miralpeix et al., 
1992). 
 In addition to its role as an insulin receptor substrate, IRS1 was shown to be the substrate for 
other molecules including those belonging to the IL-2 family such as IL-2, IL-4, IL-13 and the IL-6 
family such as oncostatin and the growth hormone (White, 1997). The finding that  Irs1-/- mice 
survived with mild insulin resistance led to the discovery of the other IRS protein initially termed 
4PS which was later designated as IRS2 based on its high sequence homology with IRS1 (see 
IL-4 signaling in section 1.13 for details on 4PS). IRS2 was shown to be the only IRS expressed 
at the protein level in a murine myeloid cell line FD-5. In fact, immunoprecipitation of both IRS1 
and IRS2 from FD-5 cells treated with insulin and followed by immunoblotting with 
phosphotyrosine (PY) antibodies implicated IRS2 as the only IRS isoform phosphorylated at 
tyrosine residues expressed in these cells (Welham et al., 1997). IRS3 is mostly expressed in 
murine adipose tissue, liver and ovary (Sesti et al., 2001), whereas IRS4 expression is limited to 
embryonic tissues, pituitary gland and brain (Welham et al., 1997; Uchida et al., 2000). 
1.10.2 Functional properties of IRS proteins 
IRS proteins act as adapter molecules as they recruit other proteins to complete their function. 
They are critical nodes that function downstream of insulin and Igf1, but also other pathways that 
interfere with the insulin signaling pathway. The latter pathways include those regulated by anti-
inflammatory cytokines such as IL-4, or inflammatory cytokines such as TNF. Once IRS 
proteins are phosphorylated at their tyrosine residues located in the center and the C terminus of 
the protein they act as docking sites for SH2 (Src-homology-2) domain-containing proteins.  
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These SH2 proteins can be either 1) adapter molecules such as the p85 subunit that activates the 
PI3K signaling pathway and the growth-factor-receptor-bound protein 2 (Grb2) that initiates the 
MAPK pathway or 2) enzymes like the protein tyrosine phosphatase (SHP2) (Myers and White, 
1996; Saltiel and Kahn, 2001).  
Additionally, IRS proteins contain pleckstrin-homology domains (PH domains) near their N 
terminus that account for the IRS binding to phospholipids such as phosphatidyl inositol 3,4,5-
trisphosphate (PIP3) and phosphotyrosine binding domains (PTB domains) responsible for 
binding to phosphotyrosine residues such as the NPEY motif of the insulin receptor (Hanke and 
Mann, 2009; Razzini et al., 2000). The PTB domain contains serine residues that when 
phosphorylated by serine kinases, inhibit IRS protein function by promoting proteosomal 
degradation, and therefore negatively regulate insulin signaling.  
Most of the serine kinases that phosphorylate IRS proteins are activated by insulin and therefore 
can constitute a negative feedback loop to inhibit insulin signaling. Among these are mammalian 
target of rapamycin (mTOR), JNK and the extracellular signal-related kinase (ERK). Previous 
studies in 3T3L1 adipocytes have shown that insulin-induced serine/threonine phosphorylation of 
IRS1 results in its proteosomal degradation leading to alterations in insulin signaling in these 
cells. Insulin treatment in these cells increases both mTOR activity and mice deficient with the S6 
kinase 1 (S6K1), a downstream effector of mTOR, are protected from HFD-induced insulin 
resistance, which itself is usually accompanied by increased mTOR activation. This protection 
seen in S6K1-/- mice is due to the absence of the enhanced serine phosphorylation of IRS1 on 
both Ser
307 
and Ser
636/639
 which are targets for S6K1. Additionally, JNK activated by anisomycin in 
3T3-L1 adipocytes, induced IRS1 phosphorylation at Ser
307 
and increased JNK activation was 
observed in tissues from insulin-resistant mice. Consistent with this, JNK-deficient mice showed 
reduced IRS1 serine phosphorylation in their liver and were therefore protected from HFD-
induced insulin resistance (Hiratani et al., 2005).  
In Fao hepatoma cells, insulin induces serine phosphorylation of IRS2 on Ser
675
 and Ser
907 
through two kinases, mTOR and ERK1/2 which phosphorylate Ser
675
 and Ser
907
,
 
respectively. 
Phosphorylation at Ser
675
 by mTOR results in IRS2 proteosomal degradation without having an 
effect on insulin signaling since this serine phosphorylation does not interfere with IRS2 binding to 
the IR. ERK1/2 is also an IRS1 serine kinase that down-regulates insulin signaling by 
phosphorylating IRS1 at Ser
612
 and Ser
632
 (Fritsche et al., 2011).  
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1.10.3 Loss of function of IRS proteins in murine models 
 
Mouse knockout models have emphasized that IRS1 and IRS2 despite their structural homology, 
complement each other. Table 1.4 provides a summary of the loss of function mutations of IR, 
IRS1 and IRS2 in several cells and tissues in mice and their corresponding phenotypes.  
 
Cell or tissue Protein Phenotypes Reference 
Systemic IR Perinatal death due to 
diabetic ketoacidosis 
(Kitamura et al., 2003) 
Systemic IRS1 Hyperinsulinemia, 
insulin resistance 
(Tamemoto et al., 
1994) 
Systemic IRS2 Insulin resistance, 
glucose intolerance, 
decreased  β cell 
mass and impaired 
insulin secretion and 
diabetic 
(Withers et al., 1998) 
Brain IRS2 Obesity, insulin 
resistance,  glucose 
intolerance 
(Choudhury et al., 
2005) 
Liver IRS1 Insulin resistance 
after refeeding 
(Kubota et al., 2008) 
Liver IRS2 No change in insulin  
sensitivity on chow 
diet, increased fasted 
glucose levels on 
HFD  
 
(Simmgen et al., 
2006)  
Liver IRS2 Insulin resistance 
after fasting 
(Kubota et al., 2008) 
Liver IRS1/IRS2 Insulin resistance, 
glucose intolerance, 
hyperinsulinemia 
(Kubota et al., 2008) 
β cells IRS2 Glucose intolerance, 
decreased  β cell 
mass and impaired 
insulin secretion  
(Choudhury et al., 
2005) 
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β cells and 
hypothalamus 
IRS2 Insulin and leptin 
resistance, obesity, 
reduced β cell mass 
and proliferation at 8 
and 12 weeks old 
(Kubota et al., 2004) 
β cells and 
hypothalamus 
IRS2 Insulin resistance, 
diabetes and obesity 
(Lin et al., 2004) 
Skeletal muscle IRS1 Normal insulin and 
glucose tolerance 
(Long et al., 2011) 
Skeletal muscle IRS2 Normal insulin and 
glucose tolerance 
(Long et al., 2011) 
Skeletal muscle IRS1/IRS2 Reduced body weight 
and insulin resistance 
(Long et al., 2011) 
Macrophage IR Protected from HFD-
induced obesity and 
insulin resistance due 
to increased skeletal 
muscle glucose 
uptake and decreased 
gluconeogenesis 
(Mauer et al., 2010) 
Adipocyte IR Reduced body weight 
and adiposity, 
protected from gold-
thioglucose (GTG)-
induced obesity and 
insulin resistance 
(Blüher et al., 2002) 
 
Table 1.4: Metabolic phenotypes of mice with targeted deletion of IR, IRS1 or IRS2 in specific 
cells and tissues.  
 
1.11 The Phosphoinositide-3-kinase (PI3K) pathway  
  
In addition to the IRS proteins critical node, the PI3K and the PKB are two additional nodes that 
constitute an important part in integrating insulin and IL-4 action. The major PI3K class IA 
complex activated by IL-4 is composed of 2 subunits: the p85 regulatory subunit and the p110 
catalytic subunit. The binding of IL-4 to its receptor induces the interaction of the p85 subunit with 
60 
 
the phosphorylated form of IRS1 or IRS2. This results in the activation of the p110 catalytic 
subunit that acts as a lipid kinase following IL-4 stimulation where it transfers phosphate groups 
from ATP molecules to the cell membrane phosphatidylinositol leading to the production of PIP3 
from phosphatidylinositol 2 phosphate (PIP2). PIP2 and PIP3 molecules act as second 
messengers for IL-4 function and help to recruit kinases to the cell membrane. A key kinase in 
insulin signaling is the 3-phosphoinositide-dependant protein kinase 1 (PDK1) (Nelms et al., 
1999). PDK1 phosphorylates downstream kinases, mainly AKT, and protein kinase C, recognized 
for their role in a range of cellular processes including proliferation and cell survival. PI3K function 
can be inhibited at the level of PIP3 by phosphatases such as the phosphatase and tensin 
homologue (PTEN) and the SH2-containing inositol 5’-phosphatase-2 (SHIP2) that 
dephosphorylate PIP3 (Cantley, 2002). 
Lymphocyte survival is regulated at the transcriptional level by transcription factors downstream 
of PI3K which regulate the expression of certain genes involved in cell cycle progression, DNA 
repair, oxidative stress and apoptosis. The forkhead family of transcription factors class O 
(FOXO) is an example of transcription factors (TF) which activity is regulated by AKT. AKT-
mediated phosphorylation of FOXO occurs in the nucleus and results in exportation to the 
cytoplasm. The interaction of FOXO with accessory TF mediate their transcriptional activity as it 
determines which genes requires FOXO binding for their expression and which genes are 
indirectly regulated by FOXO (Birkenkamp and Coffer, 2003; Hedrick et al., 2012). 
1.12 The Ras/MAPK pathway 
The Ras/MAPK pathway is mainly activated by insulin and is involved in maintenance of cell 
growth, differentiation and survival. Once IRS is phosphorylated upon insulin binding to its 
receptor, it interacts with SH2 domains of the adaptor molecule Grb2 which is associated with the 
Ras guanine exchange factor, Sos. This binding triggers the production of the active form of the 
GTPase Ras and a subsequent activation of the rapidly accelerated fibrosarcoma (Raf). Raf is a 
serine/threonine kinase which triggers a kinase cascade and eventually leads to the 
phosphorylation and subsequent activation of multiple MAPKs such as the ERK1 and 2 and the 
JNK proteins (Nelms et al., 1999; Taniguchi et al., 2006). ERK1 and ERK2 share similar features 
and compensate for each other in ERK knock-out mouse models. However, in vitro and in vivo 
studies have shown that ERK1 has a more important role in adipogenesis.  As discussed earlier 
in section 1.10.2, ERK1 and 2 provide a negative feedback loop for insulin signaling by 
phosphorylating IRS proteins on their serine residues (Taniguchi et al., 2006). 
There are three JNK-coding genes: JNK1 and JNK2 are ubiquitously expressed and JNK3 is 
restricted to brain. As discussed earlier, JNK activation inhibits insulin signaling through 
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phosphorylation of IRS proteins at serine residues. Particularly, JNK activity is increased in 
mouse models of obesity and insulin resistance and deletion of JNK1 protects mice from diet-
induced obesity and insulin resistance (Hirosumi et al., 2002; Taniguchi et al., 2006).   
1.13 Interleukin-4 signaling pathway 
1.13.1 Structure and functional properties of the IL-4 pathway 
IL-4 belongs to the short four-helix family of cytokines, and shares 25% of sequence homology 
with IL-13. Both cytokines are produced by Th2 cells, natural killer T cells (NKT), mast cells and 
basophils. Recent evidence suggest that they are also produced by eosinophils and 
macrophages upon alternative activation of the latter (Kelly-Welch et al., 2003; Heller et al., 2009)  
The IL-4 receptor becomes functional when IL-4 binds the IL4R with high affinity. IL4R then 
dimerizes with the gamma C chain (C) in hematopoietic cells to form the type I IL-4 receptor. In 
non-hematopoietic cells, IL4R dimerizes with IL13R1 to form the type II IL-4 receptor.  The 
cytoplasmic tail of the IL4R associates with JAK1 whereas the C chain associates with JAK3. 
Upon binding of IL-4 to IL4R, a series of phosphorylation events occur. First, the 
phosphorylation of JAK1 and its subsequent activation leads to the phosphorylation of the five 
conserved tyrosine residues within the cytoplasmic tail of the IL4R (Wang et al., 1992). 
Deletion and truncation mutagenesis studies of these tyrosine residues in the human IL4R chain 
in hematopoietic cells have revealed three main domains that fulfill three main functions. A 
domain that associates with JAK1 and mediates its function, another domain required for 
proliferative functions and is called I4R motif (insulin/IL-4 motif) and a third domain responsible for 
the induction of gene expression (STAT6 motif). The I4R motif mediating the proliferative 
functions of IL-4, shares sequence homology with the insulin receptor, and thus has been named 
I4R or insulin/IL-4 receptor. Once phosphorylated at its tyrosine residue, the I4R motif directly 
interacts with the N-terminal PTB domain of IRS1 and IRS2, which gets phosphorylated 
presumably through the activity of JAK1 (Wang et al., 1992).   
 
IL-4 and IL-13 are thought to fulfill overlapping functions associated with allergy and asthma, yet 
in vivo cytokine knockout mouse models as well as blocking antibodies in mice to inhibit their 
functions have indicated that IL-4 is more involved in T helper 2 (Th2) development while IL-13 
contributes more in regulating airway hypersensitivity and collagen production. IL-4 induces 
proliferation and differentiation of primary hematopoietic cells, enhances the ability of 
macrophages to present antigens on their surface and stimulates formation of giant 
multinucleated macrophages (Wang et al., 1992).  
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1.13.2 IRS2 as IL-4 substrate 
 
Earlier studies have implied that specific cellular substrates are tyrosine phosphorylated in a 
murine myeloid cell line following IL-4 stimulation. The most prominent tyrosine phosphorylated 
substrate was termed IL-4-induced phosphotyrosine substrate (4PS) and was shown to play a 
role in mitogenesis (Wang et al., 1992; Johnston et al., 1995).  Similarly, IL-4 was able to induce 
tyrosine phosphorylation of 4PS in T and B lymphoid cells. 4PS shares many characteristics with 
IRS1 but does not interact with antibodies against IRS1. Following IL-4 treatment, 4PS 
immediately associates with the p85 subunit of PI3K leading to PI3K activation (Wang et al., 
1993). This strong association is reminiscent of the association of p85 subunit with IRS1. 
However, while IRS1 was found to be cytosolic, 4PS was mostly associated to the membrane, 
implicating that these two substrates might fulfill different functions (Wang et al., 1992). Mice 
lacking IRS1 provided further evidence of the existence of 4PS, later called IRS2, in IRS1-
deficient liver and skeletal muscle (Patti et al., 1995). IRS1 and IRS2 have been shown to be 
important substrates for the proliferative function of IL-4 in 32D myeloid progenitor cells that lack 
IRS1 and IRS2. These cells do not respond to either insulin or IL-4 signaling and therefore a 
subsequent phosphorylation of IRS1 or IRS2 is absent in these cells. Expression of IRS1 in these 
cells and treatment with insulin or IL-4 induces IRS1 phosphorylation, DNA synthesis and cell 
proliferation (White and Kahn, 1994).   
 
1.14 Insulin and IL-4 signaling in macrophages: connection maps 
In macrophages, IL-4 induces the expression of macrophage alternative markers and this is 
thought to be mediated through the phosphorylation and subsequent dimerization of the 
transcription factor STAT6. STAT6 is the main member of the STAT family of transcription factors 
that responds to IL-4 signaling. Following IL-4 engagement, JAK1 and JAK3 are activated, and 
the cytoplasmic tail of the IL4R becomes phosphorylated at specific tyrosine residues thereby 
recruiting STAT6. STAT6 in turn is phosphorylated by JAK through an SH2 domain, disengages 
from the receptor and dimerizes with another STAT6 molecule. STAT6 then translocates to the 
nucleus where it binds to the promoter of specific genes to regulate cellular function. The 
mechanism by which STAT6 exerts its transcriptional activity is poorly understood. Interestingly, 
STAT6 cooperates with other transcription factors to regulate gene expression. For instance, its 
interaction with CEBP and NF-κB is responsible for the induction of immunoglobulin  (Ig) 
mRNA expression (Shen and Stavnezer, 1998; Mikita et al., 1996; Delphin and Stavnezer, 1995). 
IL-4-responsive genes include the AAM markers such as Arg1, Fizz1, Chi3l3, Mrc1, Mhc II,  Il4r  
and others (Nelms et al., 1999). 
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In macrophages, PI3K is activated following IL-4 induced IRS2 tyrosine phosphorylation. The 
contribution of IRS2-dependant PI3K signaling in the regulation of STAT6-dependant AAM gene 
expression was shown by blocking PI3K activity with the PI3K inhibitor, Wortmannin. As a result, 
the expression of Fizz1 decreased whereas the expression of Arg1 and Ym1 was not altered. 
This suggests that IRS2-dependant PI3K activity is not the only mechanism responsible for the 
induction of these genes and that other signaling cascades following IL-4 treatment such as 
recruitment of Grb2, or activation of other transcription factors downstream of PI3K and Grb2 may 
influence macrophage gene expression (Heller et al., 2009). Additionally, blocking PI3K activity 
by Wortmannin in hematopoietic cells disables IL-4 function and induces apoptosis (Taniguchi et 
al., 2006; Nelms et al., 1999).  
Signaling studies in C-/- macrophages have shown that unlike STAT6 phosphorylation, IRS2 
requires the C chain for its tyrosine phosphorylation upon IL-4 treatment. In fact, co-
immunoprecipitation studies of IRS2 with the p85 subunit of PI3K and Grb2 indicated their strong 
association in wild type macrophages compared to C-/- macrophages treated with IL-4. Based 
on the fact that type I IL-4R activation is controlled by the C chain, these results imply that this 
chain is responsible for the robust tyrosine phosphorylation of IRS2 in the presence of IL-4. IRS2 
tyrosine phosphorylation correlates with the expression of Arg1, Retlna and Chi3l3. In fact, in C-
/- macrophages when IRS2 tyrosine phosphorylation is minimal the expression of these AAM 
markers is significantly decreased compared to their expression in wild-type macrophages 
especially after 24 hours treatment with high doses of IL-4  (Heller et al., 2009). This signaling 
phenotype is controlled by the extracellular domain of C, not the cytoplasmic tail (Heller et al., 
2012).  However, the Irs2 signaling pathway does not seem to be impaired in the BMDM lacking 
the C chain since Igf1 stimulation induces IRS2 tyrosine phosphorylation to a similar extent in 
control and C-/- BMDM (Heller et al., 2009).  
Further studies demonstrated interplay between IL-4 and insulin signaling in T lymphocytes. 
Specifically, PI3K activity following IL-4 stimulation is highly dependent on IRS2 since in IRS2-
deficient T lymphocytes, this activity was reduced. However, this was not the case in STAT6-
deficient T lymphocytes where PI3K activity was not altered compared to lymphocytes from 
control mice.  Additionally, IL-4-induced STAT6 phosphorylation is independent of IRS2 since in T 
lymphocytes from Irs2-/- mice, STAT6 activation is as efficient as in control  lymphocytes 
(Wurster et al., 2002). 
1.15 The LPS/TLR4 signaling pathway 
Mammalian Toll-like receptors (TLRs) are a family of germline-encoded receptors (encoded in the 
germline DNA that does not involve gene rearrangement required in the adaptive immune 
response) that act as sensors to invading pathogens including bacterial, viral and fungal infection 
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and mediate inflammatory signaling pathways. TLRs are sensitive to specific motifs expressed on 
these pathogens and these motifs are called pathogen –associated molecular patterns (PAMPs) 
(Lu et al., 2008). 
In macrophages, the TLR4 is stimulated by several PAMPS including viral PAMPS and the 
bacterial PAMP LPS, a constituent of the outer membrane of Gram-negative bacteria. The first 
evidence that TLR4 is a sensor for LPS was gained from studies in mice defective in LPS 
signaling due to mutations in TLR4. Those mice were susceptible to Gram negative infection, a 
major cause of septic shock (Poltorak et al., 1998). 
LPS is composed of three fractions: a lipid A fraction conserved among all E.Coli strains, a core 
oligosaccharide fraction and an O polysaccharide fraction that varies between multiple strains. 
The lipid A fraction is the main PAMP of LPS since when released into the circulation it causes 
fever and diarrhea.  
Activation of TLR4 upon LPS binding induces its oligomerization and subsequently its interaction 
with Toll-interleukin-1 receptor (TIR) containing adaptor proteins including Myd88 and other 
adaptor proteins including the TIR domain-containing adaptor inducing INF-β (TRIF) and the 
TRIF-related adaptor molecule (TRAM). Activation of the Myd88 signaling pathway causes 
migration of NF-κB into the nucleus where it regulates expression of pro-inflammatory cytokines 
or CAM markers (Lu et al., 2008). Among the direct targets of NF-κB are Il1-β, Il-6, Tnf, Inos and 
Mip1.   
Serum LPS levels are elevated in type-2 diabetic people and HFD-fed mice (Harris et al., 2012; 
Kim et al., 2012). In fact, HFD increases plasma LPS concentrations and gut LPS-containing 
microbiota in mice and administration of high doses of LPS into rats causes insulin resistance. 
These findings imply that increased levels of systemic LPS and high levels of LPS in the gut due 
to alterations in gut microbial flora, constitute a high risk mechanism for obesity-induced 
inflammation, insulin resistance and non-alcoholic fatty liver disease (Sachithanandan et al., 
2011).  
Reductions of gut microbiota using antibiotics in two mouse models of obesity and insulin 
resistance ameliorated whole body glucose homeostasis and liver steatosis.  Likewise, ob/ob 
mice with modulation of gut microbiata showed improved insulin sensitivity due to reduction of 
plasma LPS concentrations, number of cecal E.Coli and Tnfα mRNA expression levels in the 
jejunum. The improvement of liver insulin sensitivity was associated with increased levels of liver 
glycogen and reduced expression levels of glucose 6 phosphate (G6P). The improved glucose 
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homeostasis was not accompanied by reduced body weight or adiposity, suggesting that gut 
microbiota is a contributing factor for glucose homeostasis but not obesity (Membrez et al., 2008).   
   
1.16 Aims of investigation 
1.16.1 Rationale for the study 
Immunometabolism is an emerging field of investigation and is of great interest since it links both 
immune system functions and metabolic diseases that affect human health and result in mortality 
worldwide. The first evidence to link immunology and metabolism have focused on the role of 
inflammation in the adipose tissues (ATs) of obese mice and humans that express high levels of 
the pro-inflammatory cytokine TNFα (Hotamisligil et al., 1993; Hotamisligil et al., 1995; 
Hotamisligil, 2006)  TNFα promotes insulin resistance by inducing serine phosphorylation of IRS1 
which disables its tyrosine phosphorylation and therefore inhibits insulin signaling in the obese AT 
(Hotamisligil et al., 1996; Paz, 1997).  
Subsequent reports (Xu et al., 2003; Weisberg et al., 2003) have investigated the nature of this 
inflammatory process and identified the role of macrophages in obesity-induced inflammation in 
WAT. These studies demonstrated that insulin resistance could be a consequence of infiltration of 
immune cells specifically macrophages into the AT. Macrophages produce inflammatory 
cytokines such as TNFα, IL-1β and IL-6 which initiate the vicious cycle of inflammation and 
promotes insulin resistance.   
Further reports (Lumeng et al., 2007a; Lumeng et al., 2007b; Lumeng et al., 2007c; Kosteli et al., 
2010; Strissel et al., 2010) have firmly established that macrophage and lymphocyte infiltration 
into the AT are hallmarks of the obese and insulin resistant state and contribute to the 
development of disordered glucose homeostasis and other obesity-associated diseases.  
 
Macrophages are classified into classically and alternatively activated macrophages (reviewed in 
table 1.2 in introduction) which are characterized by a different molecular and transcriptional 
pattern and therefore display different regulatory functions in vivo. 
Analysis of adipose tissues from obese mice has identified that recruited macrophages that 
coincide with the onset of insulin resistance are classically activated M1 macrophages (CAM) 
(Strissel et al., 2007). CAMs are induced by inflammatory signals such as dietary saturated fatty 
acids, LPS secreted from the gut microbiata or INFγ produced by Th1 cells. These molecules 
signal through macrophage receptors to activate inflammatory signaling pathways in adipose 
tissue macrophages. Such inflammatory pathways include the (interferon regulatory factor 3) 
IRF3, JNK and the NF-B signaling pathways which induce the production of pro-inflammatory 
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cytokines such as TNFα (reviewed in (Chawla et al., 2011). Unlike CAMs, alternatively activated 
M2 macrophages (AAM) arise from Th2 cytokines including the anti-inflammatory cytokines IL-4 
and IL-13 and are abundant in the lean adipose tissue. They protect mice against diet-induced 
obesity since they attenuate inflammation. This is mainly based on their transcriptional signature 
which confers an alternatively activated phenotype (reviewed in (Odegaard and Chawla, 2011). 
Recently, it has been shown that AT AAM play a role in cold-induced thermogenesis by producing 
catecholamines which act on their β3 adrenergic receptors in BAT to stimulate BAT 
thermogenesis (Nguyen et al., 2011). 
While insulin signaling in classical and non-classical insulin target tissues has been established, 
the role of insulin in macrophages remains largely unknown. In fact, macrophages express the IR 
(Bar et al., 1976, 1977) and many of the insulin signaling molecules including IRS2, although 
IRS1 (Welham et al., 1997; Liang et al., 2004) and GLU4 (Fukuzumi et al., 1996; Malide et al., 
1998) are not detectable in macrophages.  
Conditional knock-out mouse models of the insulin receptor and its substrates 1 and 2, in specific 
insulin target cells have been generated to study the contribution of tissue specific insulin 
signaling in the context of whole body energy homeostasis (reviewed in table 1.4 of the 
introduction). The role of insulin signaling in macrophages has been investigated in mouse 
models of insulin receptor  deficiency in myeloid lineages and these studies have indicated that 
IRlyzM-/- mice are protected from obesity-induced inflammation and insulin resistance (Mauer et al., 
2010) and reviewed in table 1.4 of the introduction). Moreover, transplantation of Irs2-deficient 
bone marrow cells from donor diabetic, insulin resistant and glucose intolerant (Withers et al., 
1998) Irs2-/- mice into recipient WT mice results in the accumulation of macrophages in their 
vascular wall accompanied by increased expression levels of CCL2 and the development of 
atherosclerosis (Mita et al., 2011). However, transplantation of ApoE-/-; Irs2-/- fetal liver 
hematopoietic cells into a mouse model of atherosclerosis (ApoE-/-) alleviates the atherosclerosis 
phenotype and improves glucose tolerance in these mice (Baumgartl et al., 2006). The latter two 
findings indicate that Irs2 signaling in macrophages appears to have distinct functions depending 
on the metabolic status of the recipient mice and plays a crucial role in the regulation of whole 
body energy homeostasis. 
Additionally, macrophages express the type 1 IL-4 receptor (IL-4RI) through which IL-4 signals to 
induce IRS2 tyrosine phosphorylation (Heller et al., 2009). Mice with specific deletion of the IL-
4Rα, a component of the IL-4RI in macrophages (IL-4RαyzM-/-), manifest impaired thermogenesis 
upon cold exposure due to a defect in the production of catecholamines by these macrophages, 
which have been shown to activate BAT (Nguyen et al., 2011). This is due to impaired STAT6 
signaling and a consequent abrogation in the expression of macrophage alternative markers 
(Nguyen et al., 2011). 
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The above evidences on the role of insulin signaling in macrophages in the pathophysiology of 
obesity and the fact that Irs2 regulates signaling pathways downstream of insulin, IL-4 and 
inflammatory cytokines (figure 1.5) prompted us to ask the following question: 
What is the role of the Irs2 component in macrophages in a conditional knock-out mouse model in 
the regulation of whole body energy homeostasis? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1.16.2 Hypothesis and aims of the study 
 
The discovery that macrophage signature in the WAT can greatly influence the metabolic status 
of the mice has implicated the contribution of both insulin signaling and IL-4 signaling pathways in 
macrophages in the regulation of energy homeostasis. Since Irs2 is a critical node through which 
both molecules signal to regulate downstream signaling pathways, we hypothesized that Irs2 
Figure 1.5 Irs2: a critical node in regulating insulin signaling, pro and anti-inflammatory 
signaling pathways in macrophages. 
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signaling in macrophages plays an important role in the regulation of whole body energy 
homeostasis. To address this hypothesis, we generated mice harboring a specific deletion of Irs2 
in myeloid lineages Irs2lyzM-/-, as discussed in the methods section of this thesis. These mice were 
subjected to metabolic phenotyping on both normal chow and HFD. Their whole body energy 
homeostasis was assessed. This included analyzing their glucose tolerance and insulin 
sensitivity, body weight, food intake and energy expenditure.  
We next aimed to address the molecular mechanisms underlying any physiological changes. We 
therefore used bone marrow-derived macrophages (BMDM) as a primary cell model and treated 
them with IL-4 and LPS to generate alternatively and classically activated macrophages, 
respectively. We then looked at changes in mRNA levels in macrophages in the presence and 
absence of Irs2 since their gene expression profile determines their polarization state. 
Additionally, we assessed the impact of Irs2 deletion upon mRNA levels in adipose tissue 
macrophages (ATMs) from mice on HFD. Gene expression studies were performed using RT-
PCR and mRNA sequencing experiments which allowed for the determination of the molecular 
signature of the Irs2lyzM-/- macrophages upon the various treatments. We also investigated any 
changes in the abundance of metabolites secreted from Irs2lyzM-/- macrophages upon IL-4 and 
LPS treatment by using a non-targeted metabolomic approach. Our aim was to predict common 
signaling pathways between metabolites and transcript levels that might be altered upon Irs2 
deletion based on their responses to such treatments. We also used a targeted metabolomic 
approach to determine any catecholamine release from BMDM, especially with the recent finding 
that AAMs sustain cold-induced thermogenesis by producing catecholamines. 
.  
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Chapter 2: Materials and Methods 
 
2.1 Mice 
Mice were maintained in a specific pathogen-free facility under a controlled temperature between 
21°C and 23°C and a regular 12 hours dark/12 hours light cycle, with ad libitum access to water 
and food. A list of the pathogens screened for is showed in appendix 1. The standard diet was 
normal chow diet with 11.5% energy (Kcal) from fat (RM3 SDS UK Ltd; 
http://www.sdsdiets.com/pdfs/RM3-E-FG.pdf). The high fat diet contained 45.0% energy from fat 
(D12451 OSD Inc. USA; http://www.researchdiets.com) while the percentage energy from 
carbohydrates was less relative to the RM3 diet (35.0% versus 61.6% respectively). All animal 
procedures were approved by the British Home Office Animal Scientific Procedures Act 1986 
under PPL 70/7438 held by Professor Dominic Withers.  All procedures followed local ethical and 
UK Home Office guidelines.  
2.1.1 Mouse strains 
Deletion of Irs2 in myeloid lineages was carried out using the Cre-LoxP technology using mice 
with a floxed allele of Irs2 (Choudhury et al., 2005) crossed with mice expressing Cre-
recombinase driven by the lysozyme M promoter (Clausen et al., 1999). 
2.1.1.1 Irs2 floxed mice 
Irs2 floxed mice were previously generated in the Withers laboratory (Choudhury et al., 2005). 
Briefly, a targeting vector was made containing a neomycin gene flanked by two lox P sites, 
upstream of the Irs2 exon, and a third lox P site downstream of the single Irs2 coding exon. The 
targeting vector was then electroporated into embryonic stem (ES) cells for homologous 
recombination. Southern blotting was used to screen for homologous recombination using 5’ and 
3’ probes outside the homology arm. The neomycin cassette was deleted in vitro by Cre-
mediated recombination and deletion was confirmed with an internal probe. The correctly 
targeted ES cells were then injected into blastocysts, implanted into pseudopregnant mothers and 
chimeric progeny bred to confirm germline transmission (Choudhury et al., 2005). Mice were 
subsequently back-crossed to a C57Bl/6 background for eight generations. 
2.1.1.2 Lysozyme M Cre mice 
Lysozyme M Cre mice were obtained from the Jackson Laboratory via Professor Graham 
Williams (Department of Medicine, Imperial College London) and maintained on a C57Bl6/SV129 
genetic background. These mice carry a knock-in allele of Cre recombinase cDNA at the 
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lysozyme M gene translational start site locus (Clausen et al., 1999). Lysozyme M Cre mice have 
previously been extensively used as a model for efficient deletion of genes in macrophages to 
study macrophage function in multiple diseases in mice, such as metabolic and inflammatory 
diseases (Hontecillas et al., 2011; Mauer et al., 2010; Nguyen et al., 2011; Qin et al., 2012; 
Sachithanandan et al., 2011).  
2.1.2 Breeding strategy 
To delete Irs2 in myeloid lineages, Irs2 floxed mice were crossed with lysozyme M Cre/+ mice to 
generate mice heterozygous for both alleles. Double heterozygous mice were then crossed with 
heterozygous Irs2 floxed mice to generate in the same litter wild-type (WT, +/+), Irs2 floxed/floxed 
and lysozyme M Cre/+ and the homozygous Irs2 floxed/floxed; in this thesis I have termed 
lysozyme M Cre/+ mice carrying the specific deletion of Irs2 Irs2lyzM-/- mice. Groups of mice 
referred to as control mice consist of equal numbers of WT, Irs2 floxed/floxed and lysozyme M 
Cre/+ derived from the same litters. Genetic combinations of offspring were generated at the 
expected Mendelian ratio. All these mice were maintained on a C57BL6/SV129 genetic 
background. Mice were weaned into single sex cages of mixed genotypes at 3 weeks of age and 
were identified by ear clips. Mice were caged in groups of 4 mice. Breeding cages were changed 
after 8 weeks and a new set of breeding cages was set up to generate another cohort of study. A 
minimum of two separate cohorts were generated for most of the studies.     
2.1.3 Genotyping strategies  
2.1.3.1 DNA extraction from ear biopsies 
Ear biopsies were taken from all mice before weaning at 21 days old. DNA was extracted from 
ears following overnight digestion in 250 µl of a proteinase K lysis buffer at 56°C. The lysis buffer 
consisted of 10 mM Tris hydrogen chloride (Tris HCl) PH 8.5; 5 µM ethylenediaminetetraacetic 
acid (EDTA); 0.2 % sodium dodecyl sulfate (SDS) and 0.2 M sodium chloride (NaCl). Prior to 
digestion, 1 milligram (mg) of 20 mg/milliliter (mg/ml) proteinase K stock solution was added to 1 
ml of lysis buffer. Following digestion, samples were vortexed for 1 minute (min) and then spun at 
full speed (27000 g) for 10 min. Supernatants were transferred to new tubes and an equal 
amount of isopropanol (250 microliters (µl)) was added to precipitate the DNA. Tubes were then 
spun to get rid of isopropanol and cell debris and the pellet washed with 250 µl of 70% Ethanol. 
Tubes were spun again and ethanol aspirated. The DNA was then resuspended in 50 µl H2O until 
completely dissolved. Mice were genotyped for the Cre gene and the Irs2 floxed gene by a 
polymerase chain reaction (PCR) based approach. Following amplification by PCR, PCR 
products were resolved on an agarose gel in 0.5 X TBE buffer (45 mM Tris-borate/1 mM EDTA). 
The agarose gel percentages varied between 1% and 3% depending on the resolution needed. 
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Ethidium bromide (Sigma # E1510) was added at 0.5 µg/ml to the agarose gel to permit DNA 
visualization.  
2.1.3.2 Irs2 flox genotyping 
Irs2 flox genotyping was performed using published protocols (Choudhury et al., 2005). Two 
primers (a and b) were used to amplify across the lox P site at the 3’ end of the Irs2 floxed allele 
(Figure 2.1). A band size of 200 base pairs (bp) indicated the absence of a floxed gene and 
therefore WT mice, a 250 bp band indicated homozygosity for the floxed allele mice where the 
locus is targeted with lox P sites on both alleles. Two bands, one of 200 bp and one of 250 bp 
indicated a heterozygous allele (Irs2 floxed/+). The primers location on the Irs2 floxed allele is 
shown in figure 2.1. 
 
 
 
 
 
DNA sequence of Irs2 floxed primers 
Forward primer (a): 5’ ACT TGA AGG AAG CCA CAG TCG 3’ 
Reverse primer (b): 5’ AGT CCA CTT TCC TGA CAA GC 3’  
 
Irs2 floxed PCR reaction mixture: total volume is 11 µl.  
1 µl of DNA template, 0.45 µM of each a and b primers (0.5 µl of 10 µM primer stock), 9 µl of 
Reddy PCR master mix (Thermoscientific # AB-0575/LD). 
Figure 2.1 Diagram showing a simplified genomic structure of the floxed allele of 
Irs2 and location of the primers for PCR. 
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Irs2 floxed PCR program: 
Hot lid: 105°C 30 seconds (sec) 
1. 94 °C 60 sec 
2. 94 °C 30 sec 
3. 53 °C 30 sec 
4. 72  °C 60 sec Go to 2, 30x 
5. 72  °C 600 sec 
2.1.3.3 Lysozyme M Cre genotyping 
The lysozyme M Cre band was detected using 2 primers. The Cre recombinase band was 
detected at 700 bp and the absence of a 700 bp band indicated 2 WT alleles. A positive control 
consisting of a DNA positive for the Cre (Cre/+) and a negative control with no DNA were used for 
all PCRs.   
DNA sequence of lysozyme M Cre primers 
Forward primer: 5’ CCC AGA AAT GCC AGA TTA CG3’ 
Reverse primer: 5’ CTT GGG CTG CCA GAA TTT CTC3’  
 
PCR mixture: total volume is 15 µl. 
1 µl of DNA template, 0.5 µM of each forward and reverse primers (0.375 µl of 20 µM primer 
stock), 13.25 µl of Reddy PCR master mix (Thermoscientific # AB-0575/LD). 
 
Lysozyme M Cre program 
Hot lid: 105°C 30 sec 
1. 94 °C 180 sec 
2. 94 °C 30 sec 
3. 63 °C 30 sec 
4. 72  °C 60 sec Go to 2, 35x 
5. 72  °C 120 sec 
2.1.3.4 Analysis of specificity of deletion of Irs2 in macrophages by PCR 
PCR was used to detect the recombination of the floxed Irs2 allele. 50 mg of various mouse 
tissues were collected and snap frozen. Bone marrow derived macrophages (BMDM) were 
differentiated from mouse bone marrow cells as described later in 2.9.1.  DNA was isolated from 
BMDM and mouse tissues following overnight digestion in 500 µl proteinase K lysis buffer as in 
2.1.3.1. 
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Following digestion, an equal volume (500 µl) of phenol chloroform-isoamyl alcohol (Sigma # 
P2069) was added to the DNA solution and vortexed. The mixture was then centrifuged for 5 min 
at 12000 g using a Mikro 200R centrifuge and the supernatant (250 µl) containing the DNA was 
then transferred to a new tube. An equal volume (250 µl) of chloroform was added to the 
extracted DNA to get rid of any phenol excess and mixed by inversion. Chloroform was removed 
by centrifugation for 10 min at 12000 g and the DNA present in the clean supernatant precipitated 
by the addition of 1/10
th
 volume of 3 M sodium acetate and 2.5 X ethanol. The DNA pellet was 
collected after centrifugation for 15 min at 12000 g and washed with 70% ethanol, air dried and 
resuspended in H2O. Equal amounts of DNA were used for PCR amplification to detect 
recombination of the lox P sites and therefore the specificity of deletion of Irs2 in BMDM 
compared to other tissues.  
 
Irs2 floxed deletion primers (Figure 2.1) 
Primer (a): 5’ ACT TGA AGG AAG CCA CAG TCG 3’ 
Primer (b): 5’ AGT CCA CTT TCC TGA CAA GC 3’  
Primer (c): 5’ GGG AAC CTG ACA AGT GAA TG 3’ 
 
Primers a and b will amplify the floxed allele whereas primers b and c will amplify a recombined 
band of 1.3 kilobases (Kb). In the absence of recombination, b and c primers wouldn’t be able to 
amplify a PCR product due to its high molecular weight. 
 
PCR mixture: total volume = 11 µl (similar to the mixture in 2.1.3.2 except that 3 primers a, b and 
c will be used).  
 
PCR program:  
Hot lid: 105°C 30 sec 
1. 95 °C 180 sec 
2. 95 °C 60 sec 
3. 57.4 °C 60 sec 
4. 72  °C 120 sec Go to 2, 30x 
5. 72  °C 420 sec 
2.2 High fat feeding studies and body weight measurement 
High fat feeding studies were done on female mice; Body weight measurements were done on 
both male and female mice as indicated in the results section. Each study was replicated 
therefore the data presented in the results section is the result of two separate cohorts, unless 
otherwise indicated. Feeding experiments were performed on eight week-old control and Irs2lyzM-
74 
 
/- mice which were randomly divided into two weight-matched groups each. The first group was 
maintained on chow diet and the second group on high fat diet (HFD).  Details of these diets are 
in section 2.1. In each cohort, ~ 8 to 10 mice per condition were used. 
Mice were weighed using a Kern PLJ Precision Balance (Kern PLJ600-2GM 600g x 0.01g) 
between 9 am and 11 am at 8 weeks of age and were put on HFD starting from this age. Body 
weight was monitored weekly throughout the study, for the number of weeks indicated in the 
results section. 
 
2.3 Metabolic studies 
Metabolic and physiological tests were performed on either female or male mice as indicated in 
the results section. Comparisons were made within same sex-group since the gender can 
influence the phenotype resulting from genetic manipulation. Find a detailed diagram illustrating 
the experimental design in appendix 3, including the mice age, sex, the weeks on HFD and the 
cohorts designated for each study.  
2.3.1 Fasted blood glucose levels 
Fasted blood glucose levels were measured in female mice. 8 week-old mice were fasted 
overnight and blood was collected during the early light phase between 8 am and 10 am. 16 
week-old mice on HFD were fasted for 6 hours. The reason for the 6 hours fasting on HFD is due 
to the state of insulin resistance in the HFD-fed mice which have maximal gluconeogenesis after 
6 hours. Additionally, the maximal difference in blood glucose levels between mice on chow and 
mice on HFD is observed after 6 hours fasting (Andrikopoulos et al., 2008). In the same cohort, 
the mice on chow were fasted for 6 hours so they can be comparable to the mice on HFD.  Mice 
were fasted at 8 am and blood was collected after 6 hours fast. A drop of blood was taken from 
tail vein after cutting a tip from the tail and placed on a strip inserted in a glucometer Contour 
(Bayer). Glucose levels were recorded in mmole/liter (1mmol/L= 18.018 mg/dl). 
2.3.2 Glucose tolerance test (GTT) 
GTT was performed on female mice. Mice on chow were fasted overnight while mice on HFD 
were fasted for 6 hours before measuring their basal glucose levels as in 2.3.1. Mice were then 
injected intraperitoneally (IP) with 2 g/kg (mice on chow) or 1 g/kg (mice on HFD) of D-glucose). 
Blood glucose was then measured with a glucometer Contour (Bayer) at 15, 30, 60, 90 and 120 
min post injection.  
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2.3.3 Insulin tolerance test (ITT) 
ITT was performed on female mice. During ITT, mice were not fasted except during the test itself. 
A bolus of insulin was given IP to the mice (0.45 international units (IU) of recombinant human 
insulin for mice on chow). These insulin concentrations were optimized since with higher doses of 
insulin Irs2lyzM-/- mice showed signs of hypoglycemia and had to be rescued by giving them 
glucose. Basal blood glucose was measured before IP insulin with a glucometer and at 15, 30, 
60, 90 and 120 min post injection. 
2.3.4 Homeostatic model assessment of insulin resistance (HOMA-IR) 
HOMA-IR (Turner et al., 1979) was determined using fasted glucose and insulin levels (see 2.4.1 
for insulin measurement) collected at the same time in female mice. This index is used to assess 
insulin sensitivity. An online HOMA-IR calculator is available utilizing the following formula: 
HOMA-IR= G0 x I0/405 
G0: Fasting blood glucose in mg/dl 
I0: Fasting insulin in µU/ml 
2.3.5 Analysis of fat and lean mass measurement by Echo-MRI 
Mice on either chow diet or HFD were scanned using Echo-MRI100 (EchoMRI LLC, U.S.A) that 
allows the rapid measurement of body lean and fat mass in non-anaesthetized mice (see 
http://www.echomri.com/about_us.aspx for description of the technology). Adiposity was 
measured in male mice at different ages on chow diet and in female mice on HFD. 
2.3.6 Fat pad weight measurements 
Fat pads were weighed in female mice on chow diet and HFD. Mice were culled by cervical 
dislocation. To assess adiposity, perigonadal white fat pads were carefully dissected and weighed 
using an analytical balance (ADAM with d=0.0001g readability). Both lobes of the interscapular 
brown adipose tissue were carefully dissected out and cleaned from the white adipose depots 
before being weighed.  
2.4 Hormonal measurements 
2.4.1 Fasted insulin and leptin levels measurement by 96 well-plate ELISA kit 
Following 6 hours fast of 16 week-old female mice on chow and HFD, and overnight fast for 8 
weeks old female mice, blood was collected by tail vein bleeding into capillary tubes (Sarstedt 
Microvette 300) and spun for 15 min at 4°C at 2000 g. The serum supernatant was removed into 
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a new tube and stored at -80°C. Insulin and leptin levels were measured by sandwich ELISA 
(Millipore; cat # EZRMI-13K and EZML-82K, respectively).  
2.4.2 Catecholamine levels measurement by 96 well-plate ELISA kit  
Spot urine samples were collected between 7 am and 8 am from female mice on HFD and snap 
frozen in tubes containing 6 N HCl. Norepinephrine and epinephrine levels were measured by 
solid phase enzyme-linked immnunosorbent assay (ELISA) based on the sandwich principle 
(CatCombi ELISA # RE59242, IBL international) They were normalized to creatinine, the 
concentration of which is proportional to the absorbance measured at 510 nm as a result of a 
colorimetric reaction between picrate and creatinine to form a red chromophore (Jaffe reaction). 
The assay is automated on the Siemens Dimension RxL analyzer (Siemens Creatinine assay kit).  
This ELISA was measured at the core biochemical assay laboratory at Cambridge University 
Hospitals: 
www.cuh.org.uk/research-and-development/facilities-for-research/core-biochemical-assay-
laboratory-cbal 
 
2.5 Physiological measurements 
2.5.1 Analysis of food intake in singly housed mice 
Food intake was measured by three means: 
1- Daily food intake using the indirect calorimetric CLAMS system (Comprehensive lab 
animal monitoring system) where the mice are singly housed. An acclimatization period 
of 24 hours allows the mice to familiarize themselves with the feeding system in the 
metabolic cages. This system allows precise recording of the amount of food eaten within 
every ~ 20 min using a balance with 0.01g precision. The total amount of daily food eaten 
is then aggregated (grams). The feeders in the caging system are designed to minimize 
the food spillage, but when this occurs, it can be weighed and recorded manually.          
     
2- Daily food intake by manual weighing of the food: Mice were singly housed and 
acclimatized for a week before the start of the food weighing. The acclimatization period 
is critical because the mice will lose some weight when singly housed. Unlike the CLAMS 
system, the manual weighing will allow one week acclimatization which is usually 
sufficient for the mice to recover and gain their original body weight. This way of 
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measuring food intake might be more accurate than the CLAMS system as it allows 
longer acclimatization period. Each mouse was then given the same amount of food 
~100 g in the evening and allowed ad libitum feeding. Food in the hopper was then 
weighed next morning (between 8 and 10 a.m.) and the amount of eaten food was then 
calculated from the food remaining. 
 
3- Response to fasting: Singly housed 10 week-old female mice were acclimatized to 
overnight fasting twice (few days apart) in the week before the study. Food was removed 
from the cages the evening before the study and ~40g of food was weighed, recorded 
and given to each mouse in the next morning (8am). The food was then weighed half an 
hour, 1 hour, 2 hours, 4 hours, 8 hours and 24 hours post-refeeding. 
 
2.5.2 Energy expenditure measurement using CLAMS cages 
Energy expenditure or heat dissipation was calculated in kilocalories per hour in singly housed 
mice in CLAMS cages. It reflects the amount of energy from the food used by the subject and 
was calculated from the exchange of the amount of oxygen VO2 (gas consumed) to the amount of 
carbon dioxide VCO2 (gas dissipated) during the metabolic process. Subtle changes in these 
gases are detected by sensors in the chamber. Heat dissipation is automatically calculated by the 
the CLAMS software every ~15 min using the following formula: 
Heat= (3.815 +1.232 × RER) x VO2 (RER: respiratory exchange ratio = VCO2/VO2). 
Energy expenditure was measured in male mice on chow diet and female mice on HFD. 
2.5.3 Body temperature 
Body temperature of 1 year old female fed mice was measured through a 1.2 mm digital rectal 
thermometer ± 0.2°C (# IN005A; Vet-Tech.co.uk) at 2 pm and temperature recorded.   
2.6 Histological studies 
2.6.1 Preparation and fixation of adipose tissues 
Brown adipose tissue was collected as described in 2.3.6 and fixed in 10% neutral buffered 
formalin (~4% formaldehyde in phosphate buffer saline (PBS)) overnight at 4°C. Samples were 
then briefly washed with 1 X PBS before being stored in 70% ethanol.  
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2.6.2 Tissue processing, embedding and sectioning 
Before embedding the tissues in paraffin for the purpose of sectioning, they were dehydrated in 
serial concentrations of ethanol as following: 2 hours in 85% ethanol, 2 hours in 90% ethanol and 
finally 2 hours in 100% ethanol.  Dehydrated tissues were then placed in xylene (clearing agent) 
for 1 hour and then transferred to fresh xylene overnight. Tissues were then transferred into 
paraffin wax (~60°C) for one hour and then transferred to fresh wax for another hour. Tissues 
were then embedded using a Leica Eg-1160 Histoembedder with fresh wax and immediately 
solidified on a 4°C block. Blocks were sectioned using a Leica microtome (RM 2265) at 5µm 
thickness. 
2.6.3 Haematoxylin and eosin (H&E) staining on tissue sections 
Sections were deparaffinised with xylene (twice, 5 min each) and re-hydrated as following: 100% 
ethanol (twice, 2 min each), 95% ethanol (2 min), 75% ethanol (2 min) and 50% ethanol (2 min), 
washed in distilled water (5 min), stained in haematoxylin (Mayer’s) for 3 min and washed again 
with running tap water (10 min), rinsed in distilled H2O and then briefly rinsed in 95% ethanol. 
Sections were then counterstained with eosin Y for 30 sec and dehydrated with 95% ethanol and 
100% ethanol (5 min each). Sections were finally immersed with xylene (twice, 5 min each) and 
mounted with distyrene, plasticizer and xylene (DPX) mounting medium. Brown adipose tissue 
images were taken at 20 X magnification using a Leica microscope (DM4000 B, Wetzlar, 
Germany). 
2.7 Magnetic isolation of CD11b positive fraction from the stromal vascular 
fraction of WAT  
2.7.1 Adipose tissue digestion 
Perigonadal white adipose tissue (pWAT) was collected from mice and weighed and then placed 
in Dulbecco’s Modified Eagle medium (DMEM). pWAT was then chopped thoroughly into small 
pieces using micro scissors and transferred to a collagenase digestion solution (0.3 g/ml). The 
digestion solution consisted of 2 mg/ml of collagenase type II (Sigma C6885), 70% of Hanks 
solution (Sigma H9269) and 2.25% of bovine serum albumin (BSA) (7.5% stock solution Sigma 
A8412). The WAT was digested into a shaking incubator (Innova 4300, New Brunswick Scientific) 
at 37°C, 100 rpm for 20-30 min and then the floating adipocytes were separated from the stromal 
vascular fraction (SVF) by passage through a 100 µm cell strainer (Falcon # 352360) and 
collected in a new tube. This technique was adapted from a protocol provided by Vidal-Puig 
Laboratory, Department of Clinical Biochemistry, IMS, University of Cambridge. 
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2.7.2 Positive selection of CD11b positive fraction from the SVF 
The SVF fraction was centrifuged at 500 g for 5 min at 4°C and the pellet was resuspended in 
filtered selection buffer. The selection buffer consists of: 1X PBS, 2 mM EDTA and 0.5 % BSA. 
The number of cells was counted and viability estimated using the Guava ViaCount reagent 
(Millipore # 4000-0040) and the Guava easyCyte flow cytometer (Merck Millipore). The SVF pellet 
was centrifuged again and resuspended in selection buffer at the density of 10 million cells/90 µl 
of selection buffer.  
At this stage, 10 µl of CD11b microbeads (Miltenyi Biotec) conjugated to monoclonal rat anti-
mouse/human antibody, were added to the cells and mixed gently.  Excess beads were washed 
away with selection buffer. The mixture of SVF/antibody was passed through an LS column 
(Miltenyi Biotec # 130-042-401) placed in a magnetic field. Unlabeled cells passed through the 
column and were collected with selection buffer whereas the positive fraction of the SVF 
containing CD11b antigens was retained in the column and subsequently eluted with selection 
buffer by applying pressure with the plunger to flush it out after removing the column from the 
magnetic field. The cell fractions were then centrifuged at 300 g for 15 min at 4°C counted and 
resuspended with 350 µl of RLT guanidium thiocyanate lysis buffer for RNA extraction. 
 
2.8 Cell culture  
2.8.1 Primary cells: Isolation and culture of mouse bone marrow-derived 
macrophages (BMDM) from femoral and tibial macrophage precursors 
Eight week old mice were culled by cervical dislocation and femurs and tibias were dissected out 
with autoclaved surgical tools, cleaned from skin and muscles and placed in 1X PBS (without 
calcium and magnesium). The isolation of bone marrow cells was performed in a cell culture hood 
to avoid any microbiological contamination that might alter macrophage phenotype.  
Femurs and tibias were cut at the proximity of each joint and bone marrow was flushed out with 
1X PBS washing buffer using a 25G needle and collected in a falcon tube. The cells were then 
collected after centrifugation at 500 g for 10 min and resuspended in macrophage complete 
medium (MCM) (see recipe below). They were then plated at a density of 0.5 million cells in 90 
mm sterile plastic petri dishes (sterilin # 13172211) in 8 ml of MCM and placed at  37°C  in a 5% 
CO2 incubator. This is day 0. Cells were topped up with an additional 4 ml of MCM on day 4. On 
day 7, cells were collected for characterization by flow cytometry, for RNA and protein extraction 
or immunocytochemistry as will be discussed later (Zhang et al., 2008). 
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Macrophage complete medium: 
Dulbecco’s Modified Eagle medium F-12 (DMEM-F12) + Glutamax (Invitrogen # 31331-093)  
100 µg/ml streptomycin, 100 IU/ml penicillin (PS) (PenStrep Gibco # 15140)   
10 % fetal bovine serum (FBS hyclone, Thermoscientific, with endotoxin levels < 0.125 endotoxin 
units (EU)/ml).  
 
The same FBS was used for all the studies to avoid discrepancies in results due to variation in 
endotoxin levels. Prior to use, the above medium was supplemented with either 30 ng/ml of 
mouse recombinant macrophage colony stimulating factor (M-CSF) (Sigma # M9170) or 25% of 
L929 conditioned medium as indicated in the results section. 
2.8.2 L929 cell culture 
L929 is a murine fibroblast cell line that secretes into their media M-CSF and therefore the 
conditioned medium from these cells can substitute the commercially available recombinant M-
CSF. These cells were grown in the same medium used for BMDM differentiation (macrophage 
complete medium deprived of M-CSF) and split 1/3 every three days. During passage, the 
conditioned medium was collected and stored at - 80°C until use.  
2.9 BMDM and CD11b fractions characterization by flow cytometry analysis 
2.9.1 BMDM and CD11b fractions harvesting and processing 
On day 7, cell conditioned media were discarded and cells washed with 1X PBS. Cells were 
detached from the bacterial petri dishes with a non-enzymatic cell dissociation buffer (Gibco # 
13151-014), collected in MCM and centrifuged at 400 g for 10 min at 4°C. Cell pellets were then 
washed with 1X PBS and then resuspended in 1 ml of blocking solution (5 % FBS in 1X PBS). 
Cells were then counted and ~10
6
 cells (in 100 µl medium) were added into each test tube.  
The CD11b positive and negative fractions selected from the stromal vascular fraction as 
described above (section 2.8) were centrifuged at 400 g and washed with 1 X PBS. 1x BD Pharm 
lysis buffer (BD-Biosciences # 555899) was used to lyse red blood cells in these fractions. 
 
2.9.2 BMDM and CD11b fractions staining  
To 10
6 
BMDMs, 1 µl of Fc receptor (0.5 µg) blocking antibody was added (BD Pharmingen # 
553141 clone 2.4G2) and incubated for 15 min on ice. 0.2 µg of the anti-mouse CD11b 
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fluorescein isothiocyanate (FITC) (eBiosciences # 11-0112 clone M1/70) and 0.06 µg of the anti-
mouse F4/80 phycoerythrin (PE) (eBiosciences # 12-4801 clone BM8) were then added and cells 
incubated for 30 min in the dark. Cells were then centrifuged at 400 g for 10 min and 
resuspended with 100 µl of cytofix/cytoperm reagent (BD Biosciences # 554714) for 20 min, 4°C 
in the dark. The cytofix/cytoperm reagent permitted fixation of the cells which were then washed 
with 1 X wash buffer (BD Biosciences # 554714) after brief centrifugation and finally resuspended 
in 2 % paraformaldehyde. Within 24 hours, cells were analyzed by fluorescence activated cell 
sorting (FACS) using a BD LSRII flow cytometer with BD FACSDiva software. The negative 
controls receive no antibody and are used to adjust for macrophage autofluorescence. They are 
processed exactly the same way as the other samples (Zhang et al., 2008). 
CD11b positive and negative cell fractions (~ 0.5 million cells) that have been processed as 
described in 2.9.1 were blocked with blocking buffer (5%FBS/PBS) and counted. Then they were 
incubated with Fc receptor blocking antibody followed by incubation with CD11b FITC antibody as 
described above. This allowed the determination of the percentage of CD11b cells (purity) in both 
fractions (appendix 2). 
2.10 Cell treatments and expression studies 
2.10.1 Treatment with LPS 
Pure BMDM were harvested on day 7 and plated in 6 cm cell culture plates (for RNA extraction 
described in 2.11.3.1) in macrophage medium supplemented with 30 ng/ml of M-CSF (Sigma-
Aldrich # M9170). Once adhered, BMDM were treated with either 10 ng/ml or 100 ng/ml of 
bacterial lipopolysaccharide (LPS) from Escherichia coli (Sigma-Aldrich # L2654) for 24 hours to 
induce classical activation of macrophages. Cells treated with a volume of 1X PBS similar to the 
volume used for LPS, were used as controls.     
2.10.2 Treatment with IL-4  
Pure BMDM were harvested on day 7 and plated as above. Once adhered, they were treated with 
10 ng/ml of mouse recombinant interleukin-4 (R&D Systems # 404-ML/CF) for 24 hours. They 
were then harvested and used for RNA extraction. Cells treated with 0.5 µl of 1X PBS were used 
as controls. For protein lysates, BMDM were treated with 20 ng/ml of IL-4 for 30 min before being 
lysed as described below. A concentration of 20 ng/ml was used since this concentration induced 
a robust activation of IRS2 tyrosine phosphorylation in BMDM (Heller et al., 2009). 
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2.10.3 Immunocytochemistry on BMDM 
BMDM were plated at a density of 5000 cells on Matrigel-coated glass coverslips (VWR # 631-
0149). Once adhered, they were fixed with 100% methanol for 1 min at room temperature. For 
IRS2 staining, cells were permeabilized (1X PBS with 0.1% Triton X-100 and 1% BSA) for 5 min. 
After fixing and permeabilization, cover-slips were washed with 1X PBS (3 x 5 min each) and 
blocked in blocking buffer (0.5% fish gelatin in 1X PBS) overnight. After blocking, cover-slips were 
washed with 1X PBS (3 x 10 min each) and incubated with rabbit polyclonal anti-IRS2 primary 
antibody (# 06-506; Upstate Technology Bedford, MA) (1/100 dilution: 0.01 µg/µl in blocking 
buffer) for 3 hours at room temperature. Cells were washed with 1X PBS (5 x 5 min each) and 
further incubated with goat anti-rabbit Alexa Fluor 594 secondary antibody (# A11012 Invitrogen 
Molecular probes) (1/200 dilution: 0.01 µg/µl in blocking buffer) for 30 min in the dark. Cover-slips 
were washed with 1X PBS (5 x 5 min each) to remove unbound secondary antibody and mounted 
with Vectashield® mounting medium with 4’-6-Diamidino-2-phenylindole (DAPI) (Vector labs # 
H1500) on glass slides, immobilized with clear nail polish and subjected to a Leica SP5 confocal 
microscopy.  
2.10.4 Immunoblotting (Western blotting) 
2. 10.4.1 BMDM lysis 
For whole BMDM extracts, cells cultured on 10 cm cell culture plates were washed once with 1 X 
PBS, then scraped off with 500 µl 1 X PBS and briefly centrifuged. The pellet was frozen at -80°C 
until use. Pellets were resuspended with 2 volumes of cell lysis buffer plus protease inhibitors 
(see recipe below) by gentle rocking at 4°C for 10 min. The resuspension mixture was then 
centrifuged at 27000 g for 10 min, and the supernatant stored at -80°C. Prior to western blotting, 
the supernatant was thawed and the protein content in the supernatant was quantified by 
colorimetric Lowry assay (Bio-Rad DC protein assay # 500-0116) with BSA standards and 
absorbance was measured at 750 nm. 
2.10.4.2 Western blotting protocol 
Protein lysates were re-suspended in Laemelli buffer at 1X final concentration, boiled for 5 min at 
95 °C and loaded onto 10% SDS-polyacrylamide resolving gels. Gels were run at 100 volts (V) for 
3 hours at room temperature (RT) in 1X running buffer (recipe below). Proteins on gels were then 
transferred to methanol-activated polyvinylidene fluoride (PVDF) membrane (Amersham Hybond-
P) through wet transfer in 1X transfer buffer (recipe below), at 100 V for 2 hours at 4°C. 
Membranes were then rinsed with 1X wash buffer (1X TBST) (recipe below) and placed in 
blocking buffer (5% milk in 1X TBST) for 1 hour at room temperature. Membranes were then 
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incubated overnight with primary antibodies (table 2.1) at 4 °C with gentle rotation, washed with 
1X TBST (3 x 10 min each) and incubated with goat anti-rabbit  secondary antibody conjugated to 
horse radish peroxidase (HRP) (Thermoscientific # 32460) at a concentration of 0.004 µg/ml for 1 
hour at room temperature. Membranes were then washed with 1 X TBST (3 x 10 min each) and 
HRP-conjugated secondary antibodies were detected with enhanced chemiluminescence 
detection (ECL) (# WB LUR0500, Luminata crescendo western HRP). 
Recipes of Western blotting reagents  
Complete lysis buffer: 
20 mM Tris PH 7.5; 150 mM NaCl; 1 mM EDTA.  
Just before use, the following reagents were added: complete protease inhibitors cocktail tablets 
(EDTA-free) (Roche # 05892953001) (1 tablet in 10 ml lysis buffer); phosSTOP phosphatase 
inhibitor cocktail tablets (1 tablet in 10 ml lysis buffer) (Roche # 04906845001), 1% Triton X-100. 
6x Laemmli loading dye stock: 
0.48 M Tris PH 6.8; 12% SDS, 60% glycerol; 25 g/mol β-mercaptoethanol and 0.06% 
bromophenol blue. Use at 1 X concentration. 
Wash buffer: 10 X TBST stock solution: 
200 mM Tris-base, 1.37 M NaCl in H2O. PH 7.6. Before use add 0.05 % tween-20 and use at 1 X 
concentration. 
10 X running buffer stock solution: 
248 mM Tris-base, 1.92 M glycine and 1% w/v SDS. Use at a final concentration of 1 X 
concentration. 
10 X transfer buffer stock solution: 
248 mM Tris-base, 1.92 M glycine. Use at a final concentration of 1 X and add 20% methanol 
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Table 2.1 List of primary antibodies used in western blotting. 
 
2.10.5 mRNA expression studies 
2.10.5.1 RNA extraction using Trizol reagent 
Total RNA was extracted from cells and fat tissues using Trizol reagent (Sigma). ~100 mg of 
frozen tissue were homogenized in 1ml Trizol using an IKA-T10 Ultra-Turrax homogenizer. 1 ml 
of Trizol reagent was added to day 7 BMDM, which were passed several times through a syringe 
with a 25G needle and transferred to Eppendorf tubes. Homogenates and cells were then 
centrifuged at 12000 g for 10 min at 4 °C and the supernatant transferred to new tubes. 200 µl 
chloroform was then added to denature proteins that become soluble in the organic phase while 
RNA is in the upper aqueous phase. The mixture was then vortexed, kept at RT for 15 min and 
then centrifuged at 12000 g for 15 min at 4 °C. 350 µl of the aqueous phase was taken into new 
tubes and an equal volume of isopropanol was added to precipitate the RNA. The mixture of 
aqueous phase/isopropanol was kept at RT for 10 min and then centrifuged at 12000 g for 10 
min. The pellet was then washed with 70% ethanol (in diethylpyrocarbonate (DEPC)-treated 
H2O), and centrifuged at 12000 g for 10 min. After the pellet was dried for 5 min it was 
resuspended in 30-40 µl of DEPC-treated H2O. RNA quality and quantity were assessed using 
the ND-1000 spectrophotometer Nanodrop (Thermoscientific) for real-time PCR (RT-PCR) 
purposes and a bioanalyser for mRNA sequencing purposes. 
2.10.5.2 Using RNeasy mini kit (Qiagen) 
The cell pellet collected from CD11b positive fraction (< 5 x10
6
 cells) was resuspended in 350 µl 
of RLT lysis buffer. After homogenization of the cells, RNA was precipitated with 70% ethanol and 
the sample transferred to an RNeasy spin column, washed twice and eluted by quick 
Primary PhosphoY641- 
STAT6 
STAT6 
Animal 
Source 
Rabbit polyclonal Rabbit 
polyclonal 
Supplier Abcam 
# ab54461 
Abcam 
# ab44718 
Concentration 0.046 µg/ml  1 µg/ml 
Band 
detected at  
94 kDa 100 kDa 
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centrifugation in RNase-free water.  RNA was quantified and reverse transcribed for RT-PCR 
purposes. 
2.10.5.3 Reverse transcription of RNA into complementary DNA (cDNA). 
RNA (~1 µg from BMDM and fat tissue, or 400 ng from CD11b positive fraction) was first 
decontaminated from DNA by adding DNase I in a total of 10 µl DNase buffer (DNase I Invitrogen 
# 18068-015) for 15 min at RT. The enzymatic reaction was then stopped by adding 1 µl of 25 
mM EDTA at 65°C for 10 min. 1 µl of random primers (Invitrogen # 48190-011) and 1 µl of 10 mM 
deoxyribonucleotides (dNTP) were then added and the reaction incubated at 65°C for 5 min, 
chilled on ice for 3 min after which a mixture of RNaseout (Invitrogen # 10777-019), 0.01 M 
dithiothreitol (Chen et al., 2004) and superscript II reverse transcriptase 5X first strand buffer was 
added and the reaction incubated at 25°C for 10 min followed by 42°C for 2 min. 
The sample was then divided into two tubes with 10 µl each, and 1 µl of superscript II reverse 
transcriptase enzyme (Invitrogen # 18064-022) was added to one tube and the other 10 µl was 
used as a negative control. The reaction was then incubated at 42°C for 60 min followed by 70°C 
for 15 min and samples stored at - 20°C. The cDNA was now ready for RT- PCR. 
2.10.5.4 Taqman real-time PCR 
cDNA was diluted 1/10 and 1 µl of this was used in 10 µl of RT-PCR master mix: 
1 µl of cDNA template 
0.5 µl of Taqman primer mix 
3.5 µl H2O 
5 µl Taqman universal PCR master mix (ABI # 4364340) 
 
Real-time PCR program 
1. 50°C 2 min 
2. 95°C 10 min 
3. 95°C 15 sec 
4. 60°C 1 min, Go to 3, 40x 
 
ABI Taqman probes are short oligonucleotides sequences that consist of a non-fluorescent 
quencher at 3’ end and a fluorophore (FAM) at the 5’ end of the oligonucleotide. They are listed in 
table 2.2.  
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RT-PCR reactions were run on a 384 well clear optical plate using a Taqman ABI 7900HT fast 
real time PCR machine equipped with SDS 2.3 software, which automatically  calculates  the 
fluorescent baseline, threshold and Ct (threshold cycle) values.  
Experimental Ct values were normalized to specific reference genes or internal controls 
(housekeeping genes). A relative quantification using the CT method was used. An absolute 
quantification using the standard curve method was used as indicated in the results section. 
Hypoxanthine phosphoribosyltransferase 1 (HPRT1) was the housekeeping gene used to 
normalize Ct values in macrophages (Stephens et al., 2011). HPRT1 Ct values were stable 
across BMDM and ATM samples of both genotypes and upon IL-4 and LPS treatments. To 
quantify mRNA in adipose tissues, the housekeeping genes ACTB (β-actin) and GAPDH 
(glyceraldehyde-3-phosphate dehydrogenase) were used. 
 
Gene name/symbol Taqman catalog number 
Irs2 (Insulin receptor substrate 2) Customed primers located between 200bp 
and 1000 bp of the Irs2 exon 
Ccl2 (Chemokine C-C ligand 2) Mm00441242_m1 
Ccl3 (Chemokine C-C ligand 3) Mm00441259_g1 
Ccl8 (Chemokine C-C ligand 8) Mm01297183_m1 
Il-6 (Interleukin 6) Mm00446190_m1 
Il-1β (Interleukin 1β) Mm01336189_m1 
Tnfα (Tumor necrosis factor α) Mm00443260_g1 
Cd11c (cluster of differentiation 11c) Mm00498698_m1 
Ucp1 (Uncoupling protein 1) Mm01244861_m1 
Pgc1α (Peroxisome proliferator-activated 
receptor gamma, coactivator 1 alpha)  
Mm01208835_m1 
Th (Tyrosine hydroxylase) Mm00447557-m1 
F4/80 Mm00802529_m1 
Inos (Inducible nitric oxide synthase) Mm00440502_m1 
Cd3 (Cluster of differentiation 3) Mm00442746_m1 
Cd4 (Cluster of differentiation 4) Mm00442754_m1 
Cd8 (Cluster of differentiation 8) Mm01182108_m1 
Siglec-F(Sialic acid-binding immunoglobulin-like 
lectin)  
Mm00523987_m1 
FoxP3 (Forkhead box P3) Mm00475162_m1 
Gr-1 (Granulocyte-differentiation antigen-1) Mm00459644_m1 
C-kit (CD117) Mm00445212_m1 
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Irs1 (Insulin receptor substrate 1) Mm01278327_m1 
Irs3 (Insulin receptor substrate 3) Mm00802869_g1 
Arg1 (Arginase 1) Mm00475988_m1 
Mrc1 (Mannose receptor 1) Mm00485148_m1 
Clec10a (C-type lectin domain family 10 
member A) 
Mm00546125_g1 
Retnla (Resistin-like molecule-alpha) Mm00445109_m1 
Hprt1 (Hypoxanthine phosphoribosyltransferase 
1) 
Mm00446968_m1 
Gapdh (Glyceraldehyde-3-phosphate 
dehydrogenase) 
Mm99999915_g1 
Actb (β-actin) Mm00607939_s1 
 
Table 2.2: List of real-time PCR Taqman probes. The gene name, its symbol and the 
Taqman probe catalog number are presented.  
2.11 mRNA sequencing of LPS-treated BMDM 
2.11.1 Validation of RNA quality by RNA integrity number (RIN) 
RNA quality was assessed using Agilent RNA 6000 Nano assay kit (Agilent Technologies # 5067-
1511) on a bioanalyzer (Agilent 2100 Bioanalyzer) to determine the RNA integrity number (RIN) 
which gives an estimate of RNA quality. When RIN is >8, the RNA is good enough for RNA 
sequencing. The RIN takes into consideration the whole RNA trace and therefore estimates low 
molecular weight material to the left of the RNA peaks  (indication of RNA degradation) or high 
molecular weight material to their right (indication of DNA contamination) as well as the ribosomal 
peaks (18S and 28S).  
2.11.2 cDNA library preparations and sequencing  
RNA integrity was confirmed and concentration measured using a Bioanalyzer (Agilent). cDNA 
libraries were created at the Sanger Institute from up to 5 μg total RNA as follows: Using a 
TruSeq RNA Sample Prep v2 kit (Illumina), poly-A tailed RNA (mRNA) was purified from total 
RNA using an oligo dT magnetic bead pull-down. The resulting mRNA was fragmented using 
metal ion-catalyzed hydrolysis and random priming used for the synthesis of double-stranded 
cDNA.  End repair was performed with a combination of fill-in reactions and exonuclease activity 
to produce blunt ends. A single “A” base was added to blunt ends followed by ligation to Illumina 
Paired-End Sequencing adapters containing unique index sequences, allowing samples to be 
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pooled. The resulting libraries were amplified through 10 cycles of PCR using KAPA Hifi 
Polymerase, products were pooled based on a post-PCR Agilent Bioanalyzer, then the pool was 
size-selected using the LabChip XT Caliper (200-500 bp range). There were four biological 
replicates for each group and each biological replicate was divided into eight technical replicates 
and sequenced on individual lanes on the Illumina HiSeq 2000 (100 bp paired-end read length) at 
the Sanger Institute. Sequencing data was quality controlled using the NCBIm37 reference 
genome and individual indexed library binary alignment map BAM files generated for downstream 
analysis.  
2.11.3 Data analysis  
The data was analyzed in collaboration with the Bioinformatics research support (gene and 
metabolism section) and the “Integrative Genomics and Medicine group at the Clinical Science 
Center, Medical Research Council, Imperial College. 
Comparisons were performed between control and Irs2lyzM-/- BMDM samples after treatment with 
vehicle or LPS as described above.  
Raw RNASeq reads were aligned with Tophat splice junction mapper (Trapnell et al., 2009) 
version 2.0.8 against Ensembl Mouse genome reference sequence assembly (mm9) and 
transcript annotations. Gene based read counts were then obtained using HTSeq count module 
(version 0.5.4p3). Differential expression analysis was performed on the counts data using 
DESeq Bioconductor package (Anders and Huber, 2010). The analysis was run with the default 
parameters. Independent filtering was done on the counts data prior to statistical testing to 
remove 20% of the genes with lowest counts. DESeq package uses negative binomial model to 
test for differential expression. 
Weighted gene co-expression network analysis (WGCNA) was used to extract co-
expression modules and derive their module eigengenes. WGCNA build a weighted network 
where genes that are strongly correlated are strongly connected, and extracts 
groups (modules) of strongly interconnected genes. Each module is then characterized by the 
first principal component of its expression, called the module eigengene. 
For modules with evidence for differential response to the LPS treatment, we performed gene 
ontology (GO) and pathway enrichment analysis (Kyoto Encyclopedia for genes and genomes 
(KEGG)) using database for annotation, visualization and integrated discovery (DAVID) software. 
We used the web-based tool, predicting associated transcription factors from annotated affinities 
(PASTAA) to test for enrichment in transcription factor binding site in the gene promoter regions 
(500 bp upstream of gene start). 
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2.12 Metabolomics study on IL-4 and LPS-treated BMDM secreted media 
2.12.1 Cell conditioned medium processing and freezing 
BMDM were plated at a density of 0.5 million cells/6 cm cell culture plates in 5 ml macrophage 
medium supplemented with 30 ng/ml of M-CSF (macrophage complete medium, MCM). Once 
adhered, medium was replaced and cells treated with MCM plus vehicle (1X PBS), 10 ng/ml 
recombinant mouse IL-4 or 100 ng/ml LPS for 24 hours. Each treatment was performed in 
triplicate. 50 µl of medium was collected after 24 hours treatment, frozen and stored at -80°C 
prior to analysis. 
2.12.2 Metabolite extraction 
50 µl of medium was collected and spun for 5 min at 4°C, 27000 g to get rid of dead cells. The 
supernatant was then resuspended in 750 µl of extraction buffer (see composition below) and 
mixed on a thermo mixer for 15 min at 4°C to allow extraction of the metabolites. The extracted 
metabolites were then collected in the supernatant by centrifugation for 10 min, 4°C at 27000 g. 
The supernatant was then transferred to mass spectrometry vials. 
Extraction Buffer:   
5 ml methanol (Fisher # 67-56-1) 
3 ml Acetonitrile (CTL #152516Q) 
2 ml H2O 
100 ng/ml 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) 
 
2.12.3 Mass spectrometry and sample analysis 
For LC/MS a ZIC-HILIC liquid chromatography (Merck), 4.6 X 150 mm column coupled with Mass 
spectrometry was used. The mass spectrometer used was an Orbitrap Q-Exactive (Thermo 
Scientific). The samples were run through an ion-switching mode, allowing the simultaneous 
analysis of positive and negative ions and the spectra were acquired in full mass mode. 
For targeted analysis of compounds Xcalibur Qual and Quan Browser softwares (Thermo 
Scientific) were used while the untargeted analysis was performed by using Sieve 2.0 (Thermo 
Scientific). Samples were randomized to avoid machine drift bias. 
The mass spectrometry study and its analysis were performed in the laboratory of Dr Christian 
Frezza at MRC Cancer Unit, University of Cambridge. 
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2.13 Statistical analysis 
All data is presented as mean + standard error of the mean (S.E.M) unless otherwise indicated. 
Statistical analysis was carried out using Prism 4 software. The tests used were unpaired Student 
t test when the distribution was normal and Mann-Whitney test when the distribution was not 
normal. Two-way analysis of variance (ANOVA) or repeated measures ANOVA where * p<0.05, 
**p<0.01, ***p<0.001 and ****p<0.0001 were used as indicated. For energy expenditure (EE) data 
in mice on HFD, a general linear modeling in the statistical package for the Social Sciences 
(SPSS) was used with genotype as a fixed factor, body mass as a covariate and EE as the 
dependent variable.  
For differential gene expression analysis, genes with adjusted p value of 0.05 or less were termed 
as differentially expressed genes. This analysis was performed on R 2.15 software (Anders and 
Huber, 2010; Trapnell et al., 2009). The metabolomics data analysis was performed using the 
Benjamini Hochberg algorithm, adjusted from p value of 0.05 or less. 
For co-expression module analysis, a linear model (with the module eigengene as response 
variable) was then used to test for interaction between both genotypes (control and Irs2lyzM-/-) and 
the LPS treatment, thereby testing for a differential response to the LPS treatment according to 
the genotype.  
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Chapter 3: Elucidation of the role of macrophage Irs2 in animal 
physiology: Investigation of the glucose homeostasis and 
adipose tissue homeostasis phenotypes.  
 
3.1 Introduction 
The development of obesity and its complications has been associated with the dysregulation of 
macrophage phenotypes, including the inflammatory phenotype, and this has revealed a tight link 
between metabolism and the immune system at the cellular, molecular and organismal level 
(Lumeng et al., 2007a, 2007b, 2007c; Weisberg et al., 2003). 
Macrophage infiltration and accumulation in the adipose tissue (AT) is the major contributor to 
obesity-induced inflammation and insulin resistance. These AT macrophages produce 
inflammatory cytokines which contribute to insulin resistance (Cohen et al., 2014; Ferrante, 
2013).  
While the role of macrophages in the pathophysiology of insulin resistance has been well 
established, their role in the regulation of energy expenditure in mice is still under intense 
investigation. One study has indicated a positive correlation between alternatively activated 
macrophages and energy expenditure in mice upon cold exposure (Nguyen et al., 2011).  
The aim of the studies described in this chapter is to dissect more specifically insulin function in 
macrophages during obesity-induced inflammation and insulin resistance and its role in the 
regulation of whole body energy homeostasis. To address this question, Irs2, the main Irs 
abundantly expressed in macrophages was deleted in myeloid lineages of the mouse. The in vivo 
role of Irs2 in macrophages in the regulation of glucose and fat homeostasis was studied in mice 
under normal diet conditions (chow diet) and high fat diet challenge (HFD). 
3.2 Generation of Irs2lyzM-/- mice which display efficient and specific 
deletion of Irs2 in macrophages 
Deletion of Irs2 in myeloid lineages was carried out using Cre-loxP technology as discussed in 
the Methods section. Specificity of Irs2 deletion in macrophages was confirmed by recombination 
PCR.  DNA was extracted from pure bone marrow-derived macrophages (BMDM) as well as 
other tissues such as brain, hypothalamus, liver, white adipose tissue (WAT), brown adipose 
tissue (BAT), skeletal muscle and spleen, from control and Irs2lyzM-/- mice on a chow diet. A 1.3kb 
recombined band was only detected in BMDM from Irs2lyzM-/- mice, indicating deletion of the Irs2 
gene in these cells. The deletion event was not detected in any of the other tissues tested 
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although theoretically, small populations of macrophages might be present in the tissues of mice 
on chow diet (Figure 3.1).  
To determine whether the recombined Irs2 allele is accompanied by a decrease in the expression 
levels of the gene, Irs2 expression levels were analyzed at the messenger RNA level by RT-PCR 
and at the protein level by immunocytochemistry.  
As seen in figure 3.2 A, in Irs2lyzM-/- BMDM, Irs2 expression levels are at 0.01% of control mice, 
indicating a very substantial reduction of Irs2. Irs1 and Irs3 were detected at low levels in BMDM 
compared to Irs2 as shown in the bar graph, but were not significantly altered between the control 
and the Irs2lyzM-/- BMDM upon Irs2 deletion indicating that there was no substantial compensatory 
increase in the expression of these IRS proteins. Irs4 was not detected in BMDM.  
Irs2 deletion was further confirmed at the protein level in BMDM from control and Irs2lyzM-/- BMDM 
which were immunostained with anti-rabbit IRS2 primary antibody as described in methods.   
While a cytoplasmic staining for IRS2 was observed in control BMDM, it was absent in Irs2lyzM-/- 
BMDM (Figure 3.2 B). Together these results suggest that Irs2lyzM-/- mice represent a suitable 
model to investigate the physiological role of Irs2 in myeloid cells. 
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Lane Sample Lane Sample 
1 BMDM -control 13 Skeletal muscle-control 
2 BMDM -control 14 Hypothalamus-control 
3 BMDM- Irs2lyzM-/- 15 Liver-control 
4 BMDM -control 16 Spleen-control 
5 BMDM- Irs2lyzM-/- 17 Empty lane 
6 BMDM- Irs2lyzM-/- 18 Brown adipose tissue-control 
7 White adipose tissue-control 19 Liver- Irs2lyzM-/- 
8 Skeletal muscle-control 20 White adipose tissue- Irs2lyzM-/- 
9 Hypothalamus-control 21 Hypothalamus- Irs2lyzM-/- 
10 Liver-control 22 Skeletal muscle- Irs2lyzM-/- 
11 Spleen-control 23 Spleen- Irs2lyzM-/- 
12 Brown adipose tissue-control 24 Brown adipose tissue- Irs2lyzM-/- 
 
Figure 3.1 Specificity of lysozymeM-Irs2 deletion by PCR. 
Recombination analysis of the Irs2 locus in BMDM and in indicated tissues of control and Irs2lyzM-/- 
mice. The recombined band detected is 1.3kb and is only detected in BMDM from Irs2lyzM-/- mice 
indicating recombination in macrophages and an absence of recombination in the other tissues. The 
250 bp band is the floxed allele band detected in all samples, confirming the presence of DNA 
template in all samples.  
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Figure 3.2 Efficiency of Irs2 deletion in BMDM determined at the transcript and protein 
level.  
A) Expression analysis of Irs2, Irs1 and Irs3 in BMDM of control and Irs2lyzM-/- mice. 
mRNA expression levels were quantified by real-time PCR (ABI) (n=4-6). A standard curve was 
used to compare differences in expression levels between control and Irs2lyzM-/- BMDM.  Error 
bars represent mean ± S.E.M., while significance was assessed with 2 way ANOVA (Tukey’s 
test), where *** p< 0.001, **** p< 0.0001. 
B) IRS2 immunostaining of BMDM from control and Irs2lyzM-/- mice.  
BMDM stained for IRS2 (green) and nuclear DNA with DAPI (blue).  Images were taken using a 
confocal microscope with a 20x lens and are representative of 3 mice/genotype.  Scale bars are 
~10 µm. 
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3.3 Glucose homeostasis phenotype of Irs2lyzM-/- mice on chow diet. 
3.3.1 Improved glucose homeostasis phenotype in Irs2lyzM-/- mice 
To assess the impact of deletion of Irs2 in macrophages upon glucose homeostasis, fasted 
glucose and insulin levels were measured in Irs2lyzM-/- female mice at 8 weeks of age.  The 
Irs2lyzM-/- female mice showed a small but significant decrease in their glucose levels (~16 %) 
with p<0.01 at fasted state, compared to the control mice. This decrease in glucose levels was 
accompanied by decreased insulin levels (33%) (p<0.01) in the serum of these mice (Figures 3.3 
A&B). Together these data suggest these mice have improved glucose homeostasis.  
Next, these mice were challenged with an intraperitoneal (IP) glucose tolerance test. Irs2lyzM-/- 
mice showed improved glucose tolerance at 15 and 30 minutes post glucose injection compared 
to their control littermates (Figure 3.3 C).  
3.3.2 Improved insulin sensitivity in Irs2LyzM-/- mice 
To further examine the potential insulin sensitivity phenotype in the Irs2LyzM-/- mice, the mice were 
subjected to an insulin tolerance test (ITT).  Consistent with decreased insulin levels, the Irs2LyzM-
/- mice demonstrate  better insulin sensitivity as shown by enhanced glucose clearance after 15 
minutes post insulin injection with a significant difference in area under the curve (p<0.01) (Figure 
3.3 D). These results suggest that the improved glucose homeostasis phenotype is most likely 
due to an improvement in insulin sensitivity in the Irs2LyzM-/- female mice.  
3.4 Assessment of adiposity and lean phenotype of Irs2lyzM-/- mice  
Analysis of  body composition: Body weight, fat and lean mass content on chow 
diet 
Body weight (BW) was measured weekly from 8 weeks until 23 weeks old, then measured once 
monthly thereafter. The Irs2lyzM-/- male and female mice showed no difference in body weight 
compared to the control mice on chow throughout this time. However, a trend towards a decrease 
in body weight was observed in the Irs2lyzM-/- male mice (Figures 3.4 A&B). The body composition, 
the total amount of fat and lean mass, was measured to determine whether Irs2 ablation from 
myeloid lineages has an impact on either fat or lean content. Male mice scanned on the Echo-
MRI showed no differences in percentage fat and lean mass content at 12 weeks  and 24 weeks 
of age. However, percentage fat was reduced by 17% in older (32 weeks old) Irs2lyzM-/- mice 
compared to the control mice on chow diet (Figure 3.4C) whereas percentage lean mass was 
increased by 5% (Figure 3.4D). Aged female mice did not show any difference in their adiposity. 
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Figure 3.3 Glucose tolerance and insulin sensitivity in 8 week old Irs2lyzM-/- female mice.   
A) Blood glucose levels (mmol/L) (n=21/group) (B) and serum insulin levels (ng/ml) (n=12 control and n=20 
Irs2LyzM-/-) in control and Irs2lyzM-/- female mice following an overnight fast. (Student t test; **p<0.01).  
C) Glucose tolerance test (GTT) in control and Irs2lyzM-/- female mice following an IP injection of 2g/kg 
glucose (n=8-10) (repeated measures ANOVA and Tukey test with *p<0.05). 
D) Insulin tolerance test (ITT) in 8 weeks old control and Irs2lyzM-/- female mice. Data are presented as 
percentage of initial glucose concentrations. The total area under the curve (AUC) shows increased insulin 
sensitivity in Irs2lyzM-/- female mice compared to the contol mice following 0.45 iU of insulin/kg (n=8-10) 
(Student t-test was used to compare means of AUC represented as bar graphs with **p<0.01). 
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Figure 3.4 Weight gain and adiposity in Irs2lyzM-/-  mice 
Body weight curve of control and Irs2lyzM-/-  female (A) and male (B) mice on chow diet.  Mice 
were weighed from 8 weeks of age until 23 weeks of age. No significant difference is 
observed in BW between both groups (Males: n=12-15 (1 cohort). Females n=18 (2 cohorts 
from weeks 1 to 7 and n=8 (1 cohort) from weeks 7 to 15) (Repeated measures two-way 
ANOVA and Tukey test).  
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Figure 3.4 Weight gain and adiposity in Irs2lyzM-/-  mice 
(C) % fat mass (total fat mass as measured by Echo-MRI/BW*100) is similar between both 
groups of males at 12 weeks and 24 weeks but is significantly decreased by 32 weeks.  
(D) % lean mass (total lean mass /BW*100) is consistant between groups at 12 weeks and 24 
weeks but increased at 32 weeks in the Irs2lyzM-/- males on chow. (n=8-11 at 12 weeks, n=10-16 at 
24 weeks, n=23-24 at 32 weeks).  
Bar charts represent mean + S.E.M  (Student t test when the distribution was normal and  Mann 
Whitney test when the distribution is not normal, * p<0.05) 
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3.5 Increased energy expenditure (EE) in the Irs2lyzM-/- mice on chow diet. 
We next addressed whether the lean phenotype observed with ageing in the male mice is a result 
of alterations in energy expenditure in the Irs2lyzM-/- mice. 8 week old male mice which show no 
difference in body weight (Figure 3.4 B) were singly housed in metabolic cages (CLAMS) and 
acclimatised for 24 hours before assessing their metabolic rate. EE was recorded every 15 min 
throughout a period of 24 hours. Irs2lyzM-/- mice displayed increased energy expenditure during 
both light and dark cycles (Figures 3.5 A&B) compared to their control littermates.  
3.6 Increased food intake in Irs2lyzM-/- mice on chow diet. 
Despite the increased energy expenditure phenotype observed in the Irs2lyzM-/- mice at 8 weeks 
old, they maintain similar body weight, total fat and lean content. To resolve this paradox of 
increased energy spent with no changes in fat content or body weight, energy consumption was 
measured in the same mice. Food intake monitored by the CLAMS over a period of 24 hours 
indicated increased food uptake by Irs2lyzM-/-  male mice compared to the control mice, when body 
weight was the same (Figures 3.6 A&B).  
Increased food intake in female Irs2lyzM-/- mice compared to the control mice was also found when 
this was measured manually weighing food intake in singly housed mice. This was normalised to 
body weight and plotted as daily amount of food eaten/body weight (Figure 3.6 C). Additionally, 
there was increased cumulative food intake in 10 weeks old Irs2lyzM-/- mice 8 and 24 hours after 
refeeding (Figure 3.6 D). These results corroborate the increased food intake seen in the 8 weeks 
old female mice.  
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Figure 3.5 Energy expenditure measured by indirect calorimetry using CLAMS over a 
period of 24 hours 
A,B) Energy expenditure (EE) in Kcal/hour. Graph plots represent the mean EE + S.E.M.  The mean 
represents the average of all EE values recorded every 15 min for each mouse during the day (7 
a.m to 7 p.m) or the night (7 p.m to 7 a.m). Student t-test with **p<0.01 and ***p<0.001 (n=22-26). 
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Figure 3.6 Food intake of Irs2lyzM-/-  mice  
(A) Body weight (g) of 8 week old male mice singly housed in CLAMS cages (n=22-26). 
(B) Food intake calculated as the average of the amount of food eaten every 15 minutes by 8 week 
old male mice during the 24 hours period (n=22-26). 
(C) Food intake calculated manually as the food added into the hopper minus the remaining food 
after a 24 hour period. Bar graphs represent the amount of food eaten by 8 week old female mice 
singly housed and normalised to their body weight.  
D) Fast-refeeding response following an overnight fast in 10 week-old female mice.  
All data are plotted as means + S.E.M (Student t test with *p<0.05 and **p<0.01).  
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3.7  Improved glucose tolerance and insulin sensitivity in Irs2LyzM-/- mice on 
HFD. 
As macrophages have been strongly implicated in the pathophysiology of the insulin resistance 
seen in obesity, 8 week old control and Irs2LyzM-/- female mice were challenged with high fat diet 
(HFD). Feeding a HFD to control mice resulted in hyperglycemia, hyperinsulinemia and increased 
HOMA-IR (p<0.001, p< 0.5 and p<0.01 respectively) (Figures 3.7 A, B & C) after 8 weeks on the 
HFD. In contrast, Irs2LyzM-/- mice were protected from these effects. Glucose and insulin levels in 
Irs2LyzM-/- were significantly lower with p<0.01 (Figures 3.7 A & B) and same was HOMA-IR 
(Figure 3.7 C), relative to HFD-fed control mice. After 16 weeks on HFD, the Irs2LyzM-/- mice still 
retained the beneficial glucose homeostasis phenotype, manifested by lower glucose levels and 
lower homeostatic model assessment (HOMA), implicating improved insulin sensitivity (Figures 
3.7 D, E & F). In addition, they handled glucose better than their control littermates as 
demonstrated by improved glucose tolerance (Figures 3.7 G&H). These results indicate that 
macrophage Irs2 signaling promotes HFD-induced insulin-resistance and type 2–diabetes and 
that abrogating Irs2-dependent signaling events in macrophages can protect mice from high fat 
diet-induced insulin resistance.   
3.8 Role of macrophage Irs2 in adiposity and weight gain on HFD. 
8 week-old control and Irs2lyzM-/- female mice were put on HFD and their body weight was 
monitored for 15 weeks. While control mice gained significantly more body weight after 4 weeks 
on HFD and onwards compared to the control mice on normal chow diet, the Irs2lyzM-/- mice 
gained significantly less weight when compared to the control mice on HFD (Figure 3.8 A). 
To ascertain the decreased body weight phenotype in Irs2lyzM-/- female mice observed even after 
24 weeks on HFD (Figure 3.8 B), their adiposity was assessed by Echo-MRI. There was a 
significant decrease in the % fat content in the Irs2lyzM-/- mice compared to the high-fat fed contol 
mice (Figure 3.8 C). The % lean mass was slightly increased in Irs2lyzM-/- mice (Figure 3.8 D). 
 
Consistent with decreased fat content (Figure 3.8 C), perigonadal fat pads (Figure 3.8 E) and 
interscapular brown adipose tissue (Figure 3.8 F) weighed significantly less in the Irs2lyzM-/- mice 
compared to the control mice after 40 weeks on HFD, when these mice were culled. However, 
when normalized to body weight, % fat pad weights  were not significantly different than their 
controls (Figure 3.8 G) whereas % BAT weights remained lower (Figure 3.8 H). 
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Figure 3.7 Improved glucose homeostasis phenotype in the Irs2lyzM-/- mice on HFD 
A, B, C) Blood glucose levels (mmol/L) (A), insulin levels (ng/ml) (B) and HOMA insulin resistance 
(HOMA-IR) in 16 week-old control and Irs2lyzM-/- female mice on chow and HFD (8 weeks) after 6 
hours fast (n=8-9). (Two way ANOVA, Tukey’s test with *p<0.05, **p<0.01   and ***p<0.001). 
D, E, F) Blood glucose levels (mmol/L) (C), insulin levels  (ng/ml) (D) and HOMA-IR (E) in 32 week-old 
female mice (24 weeks on HFD) after 16 hours fast (n=20-22). (Student t test with *p<0.05 and 
**p<0.01) 
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Figure 3.7 Improved glucose homeostasis phenotype in the Irs2lyzM-/- mice on HFD. 
G, H) Decreased glucose levels (F) and improved glucose tolerance test (1g/kg) (G) after 6 hours fast 
in 24 week-old Irs2LyzM-/- female mice on HFD (16 weeks) (n=20-22). (Student t-test with p<0.0001 and 
repeated measures ANOVA, Tukey's test with **p<0.01 and ****p<0.0001). 
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Figure 3.8 Attenuation of HFD-induced weight gain and adiposity in Irs2lyzM-/-  mice 
A) Body weight (BW) curve of control and Irs2lyzM-/- female mice on chow diet and HFD showing 
weekly BW, starting from 8 weeks of age, for 15 weeks. Repeated measures two way ANOVA was 
used to compare mean BW between all four groups at different time points. Statistical significance 
is noted after 4 weeks on HFD between control group on chow and control group on HFD. 
Similarly, a significant difference between control group on HFD and Irs2lyzM-/- group on HFD was 
also noted after 4 weeks on HFD. (* denotes significance from control chow; 
&
 denotes 
significance from the control HFD relative to Irs2lyzM-/- on HFD). (n=18-23 (2 cohorts) between 1
st
 
week and week 7; n=8-11 (1 cohort) between week 7 and week 15). 
B, C, D) Decreased BW (g), % fat mass (fat/BW) and increased % lean mass (Lean/BW) in 32 week- 
old Irs2lyzM-/- female mice compard to their control littermates after 24 weeks on HFD. Values are 
means + S.E.M (Student t-test with *p<0.05 and **p<0.01) (n=23). 
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Figure 3.8 Attenuation of HFD-induced weight gain and adiposity in Irs2lyzM-/-  mice  
E,F) Perigonadal fat pad weight (g) (n=18-21) and interscapular BAT weight (g) (n=8-11) from control 
and Irs2lyzM-/-  female mice on chow and HFD.  
G,H) % fat pad weight and % interscapular BAT weight (raw weights normalised to body weight).  
Values are means + S.E.M (Two way ANOVA and Tukey test where 
&
 is significant from control 
chow, 
#
 significant from Irs2lyzM-/- chow, * significant from control HFD, *p<0.05, **p<0.01, 
#
p<0.05 
and 
&&&&
p<0.0001). 
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3.9 Decreased fasting leptin levels in the serum of Irs2lyzM-/- mice on HFD 
diet 
Consistent with reduced adiposity in the Irs2lyzM-/- mice on HFD, the serum levels of the hormone 
leptin were significantly lower after a six hours fast of the 10 week-old Irs2lyzM-/- mice compared to 
the wild-type mice after 8 weeks on HFD (Figure 3.9). 
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Figure 3.9 Leptin levels in the serum of control and Irs2lyzM-/-  mice on chow and HFD.  
16 week-old female mice on chow and on HFD for 8 weeks were tail bled and serum was collected 
after spinning the coagulated blood. Leptin levels (ng/ml)  were measured by ELISA (n=7-8 on 
chow and n=10-12 on HFD) where the intensity of the colour developed following the addition of 
the enzyme substrate is proportional to the levels of leptin present in the serum.  Plots represent 
mean + S.E.M (Two way ANOVA and Tukey test with ****p<0.0001 relative to control chow, 
&&& 
relative to control on HFD, 
# 
relative to Irs2lyzM-/- on chow .  
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3.10 Increased energy expenditure in Irs2lyzM-/-  mice upon HFD exposure. 
To investigate the mechanism behind the resistance to diet-induced obesity, mice were put in 
CLAMS cages after 32 weeks on HFD to measure their metabolic rate. Food hoppers were 
prepared with minced HFD rather than the regular chow diet.  Energy expenditure was monitored 
for 24 hours following a 24 hour acclimitisation period.   
As expected, the Irs2lyzM-/- mice manifested a greater increase in energy expenditure calculated as 
Kcal/hour compared to the control mice despite their decreased body weight (Figure 3.10 A) 
during both light and dark cycles (Figure 3.10 B).  
3.11  Increased core body temparature of Irs2lyzM-/-  mice on HFD. 
Alterations in BAT activity have a great impact on core body temperature. High body temperature 
is generally associated with increased heat production and is a consequence of increased BAT 
activity. Consistent with increased food intake and increased energy expenditure, the core body 
temperature was significantly higher in Irs2lyzM-/- mice compared to control mice after 40 weeks on 
HFD (Figure 3.11). 
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Figure 3.10 Energy expenditure (Kcal/hour) measured by CLAMS in HFD-fed mice for 32 
weeks.  
(A) Body weight (g) is significantly decreased in the Irs2lyzM-/- female mice compared to the control 
mice after 32 weeks on HFD. Data is presented as mean BW + S.E.M  (t-test with *p<0.05). 
(B) EE (Kcal/hour) during the light cycle (7 a.m to 7 p.m) and the dark cycle (7 p.m to 7 a.m) between 
both groups after 32 weeks on HFD.  
Mean values were plotted + S.E.M. A general linear model with genotype as a fixed factor, body weight 
as a covariant and EE as the dependant variable is used  (n=22-23, *p<0.05). 
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Figure 3.11 Measurement of core body temperature 
Core body temperature measured with a rectal probe at 2 p.m is signifcantly increased in the 
Irs2lyzM-/- female mice compared to the control mice after 40 weeks on HFD (n=9-11, t-test and 
p=0.05).  
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3.12 Discussion 
The results presented in this chapter describe the generation of a conditional knockout mouse 
model to investigate the role of Irs2 in myeloid cells specifically macrophages in the regulation of 
whole body energy homeostasis.  
The deletion of Irs2 in macrophages was highly efficient as shown by DNA recombination as well 
as mRNA and protein expression studies. Irs2 recombination was specific to BMDM and absent 
in peripheral tissues. At the mRNA level, Irs2 deletion was confirmed in BMDM where it was 
shown to be decreased respectively.  
These results indicate that Irs2lyzM-/- mice are a suitable model to study the impact of Irs2 deletion 
in macrophages on whole body energy homeostasis. 
As these results demonstrate, deletion of Irs2 in macrophages has beneficial metabolic effects in 
mice. Irs2lyzM-/- female mice show improved glucose homeostasis phenotype manifested by 
improved glucose tolerance and insulin sensitivity at 8 weeks old on chow diet.  When challenged 
with a HFD, Irs2lyzM-/- female mice are protected from diet-induced weight gain, adiposity and 
insulin resistance. The increased energy expenditure on HFD and increased thermogenesis 
(body temperature) may account for their lean phenotype. An interesting phenotype was 
observed in male Irs2lyzM-/- mice which show reduced fat content at 32 weeks old on chow diet, 
yet they have no difference in adiposity at earlier ages.  Irs2lyzM-/- male mice show increased 
energy expenditure and food intake at 8 weeks old and have a body weight comparable to their 
control littermates.  
The metabolic changes in these mice might implicate changes in the macrophage phenotype and 
studies in subsequent chapters will reveal some of the molecular mechanisms underlying these 
metabolic changes.   
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Chapter 4: Molecular mechanisms underlying the phenotypic 
changes in Irs2LyzM-/- mice. 
 
4.1 Introduction 
In the lean state, adipose tissue macrophages normally have an anti-inflammatory phenotype and 
they are referred to as “alternatively activated macrophages-(AAMs)”.  As discussed earlier, their 
presence in the AT is highly dependent on IL-4 (Chawla et al., 2011) and is crucial in the 
maintenance of cold-induced thermogenesis, whereas their absence impairs metabolic 
adaptation to cold. This is dependent on their capacity to secrete catecholamines and their 
presence in the BAT is associated with increased expression of thermogenic markers. AAMs 
express the cell surface markers Mrc1, Clec10a and genes encoding enzymes such as Arg1 
(Chawla et al., 2011). These macrophages are less prominent in the obese state and are 
replaced by a group of inflammatory macrophages (classically activated macrophages). These 
macrophages have a different molecular signature and transcriptional profile than AAMs as they 
express high levels of Cd11c and pro-inflammatory cytokines including Tnfα, Inos, Il-6 and Il-1β. 
They are implicated in obesity-induced insulin resistance, an effect often associated with reduced 
energy expenditure. In addition to the role of macrophages in this process, additional cells of the 
immune system have been implicated in the development of obesity-induced metabolic disorders 
(Mathis, 2013) and reviewed in the introduction sections 1.6.2 and 1.7. 
In the previous chapter, we have shown that IrslyzM-/- mice are protected from HFD-induced 
obesity and insulin resistance and counteract the HFD challenge with increased energy 
expenditure and body temperature which result in reduced adiposity. Additionally, we have 
demonstrated that IrslyzM-/- mice show improved insulin sensitivity, glucose tolerance and 
increased energy expenditure on chow diet.  
These beneficial metabolic phenotypes as manifested by resistance to HFD challenge might 
suggest that IrslyzM-/- macrophages are characterized by an anti-inflammatory phenotype. 
The studies in this chapter aim to address the mechanisms by which loss of Irs2 in macrophages 
results in the metabolic phenotypes seen in Irs2lyzM-/- mice described in the preceding chapter.  
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4.2 Molecular characterization of the improved energy homeostasis in 
Irs2LyzM-/- mice. 
4.2.1 Gene expression changes of CAM markers in adipose tissues of Irs2LyzM-/- 
mice on chow and HFD. 
The improved glucose tolerance and insulin action in Irs2LyzM-/- mice under the chow diet and 
HFD led us to measure inflammatory gene expression levels in AT to correlate inflammatory 
changes with glucose homeostasis phenotype in the absence of Irs2.  
Gene expression levels of a number of the pro-inflammatory macrophage markers such as F4/80 
and CD11c were measured in the perigoanadal WAT (pWAT) of 24 week-old male Irs2LyzM-/- 
mice on chow and HFD (16 weeks on HFD). Additionally, the expression levels of a range of 
chemokines including Ccl2, Ccl3 and Ccl8 were measured in pWAT of these mice.  
While mRNA levels of F4/80 and Cd11c were increased by ~3 fold (p<0.0001 and p<0.001, 
respectively) in pWAT of control mice on HFD relative to control mice on chow diet, this increase 
was minimal in Irs2LyzM-/- mice.  There was a significant reduction (p<0.0001) in the expression 
levels of both markers in the pWAT of Irs2LyzM-/- mice compared to control mice on HFD (Figures 
4.1 A&B). Similarly, HFD significantly increased mRNA levels of Ccl2, Ccl3 and Ccl8 in the pWAT 
of control mice (p<0.0001 and p<0.05), and mRNA levels of Ccl2 and Ccl3 were significantly 
reduced in pWAT of Irs2LyzM-/- mice compared to HFD-fed control mice. Ccl8 was not significantly 
different between both groups (Figure 4.1C). 
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Figure 4.1 Gene expression changes of inflammatory markers in the pWAT of mice on chow 
and HFD. 
A,B) mRNA levels of the macrophage marker F4/80 and CAM marker Cd11c in pWAT of males on chow 
and HFD relative to control mice on chow (considered as 1) (n=10-12). 2 way ANOVA and Tukey test with 
****p<0.0001 compared to control chow and 
&&&&
p<0.0001 compared to control HFD. 
C) mRNA levels of chemotactic markers Ccl2, Ccl3 and Ccl8 relative to control on chow (considered as 
1) (n=10-12). Bar graphs represent mean values as fold change from the control chow. 
Error bars are mean + S.E.M.  (Two way ANOVA and Tukey test with 
&
 p<0.05 and 
&&&&
 p<0.0001 relative 
to control on chow; *p<0.05 and ***p<0.001 relative to control on HFD). GAPDH and -actin were used as 
housekeeping genes. 
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4.2.2 Molecular and cellular changes in BAT that might explain the increased 
energy expenditure phenotype in the Irs2lyzM-/- mice. 
4.2.2.1 Gene expression changes of thermogenic markers in the BAT of mice on chow diet 
Since increased energy expenditure is associated with increased thermogenic activity in BAT, we 
assessed mRNA levels of thermogenic markers in this tissue. Ucp1 and Pgc1α were increased in 
the BAT of 12 week- and 32 week-old  Irs2lyzM-/- mice compared to the control mice on chow diet. 
We also looked at the mRNA levels of the gene encoding tyrosine hydroxylase (TH), the key 
enzyme in the synthesis of catecholamines, in BAT from control and Irs2LyzM-/- mice. Th was 
increased in BAT from Irs2lyzM-/- mice compared to control mice, implicating perhaps increased 
catecholamine production in the BAT (Figure 4.2).  
4.2.2.2 Brown adipose tissue morphology on chow and HFD 
Similar to WAT, BAT stores triglycerides and under high sympathetic drive undergoes PKA-
activated lipolysis. Activation of lipolysis increases UCP1 activity in BAT (Greenberg et al., 2011). 
Increased Ucp1 mRNA levels in BAT under normal chow diet prompted us to look at BAT lipid 
droplets to assess its lipid utilization under both normal chow and HFD challenge. 
Hematoxylin and eosin staining of 5 m BAT sections from mice on chow and HFD indicated 
increased lipid droplet size in 48 week-old control mice after 40 weeks on HFD compared to 
control mice on chow diet. This was blunted in HFD-fed Irs2lyzM-/- mice which manifested smaller 
lipid droplets, suggesting increased lipid utilization following long exposure to HFD (Figure 4.3). 
Additionally, the staining indicated reduced lipid droplet size in Irs2lyzM-/- mice on chow compared 
to control mice on chow (Figure 4.3 top panel). 
The decreased lipid content in BAT from Irs2lyzM-/- mice under both chow and HFD suggests 
increased BAT activity and as a consequence increased non-shivering thermogenesis in Irs2lyzM-/- 
mice under normal conditions and upon long exposure to HFD.  
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Figure 4.2 Thermogenic markers in the brown adipose tissue of control and Irs2lyzM-/-  
mice on chow diet. 
Gene expression analysis by RT-PCR of Ucp1,  Pgc1 and Th in the BAT of 12 week-old (n=6-8) 
and 32 week-old control and Irs2lyzM-/- mice (n=10-16). Data is expressed as fold change relative 
to control (considered as 1). -actin was used as housekeeping gene. Student t-test was used 
with *p<0.05, **p<0.01 and ***p<0.001. 
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Figure 4.3 Hematoxylin and eosin (H&E) staining of 5 m sections of interscapular BAT. 
The top panel represent H&E staining of BAT sections from 12 weeks old mice on chow diet and 
shows smaller lipid droplets in BAT from Irs2lyzM-/- mice. Hematoxylin stains the nuclei blue/purple 
(seen as blue dots) and the eosin stains the cytoplasm pink. The images were taken using 20 X 
magnification. The bilocular magnification is 4 X so the final magnification is 80x. Scale bars are 1 
mm. 
The lower panels show differences of fat accumulation in the BAT between the two groups on HFD 
(n=4-5).  
 
118 
 
4.2.2.3 Increased catecholamine levels in urine samples from Irs2lyzM-/- mice on HFD. 
We aimed to determine the molecular mechanisms behind the increased energy expenditure by 
assessing catecholamine levels in the urine. We measured epinephrine and norepinephrine 
levels in the urine of female mice on HFD, since increased energy expenditure in mice could be a 
result of increased levels of these catecholamines. There was a marked increase in both 
epinephrine (Figure 4.4 A) and norepinephrine levels (Figure 4.4 B) in the urine of Irs2lyzM-/- mice  
compared to their control littermates on HFD.  
4.2.2.4 Norepinephrine secretion by Irs2lyzM-/-   BMDM.  
Increased catecholamine secretion by alternatively activated macrophages has been associated 
with increased energy expenditure during cold-induced thermogenesis. This secretion is IL-
4/STAT6 dependent and abrogation of this pathway in macrophages impairs metabolic 
adaptation to cold in mice. Catecholamine levels were detected in the secreted media from 
BMDM (Nguyen et al., 2011). 
Since mice carrying Irs2 deletion in macrophages manifest increased energy expenditure upon 
HFD challenge, we measured catecholamine secretion in the media of control (PBS) treated and 
IL-4 treated BMDM in the presence and absence of Irs2 by using a targeted metabolomics 
approach (details on the metabolomics technique are in the methods section and details on its 
rational are in the next result chapter). PBS-treated BMDM were used as a control. These BMDM 
were isolated from 12 week-old male mice on chow diet.  . 
Targeted analysis was able to detect norepinephrine in the medium of BMDM. Norepinephrine 
was significantly reduced upon IL-4 treatment in control BMDM. There was a trend towards 
increased norepinephrine levels in Irs2lyzM-/- BMDM upon IL-4 treatment compared to control-
treated Irs2lyzM-/- BMDM (Figure 4.5).  
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Figure 4.4 Catecholamine levels in urine samples from control and the Irs2lyzM-/- mice on 
HFD. 
(A,B) Epinephrine and norepinephrine levels in urine samples run by duplicate, measured by 
sandwich ELISA and normalised to millimole of creatinine levels.  Urine was collected from 40 week -
old female mice following 32 weeks on HFD (n=9-11). Student t-test was used with * p<0.05. 
The ELISA was run by Keith Burling from the core biochemical assay laboratoy at Cambridge 
university Hospitals.  
 
Figure 4.5 Alteration of norepinephrine levels in the media of Irs2lyzM-/- BMDM.  
Norepinephrine changes in Irs2lyzM-/- BMDM upon IL-4 treatment.  The unit value is signal intensity. Bar 
graphs represent the mean + S.E.M.  N=3 biological samples and n=3 technical triplicates per sample. 
For statistical significance, two way ANOVA and Tukey test was used for significance *p<0.05. 
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4.2.2.5 ATM signature in Irs2lyzM-/- mice on HFD.  
 
To determine the signature of macrophages in vivo, CD11b positive fraction was isolated from the 
stromal vascular fraction (SVF) of pWAT from 32 week-old control and Irs2lyzM-/- mice on HFD (24 
weeks on HFD). Details on the magnetic isolation of CD11b positive fraction from the pWAT SVF 
is described in methods. The whole eluate (CD11b positive fraction) consisting of adipose tissue 
macrophages (ATM) from control and Irs2lyzM-/- mice on HFD was used to determine gene 
expression levels of macrophage markers. 
The AAM marker Arg1, a direct target of STAT6 was increased by ~ 10-fold in Irs2lyzM-/- ATM 
whereas other STAT6 targets including Mrc1,Clec10a and Retnla were not altered at the mRNA 
level (Figure 4.6). 
The mRNA levels of the cell surface marker F4/80 were not changed between both groups. Inos 
mRNA levels were decreased by ~ 3 fold indicating reduced inflammation in the AT from Irs2lyzM-/- 
mice on HFD. Alterations in Arg1 and Inos mRNA levels in the pWAT imply changes in their 
enzymatic activities and in the urea cycle. This will be discussed further in the next chapter. 
 
This result might also indicate that transcription factors other than STAT6 regulate Arg1 
expression. Further studies in the next chapter will reveal candidate transcription factors which 
regulate Arg1 expression.   
 
 4.2.2.6 IL-4-induced STAT6 tyrosine phosphorylation is independent of Irs2.  
 
We next aimed at determining STAT6 activity in BMDM in the presence and absence of Irs2 upon 
IL-4 treatment. STAT6 initial activity was detected by its tyrosine phosphorylation (STAT6-Tyr
641
). 
As expected, STAT6 tyrosine phosphorylation is completely independent of the expression of Irs2 
(Figure 4.7).  
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Figure 4.6 mRNA levels of macrophage markers in ATM from Irs2lyzM-/- mice on HFD. 
Relative gene expression of the alternative macrophage makers, Arg1, Mrc1, Clec10a, Retnla and 
inflammatory markers F4/80 and Inos in ATM from control and Irs2lyzM-/- male mice on HFD (pool of 
n=3 mice and the experiment was repeated twice). Student t-test with **p<0.01 and **** p<0.0001. 
 
 
Figure 4.7 STAT6 phosphorylation upon IL-4 treatment in control and Irs2lyzM-/-  BMDM. 
Western blotting of protein lysates from control and Irs2lyzM-/- BMDM treated with 20 ng/ml of IL-4 for 
30 min. Antibodies against phosphoSTAT6 tyrosine 641, and total STAT6 were used. Total STAT6 
was used for normalization. 
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4.2.3 Innate and adaptive immune cells alteration in the AT of Irs2lyzM-/- mice  
 
To explain the potential contribution of immune cells behind the metabolic  phenotype, we looked 
at the mRNA levels of markers of other innate cells as well as adaptive immune cells by RT-PCR 
since their abundance in the AT could be associated with obesity-induced inflammation and 
insulin resistance. mRNA levels were measured in 32-week old mice after 24 weeks on HFD. 
The clusters of differentiation Cd3, Cd4 and Cd8, predominanatly expressed in mature T cells, T 
helper cells and cytotoxic T cells, respectively, as well as the transcription factor Foxp3, that 
defines both natural T regulatory cells and adaptive T reg cells, were unchanged between control 
and Irs2lyzM-/- pWAT. The eosinophil marker Siglec-F and the granulocyte marker Gr-1 were also 
unchanged between both groups. In contrast a significant decrease in the expression of C-kit, a 
marker of mast cells, was observed (Figure 4.8). 
 
 
 
 
 
Figure 4.8 Gene expression of immune cell markers in perigonadal white adipose tissue 
of mice on HFD.  
Relative gene expression of immune cell markers Cd3, Cd4, Cd8, Foxp3, Siglec-F, Gr-1 and  
C-kit in pWAT of males on HFD (n=10-12). Student t-test with **p<0.01. 
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4.3 Discussion 
 
The results present in this chapter define a novel role for Irs2 in regulating inflammatory pathways 
in ATMs from mice on chow and HFD and therefore provide evidence for the role of Irs2 signaling 
in macrophages in the regulation of energy homeostasis. 
Irs2 deletion in macrophages prevents accumulation of inflammatory macrophages in the adipose 
tissue. mRNA levels of the macrophage cell surface marker F4/80 and the dendritic cell surface 
marker Cd11c were decreased in the pWAT from Irs2lyzM-/- mice on both chow and HFD. These 
findings are consistent with previous reports showing that a macrophage population with 
decreased F4/80 expression is abundant in the lean AT and an F4/80 and  CD11c rich population 
is abundant in the obese (Lumeng et al., 2007a). Therefore improved insulin sensitivity and 
reduced adiposity in Irs2lyzM-/- mice could be attributed to reduced macrophage inflammatory 
phenotype. However, immunostaining of macrophage markers, for example CD68 or F4/80, on 
pWAT sections would be essential to determine any changes in macrophage number in this 
tissue.  
The reduced mRNA expression levels of F4/80 in the lean pWAT from Irs2lyzM-/- mice might 
indicate reduced macrophage number in pWAT. This could be due to either reduced migration of 
monocytes from the bloodstream or a defect in the proliferation of resident macrophages in 
pWAT. Both mechanisms were shown to influence obesity-induced inflammation, and both 
mechanisms are driven by the chemotactic marker CCL2 (Amano et al., 2014). However,  recent 
studies have shown that in vivo macrophage proliferation is dependent on the IL-4/AKT signaling 
(Rückerl et al., 2012). Since Irs2 mediates the IL-4 signaling in macrophages, we speculate that 
there might be a defect in resident macrophage proliferation in the AT of Irs2lyzM-/- mice. 
Nonethless Irs2 mediates insulin signaling as well and previous studies have indicated that 
alteration of insulin signaling in monocytes and macrophages results in a reduction in the 
recruitment of monocytes into the AT (Mauer et al., 2010). Therefore Irs2 in macrophages might 
be responsible for the proliferative effect of IL-4 or could be critical for macrophage recruitment to 
WAT by mediating insulin signaling.  
 
Another characteristic of Irs2lyzM-/- mice that contributes to their lean phenotype on HFD is 
increased energy expenditure and increased body temperature. There was increased 
catecholamine levels in the urine from Irs2lyzM-/- mice compared to control mice (Figure 4.4) and a 
rise in mRNA levels of some thermogenic markers in BAT including Ucp1 and its upstream 
regulator Pgc1α (Figure 4.2). Additionally, the expression of Th was increased  in the BAT from 
Irs2lyzM-/- mice suggesting increased catecholamine content. Moreover mRNA levels of the AAM 
marker Arg1 were significantly increased, whereas Inos levels were reduced in the ATMs isolated 
from pWATof Irs2lyzM-/- mice on HFD compared to control mice.  
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BAT sections from Irs2lyzM-/- mice revealed decreased number of lipid droplets on HFD compared 
to control mice which might indicate increased BAT activity. This is a consequence of increased 
β3-adrenergic stimulation and catecholamine production in BAT. 
 
With the finding that murine BMDM produce epinephrine and norepinephrine (Nguyen et al., 
2011), we looked for catecholamine production in the conditioned medium (CM) from BMDM and 
were able to detect norepinephrine by using a targeted metabolomic approach. Epinephrine was 
not detectable using this approach. Our results indicated a trend towards increased 
norepinephrine levels in the CM from Irs2lyzM-/- BMDM upon IL-4 treatment compared to control 
BMDM. Previous reports demonstrated reduced norepinephrine levels in the CM from STAT6-/- 
BMDM upon IL-4 treatment (Nguyen et al., 2011). Our findings suggest that IL-4 signals through 
Irs2 to regulate norepinephrine production independantly of STAT6. In fact, STAT6 initial 
activation upon IL-4 treatment as determined by its tyrosine phosphorylation is independent of 
Irs2 (Figure 4.7).  
 
Additional innate and adaptive immune cells have been implicated in the regulation of obesity-
induced metabolic disorders (reviewed in introduction sections 1.6.2 and 1.7). We checked for 
differences in gene expression levels of innate and adaptive immune cell markers in pWAT of 
mice on HFD and found a significant decrease in the mRNA levels of the mast cell marker  C-kit  
in the pWAT from Irs2lyzM-/- mice after 24 weeks on HFD.  
In the AT, C-KIT is  predominantly expressed in mast cells, and its knock-out from mast cells has 
been associated with reduced body weight and a lean phenotype in mice on western diet (Liu et 
al., 2009). Our findings of an alteration of C-kit mRNA levels might suggest a reduced mast cell 
number or an alteration in their differentiation in the pWAT of Irs2lyzM-/- mice. However, 
immunostaining of C-KIT on pWAT sections would be essential to determine any defect in mast 
cell number.  
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Chapter 5: Characterization of Irs2lyzM-/- macrophages and their 
impact on whole body energy homeostasis. 
5.1 Introduction 
In the previous results chapters, we have shown that Irs2 signaling in macrophages regulates the 
macrophage signature in the AT with Irs2lyzM-/- AT macrophages displaying a reduced 
inflammatory phenotype compared to control macrophages. This manifested as a reduction in the 
mRNA levels of F4/80, Cd11c, Ccl2 and Ccl3 in the pWAT of Irs2lyzM-/- mice.   
The increased energy expenditure in the Irs2lyzM-/- mice was attributed to increased circulating 
catecholamine levels in particluar increased norepinephrine levels in the urine. The elevated 
catecholamines act on the BAT to stimulate the thermogenic gene expression program. The 
increased mRNA levels of tyrosine hydroxylase (Th) suggests an increased production of 
norepinephrine from BAT, most likely due to its production by BAT macrophages. In fact, Irs2lyzM-/- 
BMDM manifested a trend towards increased secretion of norepinephrine in the conditioned 
media (CM) compared to control BMDM upon IL-4 treatment.  
In vitro cell culture systems of macrophage differentiation were previously used to define the 
molecular signature of macrophages. Stimulation of BMDM with bacterial products like LPS leads 
to the generation of macrophages with a CAM phenotype that express pro-inflammatory 
cytokines such as Tnfα, IL-6 and Inos and produce reactive oxygen species (ROS) and nitric 
oxide (NO) (Liao et al., 2011; Qin et al., 2012). 
In contrast when BMDM are treated with Th2 cytokines such as IL-4 and IL-13 they take on an 
AAM phenotype. Several genes that are up-regulated in AAMs including Arg1, Mrc1, and Clec10a 
are transcriptionally regulated by transcription factors such as STAT6 (Liao et al., 2011; Nguyen 
et al., 2011). 
The aim of the studies described in this chapter is to obtain pure BMDM from control and Irs2lyzM-/- 
bone marrow cells, and identify molecular fingerprints of classical and alternative macrophage 
markers in addition to secreted metabolites through in vitro inflammatory and anti-inflammatory 
challenges.  
 
5.2 Characterization of BMDM purity 
To achieve this aim, we first generated macrophages from bone marrow cells since thorough in 
vitro protocols have been developed to successfully differentiate macrophages from bone marrow 
progenitors using the macrophage colony-stimulating factor (M-CSF). M-CSF and L929 CM were 
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compared to characterize macrophages. Fully differentiated macrophages were then harvested 
and prepared for flow cytometric analysis as described in methods.  
Both M-CSF and L929 CM yielded similar macrophage purity (Figure 5.1 A-F) and therefore we 
used the L929 CM in the rest of the studies due to its lower cost, unless otherwise indicated. 
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Figure 5.1 Comparative analysis by flow cytometry of BMDM surface markers using M-CSF 
and L929. 
A and B panels show macrophage preparation using M-CSF. The macrophage population 
was selected and cell debris eliminated based on their small FSC (A). In the absence of labeled 
antibody, most of the cells (~95%) are present in Q3 showing no positive cells (B). 
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Figure 5.1 Comparative analysis by flow cytometry of BMDM surface markers using M-
CSF and L929.  
C) A double staining using CD11b FITC and F4/80 PE antibodies yielded 98% double positive 
cells in M-CSF-differentiated macrophages. 
 
129 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 Comparative analysis by flow cytometry of BMDM surface markers using M-
CSF and L929.  
D and E panels show macrophage preparation using L-929 CM. The macrophage population 
was selected and cell debris eliminated based on their small FSC (D). In the absence of labeled 
antibody, most of the cells (~95%) are present in Q3 showing no positive cells as expected (E). 
 
130 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 Comparative analysis by flow cytometry of BMDM surface markers using M-
CSF and L929.  
F) A double staining using CD11b FITC and F4/80 PE antibodies yielded 96% double positive 
cells in L-929-differentiated macrophages. 
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5.3 Role of Irs2 in the polarization of macrophages 
To determine whether Irs2 signaling in BMDM has an impact on macrophage polarization, we 
analyzed the molecular signature of BMDM in the presence and absence of Irs2 using two 
approaches: real-time PCR which allows the identification of single gene expression, and a non-
biased high throughput sequencing of mRNA. The latter permits the quantification of a large 
number of transcripts and their integration in a functional expression network. It also permits the 
identification of transcription factors that regulate the expression of a set of genes which are 
altered upon Irs2 deletion in a specific network. We challenged BMDM from control mice using 
either LPS or IL-4. Additionally, loss of Irs2 expression permitted the analysis of inflammatory 
signaling pathways thought to be regulated by Irs2, as identified in earlier studies (O’Connor et 
al., 2007; Osborn and Olefsky, 2012).  
While LPS significantly increased the mRNA expression levels of inflammatory cytokines Tnf, Il-
1 and Il-6, and the expression of Inos in control BMDM, it induced these changes to a lesser 
extent in Irs2lyzM-/- BMDM.  Specifically, 10 ng/ml and 100 ng/ml of LPS significantly increased 
mRNA levels of TNF by 20 and 40 fold, respectively (p<0.0001) whereas this increase was of 
the order of 10 fold in Irs2lyzM-/- BMDM. Inos expression levels were increased by 60 fold 
(p<0.001) using 100 ng/ml of LPS in control BMDM but only by 10 fold in Irs2lyzM-/- BMDM. In 
contrast Il-6 and Il-1 did not show any significant difference between 100 ng/ml LPS-treated 
control BMDM versus Irs2lyzM-/- BMDM (Figures 5.2 A, B, C &D). 
These results indicate that Irs2 signaling has pro-inflammatory effects and deletion of Irs2 in 
BMDM results in a less inflammatory phenotype upon LPS treatment.  
 
IL-4 treatment in BMDM increases the mRNA levels of AAM markers including Arg1, Mrc1 and 
Clec10a in a STAT6-dependent manner (Nguyen et al., 2011). As expected, 10ng/ml of IL-4 
significantly increases expression levels of all these AAM markers in control BMDM after 24 
hours of treatment. In Irs2lyzM-/- BMDM, the expression levels of these markers were still increased 
but there was no significant difference between both groups (Figs 5.3 A-C). These results imply 
that AAM polarization is not dependent on Irs2. 
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Figure 5.2 Pro-inflammatory cytokines and Inos gene expression levels are reduced in 
Irs2lyzM-/- BMDM. 
Tnf (A), Inos (B), Il-6 (C) and Il-1 (D) mRNA levels in control and Irs2lyzM-/- BMDM following control 
(1X PBS) and LPS treatments. Data were normalized to Hprt1 housekeeping gene (n=6). 
Two way ANOVA and Tukey test with *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001 compared to 
control untreated. 
###
p<0.001 and 
####
p<0.0001 compared to control treated with LPS. 
&
p<0.1 compared 
to Irs2lyzM-/- BMDM untreated. Bar graphs represent mean values +S.E.M.  
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Figure 5.3 STAT6-dependant AAM  markers gene expression in control (PBS) and IL4-
treated BMDM in the presence and absence of Irs2. 
BMDM were treated with vehicle (1X PBS) and 10 ng/ml of IL-4 for 24 hours. Gene expression levels of AAM 
markers: Arg1 (A), Mrc1 (B) and Clec10a (C) in Irs2lyzM-/-  BMDM compared to control BMDM (considered as 
1) (n=6). 
Data were normalized to Hprt1 housekeeping gene. Values are represented as means + S.E.M. 
Two way ANOVA and Tukey test with **p<0.01, ***p<0.001 and ****p<0.0001 compared to untreated. 
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5.4 mRNA sequencing of LPS-treated BMDM 
5.4.1 Assessment of RNA quality 
Having shown that a subset of macrophage gene expression markers are modulated by deletion 
of Irs2 we next looked at the global changes in gene expression in the absence of Irs2 in BMDM 
upon LPS treatment using RNA sequencing technology. Total RNA was extracted and its quality 
was assessed on the bioanalyzer as described in methods. The RNA integrity number (RIN) of all 
BMDM RNA samples, treated with vehicle or LPS, was between 9 and 10, indicating intact RNA 
(Schroeder et al., 2006) and alluding to the absence of both degradation and DNA contamination; 
an example is shown in Figure 5.4. Therefore we did not perform a DNA decontamination step 
before performing the RNA sequencing. The RNA sequencing was done at the Sanger Institute.  
We used four conditions where control and Irs2lyzM-/- BMDM were treated with control (1X PBS) or 
LPS. The details of cDNA library preparation, RNA sequencing and the data analysis are 
described in methods. 
 
 
 
 
 
 
 
 
 
Figure 5.4 Example of an RNA electropherogram showing both 18S and 28S peaks of 
total RNA extracted from BMDM.  
The x axis represents the migration time (seconds [s]) and the y axis represents fluorescence units 
(Fu).  
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5.4.2 mRNA sequencing analysis 
5.4.2.1 Analysis of differentially expressed genes and signaling pathways.  
The differential expression analysis (details in methods) aimed to find differentially expressed 
genes between control and Irs2lyzM-/- BMDM following LPS treatment.  
We show that upon LPS treatment, 2131 genes were significantly differentially expressed 
between control and Irs2lyzM-/- BMDM with 1050 genes up-regulated and 1081 genes down-
regulated in Irs2lyzM-/- BMDM compared to control BMDM. A list of the top 8 up-regulated and 
down-regulated genes with adjusted p values is shown in table 5.1.  
We then performed an unbiased analysis on all the differentially expressed genes (1050 up-
regulated and 1081 down-regulated genes) and extracted signaling pathways using the online  
database for annotation, visualization and integrated discovery (DAVID) and the Kyoto 
Encyclopedia of genes and genomes (KEGG). Down-regulated and up-regulated pathways in 
Irs2lyzM-/- BMDM compared to control BMDM upon LPS treatment are shown in table 5.2.  
 
Among the down-regulated pathways, the cytokine-cytokine receptor interaction pathway is the 
most significantly reduced in BMDM lacking Irs2 (table 5.2). We therefore looked at the list of 
genes down-regulated in this pathway (32 genes) and found among others, the inflammatory 
genes Tnfα, Ccl2, Ccl3 and Ccl8 to be down-regulated in Irs2lyzM-/- BMDM upon LPS treatment. 
Table 5.3 shows a list of these genes and their corresponding fold change in Irs2lyzM-/- BMDM 
compared to control BMDM and the corresponding adjusted p values (Benjamini). 
These findings corroborate the real-time PCR data showing reduced Tnfα mRNA levels in LPS-
treated Irs2lyzM-/- BMDM compared to wild-type BMDM and imply that Irs2 signaling regulates Tnfα 
expression and TNFα signaling pathway in BMDM.  
Moreover, they indicate that Irs2 signaling positively regulates the C-C chemokine signaling 
pathway particularly the expression of C-C motif ligands which have a role in monocyte (CCL2), 
neutrophil (CCL3), basophil and eosinophil (CCL8) recruitment. Additionally, the mRNA levels of 
these chemokines were significantly reduced in the pWAT of HFD-fed Irs2lyzM-/- mice compared to 
wild-type mice (chapter 4). 
We next looked at the mRNA levels of Inos and Arg1, two genes that encode enzymes involved 
in the regulation of the arginine metabolism pathway and which were shown to be altered in 
adipose tissue macrophages from Irs2lyzM-/- mice maintained on HFD compared to control mice 
(Figure 4.6, chapter 4).  
The finding that Inos mRNA levels were significantly reduced in LPS-treated Irs2lyzM-/- BMDM 
relative to LPS-treated control BMDM (table 5.3) corroborated with the real-time PCR analysis 
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(Figure 5.2). mRNA levels of Arg1 were significantly increased upon LPS treatment in Irs2lyzM-/-  
BMDM (table 5.3). 
 
 
 Downregulated genes 
MGI (mouse genome 
informatics)_symbol 
Fold change (Irs2lyzM-/-  BMDM 
relative to control BMDM) 
Benjamini value 
Irs2 -111.11 6.39E-76 
Rsad2 -13.89 3.42E-60 
Cxcl11 -18.18 7.39E-56 
Tgtp1 -21.27 4.41E-48 
Clic5 -21.27 3.34E-46 
Bc023105 -20 1.02E-45 
Hgsnat -8.47 1.70E-45 
Ifit2 -9.17 3.26E-45 
Upregulated genes 
MGI (mouse genome 
informatics)_symbol 
Fold change (Irs2lyzM-/-  BMDM 
relative to control BMDM) 
Benjamini value 
Cxcl5 1382 3.84E-77 
Ppbp 1018 1.88E-70 
Draxin 1189 7.85E-59 
Slc13a3 2232 5.17E-53 
Itga1 890 1.01E-46 
Ifitm1 1404 4.88E-45 
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Col5a1 353 4.09E-41 
Cd163 527 2.61E-37 
 
Table 5.1: List of the top 8 down- and up-regulated genes in Irs2lyzM-/- BMDM compared to 
control BMDM upon LPS treatment. Genes are represented by their MGI (mouse genome 
informatics) symbol along with the fold change and the adjusted p value (Benjamini value). 
 
 
Downregulated pathways in Irs2lyzM-/-  BMDM compared to control BMDM upon 
LPS treatment 
Signaling pathway Benjamni value Number of Genes 
Cytokine-cytokine receptor 
interaction 
5.06E-05 32 
NOD-like receptor signaling 
pathway 
0.01 12 
MAPK signaling pathway 0.03 26 
Toll-like receptor signaling 
pathway 
0.02 14 
Upregulated pathways in Irs2lyzM-/-  BMDM compared to control BMDM upon LPS 
treatment 
Signaling pathway Benjamni value  Number of Genes 
Ribosome 4.5E-44 59 
 
Table 5.2: Signaling pathways down- and up-regulated in Irs2lyzM-/- BMDM compared to 
control BMDM upon LPS treatment.  
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Downregulated genes 
MGI (mouse genome 
informatics)_symbol 
Fold change (Irs2lyzM-/- BMDM 
relative to control BMDM) 
Benjamini value 
Tnfα -2.32 2.26E-08 
Ccl2 -5.56 1.58E-29 
Ccl3 -2.63 1.49E-11 
Ccl8 -9.10 1.74E-28 
Inos -3.12 4.40E-12 
Upregulated genes 
MGI (mouse genome 
informatics)_symbol 
Fold change (Irs2lyzM-/- BMDM 
relative to control BMDM) 
Benjamini value 
Arg1 1.87 0.000179 
 
Table 5.3: List of differentially expressed inflammatory genes and genes encoding 
enzymes involved in the urea cycle in Irs2lyzM-/- BMDM compared to control BMDM. 
Genes are represented by their MGI symbol along with the fold change and the adjusted p value 
(Benjamini). 
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5.4.2.2 Identification of significant co-expression networks and pathways in BMDM upon 
Irs2 deletion 
We next performed a co-expression network analysis which allowed the identification of gene 
interactions and cellular processes. More specifically, genes that are strongly interacting together 
will be detected as connected and therefore will be highlighted by this analysis. We then 
extracted from these co-expression networks signaling pathways using KEGG, similar to what we 
did with the list of differentially expressed genes in table 5.2. Two co-expression networks were 
identified and are labeled A and B. In each of these networks, when a set of genes regulating a 
certain pathway is up-regulated following LPS treatment, another set of genes is down-regulated 
in parallel under the same conditions. 
Networks A and B showed a reduced expression of genes in Irs2lyzM-/- BMDM compared to control 
BMDM upon LPS treatment with network A showing a stronger reduction.  As highlighted in table 
5.4, co-expression analysis of networks A and B show changes in inflammatory signaling 
pathways which were down-regulated in LPS-treated Irs2lyzM-/- BMDM.  
Pathway analysis indicated that in both networks the cytosolic DNA-sensing, the NOD 
(nucleotide-binding oligomerization domain) signaling and the Toll-like receptor signaling 
pathways were down-regulated in Irs2lyzM-/- BMDM compared to control BMDM upon LPS 
treatment. These two pathways comprise inflammatory cytokines including TNFα, IL-6 and the 
chemokine (C-C motif) ligand 5 (CCL5).  
Parallel to decreased inflammatory signaling, pathways related to spliceosomes and ribosomes, 
which participate in RNA and protein maturation, were up-regulated in Irs2lyzM-/- BMDM compared 
to control BMDM upon LPS treatment.  
 
In network A, the oxidative phosphorylation and the amino and nucleotide sugar metabolism 
pathways were up-regulated indicating increased cellular metabolism in LPS-treated Irs2lyzM-/- 
BMDM compared to control BMDM. For the purpose of this thesis, we will be only focusing on the 
inflammatory signaling pathways in BMDM to explain the metabolic changes in HFD-fed Irs2lyzM-/- 
mice, since thorough studies have implied the contribution of inflammatory macrophages in the 
development of obesity-induced insulin resistance.  
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Network Signaling pathways down-regulated 
in LPS-treated Irs2lyzM-/-  BMDM   
Signaling pathways up-regulated 
in LPS-treated Irs2lyzM-/-  BMDM 
 
A*** 
 
1-Cytosolic DNA-sensing pathway  
2-NOD-like receptor signaling pathway 
 
 
1-Ribosome 
2-Amino sugar and nucleotide sugar 
metabolism 
3-Oxidative phosphorylation 
 
 
B* 
 
Toll-like receptor signaling pathway 
 
 
 1-Spliceosome 
 2-Ribosome 
 
 
Table 5.4 Significant pathways extracted from DAVID in control and Irs2lyzM-/- BMDM upon 
vehicle (PBS) and LPS treatment, corresponding to networks A and B.  Linear modeling (with 
the module eigengene as variable) was used to detect statistical significance. The interaction 
treatment-genotype is significant in both networks with p=0.0006 (A) and p=0.01 (B). 
 
5.4.2.3 Identification of transcription factors in the set of co-expression genes. 
Previous studies have highlighted the role of some transcription factors (TF) in myeloid cells in 
the regulation of whole body energy homeostasis. Deletion of TFs (PPARγ, PPARδ and KLF4) in 
macrophages induces some phenotypic changes in mice which are listed in table 3 of the 
introduction. For instance, deletion of IKK-β, a kinase that activates the TF NF-κB and prevents 
NF-κB signaling in macrophages, inhibits production of pro-inflammatory cytokines such as IL-6, 
IL-1β and TNFα and prevents insulin resistance upon HFD exposure in mice (Arkan et al., 2005).  
To identify TFs associated with sets of co-regulated genes, we used the method predicting 
associated TFs from annotated affinities (PASTAA) which utilizes the binding affinity of TFs to 
gene promoters in a set of co-expressed genes (Roider et al., 2009). One network of TF targets 
was shown to be statistically significant (interaction LPS-genotype Benjamini value is 0.0006) and 
corresponds to network A and its corresponding signaling pathways in table 5.4. 
In this network we identified several TF targets, including the interferon regulatory factors IRF1, 
IRF2 and IRF7 as well as NF-кB targets, to be significantly down-regulated in Irs2lyzM-/-  BMDM 
compared to wild-type BMDM treated with LPS. Irf1, Irf2 and Irf7 promoter regions contain a 
binding site for kappa B and are therefore direct targets of NF-кB  (Harada et al., 1994; Lu et al., 
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2002; Robinson et al., 2006). A major function of these TFs is to regulate expression of genes 
involved in cell growth and survival and therefore control cellular responses implicated in 
oncogenesis (Yanai et al., 2012). NF-кB also regulates expression of genes involved in 
inflammatory responses, since direct targets of NF-кB, such as Tnfα, Inos, Ccl2 and Ccl3, were 
shown to be significantly decreased in LPS-treated Irs2lyzM-/- BMDM (DAVID analysis).  NF-кB is 
present in an inactive state in the cell and is activated upon stress stimuli such as TNFα and LPS- 
stimulated TLR4 signaling pathways. More details on the NF-кB signaling pathway are in section 
1.15 of the introduction.  These results indicate that abrogation of Irs2 signaling in macrophages 
reduces NF-кB signaling and downstream inflammatory pathways and reinforces the concept that 
the alteration of NF-кB signaling in macrophages improves glucose homeostasis in mice on HFD 
(Arkan et al., 2005).  
 
In the same network, a set of TF targets was found to be up-regulated in Irs2lyzM-/- BMDM 
compared to control BMDM. This includes the zinc factor protein X-linked (Zfx), the stimulated by 
retinoic acid 13 (Stra13) and the krüppel-like factor 4 (KLF4) TFs. We focused on KLF4 for 
multiple reasons. KLF4 is a TF that has many consensus binding sites on the Irs2 promoter and 
the Biologically Anchored Knowledge Expansion (BAKE) approach revealed that KLF4 belongs to 
the cluster of genes perturbed upon Irs2 alteration. In fact, previous studies indicated that in 
adipocytes isolated from Klf4+/- mice, Irs2 expression was decreased by 3.5 fold (Muthiah et al., 
2013). This indicates a link between Irs2 and Klf4. Most importantly, Arg1, a direct target of KLF4 
was shown to be up-regulated by 1.9 fold in Irs2lyzM-/- BMDM compared to control BMDM upon 
LPS treatment (table 5.3). These KLF4 binding sites on the Arg1 promoter lie within an IL-4 
responsive enhancer element that also contains a STAT6- binding site (Liao et al., 2011). 
However, STAT6 was not found to be altered. Therefore it is possible that Arg1 expression levels 
might be increased following increased KLF4 activity upon Irs2 deletion in macrophages. 
 
5.5 Determination of potential metabolites produced by BMDM and altered 
upon Irs2 deletion  
To further investigate the molecular and metabolic signature of Irs2lyzM-/- BMDM, we analyzed 
secreted metabolites in the BMDM cell culture media using metabolomics technology (Patti et al., 
2012). We therefore looked at small secreted molecules from macrophages using a non-biased 
untargeted metabolomics approach. Metabolomics is the study of biochemical processes 
involving small molecules (less or equal to 1500 Daltons). It is firmly established as a powerful 
tool as it provides insights into the pathogenesis of obesity, type-2 diabetes and cardiovascular 
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diseases and identifies mechanisms that can be targeted to treat these complex diseases 
(Huffman et al., 2011).  
This technique potentially permits the identification of alterations in metabolism by looking at the 
final products of biochemical pathways in BMDM harboring Irs2 deletion. By using a combination 
of transcript and metabolite analysis, we investigated the role of Irs2 deletion in macrophages on 
the phenotype of macrophages to gain insights into the effects on whole body energy 
homeostasis. We integrated the metabolomics findings with the transcriptome analysis by looking 
at common signaling pathways with the aim of understanding how metabolic transformation at the 
mRNA and metabolite level regulates macrophage signature and impact on whole body energy 
homeostasis 
Following treatment of differentiated control and Irs2lyzM-/- BMDM with LPS (100 ng/ml) and IL-4 
(10 ng/ml) for 24 hours, metabolite extraction was performed from cell media which contained 
BMDM secreted molecules. The supernatant was collected and run on both positive and negative 
mode using liquid chromatography-mass spectrometry (LC-MS) and analyzed using both targeted 
and untargeted statistical techniques. Technical details are described in the methods section. 
The major differences first identified using the non-targeted approach were in the urea cycle, 
where ornithine, citrulline and urea were significantly different between the control (PBS)-treated, 
IL-4-treated and LPS-treated control BMDM. In fact, as shown in figure 5.5 (A & B), IL-4 
significantly increased ornithine and urea levels while LPS increased citrulline levels in control 
BMDM.   
 
Irs2 deletion in BMDM was shown to have an impact on citrulline levels which were significantly 
decreased in Irs2lyzM-/- BMDM compared to control BMDM upon LPS treatment. However, 
ornithine levels were not significantly changed with IL-4 treatment in Irs2lyzM-/- BMDM (Figures 5.5 
C&D). The reduced citrulline levels could be a consequence of reduced Inos mRNA levels in 
Irs2lyzM-/- BMDM, and therefore INOS enzymatic activity. This approach also showed changes in 
norepinephrine levels corroborating the changes in the urine catecholamine levels presented in 
chapter 4. 
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Figure 5.5 Alteration of the urea cycle metabolites in the presence and absence of Irs2 in 
BMDM upon IL-4 and LPS treatment.  
BMDM were treated with either control (PBS), IL-4 or LPS for 24 hours. Levels of ornithine, citrulline 
(A) and urea (B) were assessed in the media from control BMDM by LC-MS. For statistical 
significance, Benjamini Hochberg algorithm was used with ****p<0.0001. 
Ornithine (C) and citrulline (D) levels were compared between control BMDM and Irs2lyzM-/- BMDM 
upon IL-4 and LPS, respectively. Signal intensity represents the raw data. Bar graphs represent the 
mean + S.E.M.  N=3 biological triplicates and n=3 technical triplicates. For statistical significance, 
Benjamini Hochberg algorithm was used for significance between control and Irs2lyzM-/- BMDM for 
each of the treatments. Adjusted p value (Benjamini value) **p<0.01 and ****p<0.0001. 
Irs2
LyzM
-/-
Control
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5.6 Discussion 
 
From the data presented in this chapter, it is clear that Irs2 in BMDM regulates several molecular 
processes involved in inflammatory and anti-inflammatory signaling pathways.  
This was demonstrated by looking at mRNA levels of some specific macrophage inflammatory 
markers that we predicted based on the literature. We then undertook an unbiased approach  by 
performing mRNA sequencing. This allowed the identification of differentially regulated genes as 
well as significant signaling pathways and transcription factors within networks  between control 
and Irs2lyzM-/- BMDM upon LPS treatment.  
Finally, we looked at potential metabolites produced by BMDM upon LPS and IL-4 treatment 
which might be altered upon Irs2 deletion using a non-targeted metabolomic approach.  
 
First, the differential expression analysis from the mRNA sequencing confirmed the real-time 
PCR analysis. mRNA levels of Inos and Tnfα were significantly reduced in Irs2lyzM-/- BMDM 
compared to control BMDM. KEGG pathway analysis associated with the set of down-regulated 
genes in LPS-treated Irs2lyzM-/- BMDM compared to LPS-treated control BMDM identified 
significant inflammatory pathways, where the cytokine-cytokine receptor interaction pathway is 
the most significant. This pathway includes interaction between chemokines and their receptors 
(the C-C subfamily and the CXC subfamily), the TNF-α and the transforming growth factor β 
(TGF-β) family members and their receptors, as well as genes belonging to the interleukin-1 (IL-
1) family and their receptors.   
 
We looked at the list of genes regulating these pathways and found that the inhibin β-A (INHBA) 
in the TGF-β signaling pathway was down-regulated in LPS-treated Irs2lyzM-/- BMDM compared to 
LPS-treated control BMDM. INHBA gene is abundant in the stromal vascular fraction of the 
adipose tissue and its mRNA levels seem to be increased in obese compared to lean individuals 
(Sethi, 2010).  
Among the genes belonging to the IL-1 signaling pathway are the IL-1α and its receptor the IL-1 
type 1 receptor (IL-1R1). IL-1α mRNA levels were significantly reduced in LPS-treated Irs2lyzM-/- 
BMDM. Transplantation of bone marrow cells from IL-1α-/- into irradiated Ldlr-/- (low-density 
lipoprotein receptor) hypercholesterolemic mice (Ishibashi et al., 1993) maintained on a high 
cholesterol diet reduced the severity of atherosclerotic lesions compared to Ldlr-/- mice 
transplanted with wild-type bone marrow cells (Freigang et al., 2013). 
Similar to Irs2lyzM-/- mice, mice deficient in IL-1R1 are partially protected from HFD-induced insulin 
resistance and are more glucose tolerant than their wild-type littermates. This is associated with 
reduced IL-6 and TNFα secretion from ATMs (McGillicuddy et al., 2011). 
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The CXC family of chemokines include CXCL11 which mRNA levels were reduced in the visceral 
fat derived ATM from NLRP3 (NOD-like receptor inflammasome P3) knock-out mice. NLRP3 -/- 
mice are protected from obesity-induced insulin resistance, a metabolic phenotype similar to the 
one observed in Irs2lyzM-/- mice (Vandanmagsar et al., 2011). 
  
The co-expression network analysis further confirmed that inflammatory signaling pathways 
including the NOD-like receptor and the Toll-like receptor signaling pathways were down-
regulated in LPS-treated Irs2lyzM-/- BMDM compared to wild-type BMDM. Moreover, the NF-кB 
signaling pathway which belongs to the cytosolic DNA-sensing pathway was also significantly 
reduced. Interestingly, such co-expression networks permitted the analysis of clusters of genes 
which are highly correlated; for instance a set of genes which is up-regulated is paralleled by a 
set of down-regulated genes upon the same treatment or condition. Upon LPS treatment, the 
reduction in the pro-inflammatory pathways in Irs2lyzM-/- BMDM is mirrored by an up-regulation of 
pathways related to cellular respiration and sugar metabolism (table 5.4). 
 
Studies have correlated macrophage polarization with their energy metabolism. In fact, CAMs rely 
more on anaerobic glycolysis for their cellular function and microbicidal activity. However, AAMs 
use aerobic oxidative metabolism since IL-4 increases the uptake and oxidation of fatty acids as 
well as mitochondrial biogenesis (Chawla et al., 2011; Shapiro et al., 2011; Tavakoli et al., 2013). 
In LPS-treated Irs2lyzM-/- BMDM, the strongest gene ontology enrichment was observed in 
pathways regulating glucose metabolism where genes involved in both glycolysis and 
gluconeogenesis were increased. However, the glucose metabolism pathway was shown to be 
independent of the macrophage polarization state upon LPS treatment in macrophages (Tavakoli 
et al., 2013).  
Most importantly, mitochondrial oxidative phosphorylation which is the bioenergetic pathway used 
by AAMs to generate adenosine triphosphate (ATP) was increased in LPS-treated Irs2lyzM-/- 
BMDM compared to LPS-treated control BMDM.  
Additionally, PASTAA analysis allowed the identification of transcription factors associated with 
the sets of co-expressed genes and indicated NF-кB downstream targets to be down-regulated in 
Irs2lyzM-/- BMDM compared to control BMDM upon LPS treatment.  
Parallel to reduced NF-кB signaling, KLF4 targets were up-regulated and among these targets is 
Arg1 which was shown to be increased by ~1.9 fold in LPS-treated Irs2lyzM-/- BMDM.  .  
PASTAA along with the co-expression network analysis indicated that Irs2lyzM-/- BMDMs have an 
anti-inflammatory phenotype upon LPS treatment, manifested by reduced NF-кB signaling. 
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Moreover, the increased KLF4/ARG1 pathway and the mitochondrial biogenesis might imply a 
shift of these Irs2lyzM-/- BMDM towards an AAM phenotype upon LPS treatment.   
The untargeted metabolomics tool precisely pinned down the role of Irs2 in BMDM in regulating 
components of the urea cycle. It also showed clearly the effect of IL-4 and LPS on the levels of 
urea, citrulline and ornithine, components of the urea cycle.  
As expected in wild-type BMDM and from what we know from the literature, the levels of ornithine 
and urea are increased in AAMs via increased arginase-1 activity in an IL-4-dependent manner. 
However, LPS increased the levels of citrulline via increased INOS activity, a characteristic of 
CAMs (Odegaard and Chawla, 2011).  
 
The reduced levels of citrulline in Irs2lyzM-/- BMDM confirmed the decreased mRNA levels of Inos 
and subsequently the reduced inflammatory phenotype of Irs2lyzM-/- BMDM. This finding, in 
addition to the reduced inflammatory pathways in Irs2lyzM-/- BMDM which were discussed earlier, 
might explain the metabolic phenotypes of Irs2lyzM-/- mice. 
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Chapter 6: Discussion 
 
6.1 Discussion of the Irs2lyzM-/- mice 
6.1.1 Overview  
The work presented in this thesis provides evidence for the role of inflammatory processes and in 
particular the involvement of macrophages in the pathophysiology of metabolic diseases such as 
insulin resistance and type-2 diabetes. It implicates a novel role for Irs2 in macrophages in the 
regulation of glucose homeostasis and energy expenditure under basal conditions and high fat 
diet challenge. 
To generate Irs2lyzM-/- mice, Irs2 floxed mice were bred with mice expressing Cre recombinase 
driven by the myeloid-specific lysozyme M promoter. Effective deletion of Irs2 was achieved in 
BMDM of Irs2lyzM-/- mice at both mRNA and protein levels.  
 
Eight week-old female mice with specific deletion of Irs2 in myeloid lineages (Irs2lyzM-/- mice) 
displayed improved glucose tolerance and insulin sensitivity on normal chow diet compared to 
their littermate controls. Specifically, blood glucose and serum insulin levels were significantly 
lower in these mice following an overnight fast. Glucose tolerance testing indicated better glucose 
clearance at 15 and 30 min post injection, suggesting better insulin sensitivity based on the 
decreased insulin levels in these mice. Insulin tolerance test confirmed the improved insulin 
action in these mice. These results implicate that at 8 weeks of age Irs2lyzM-/- female mice have 
increased glucose disposal due to increased insulin action in insulin target tissues like muscle, 
liver, fat and brain. 
Irs2lyzM-/- mice maintained a similar body weight to control mice when fed a chow diet yet they 
showed increased energy expenditure at 8 weeks of age. This was accompanied by increased 
food intake which might explain the similar body weight. The beneficial phenotypes observed in 
young mice, i.e. the improved glucose homeostasis and the increased energy expenditure most 
likely account for the lean phenotype observed in older mice on chow diet. These mice were 
therefore resistant to age dependent increase in adiposity and deterioration in glucose 
homeostasis. 
 
When challenged with HFD, Irs2lyzM-/- mice were protected from HFD-induced hyperglycemia, 
hyperinsulinemia and insulin resistance as manifested by reduced fasted basal glucose and 
insulin levels, reduced HOMA-IR and improved glucose tolerance. They were also protected from 
HFD-induced weight gain and obesity as they showed reduced body weight after 4 weeks on 
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HFD and throughout the study as well as reduced total adiposity compared to control mice. This 
lean phenotype was partially due to the increased energy expenditure and was accompanied by 
increased body temperature in Irs2lyzM-/- mice on HFD.  
The potential cellular and molecular mechanisms underlying these physiological changes were 
then studied. The improved glucose homeostasis phenotype was attributed to reduced 
inflammatory macrophage phenotype and possibly reduced macrophage number in the WAT. In 
fact there were decreased mRNA levels of the macrophage marker F4/80 and the inflammatory 
marker Cd11c in the perigonadal WAT (pWAT) under both chow and HFD conditions. In addition 
there were reduced mRNA levels of the macrophage ligands with chemotactic properties, the 
chemokine (C-C motif) ligand 2 and 3 (Ccl2 and Ccl3) in the pWAT under HFD conditions only.  
 
Additionally, there were alterations in BAT function that may lead to increased energy 
expenditure. There were increased mRNA levels of two thermogenic markers Ucp1 and Pgc1α, 
which may underpin the increased energy expenditure and the lean phenotype in these mice. 
Histological studies in BAT from mice maintained on HFD for 40 weeks revealed smaller lipid 
droplets in Irs2lyzM-/- BAT sections compared to control mice, which may suggest increased BAT 
thermogenic activity. Similarly, urinary catecholamine excretion was higher in Irs2lyzM-/- mice, an 
indication of increased sympathetic activity which can drive increased energy expenditure.  
Recent reports that alternatively activated macrophages (AAM) themselves may secrete 
catecholamines, allowing mice to sustain cold-adaptive thermogenesis (Nguyen et al., 2011), 
prompted us to look for potential alterations in catecholamine production by BMDM from control 
and Irs2lyzM-/- mice using a targeted metabolic approach. Norepinephrine is detectable in BMDM 
conditioned medium (CM) with a trend towards higher levels in the medium from IL-4-treated 
Irs2lyzM-/- BMDM compared to control BMDM.   
Additionally, a positive correlation exists between AAMs in adipose tissue and catecholamine 
production following cold exposure in mice. In fact, exposure to cold triggers an alternative 
activation of macrophages and in the absence of such activation mice cannot sustain cold-
induced thermogenesis as their tissue macrophages fail to produce catecholamines.   
However, no studies of such correlation were previously performed on mice maintained on HFD.  
Our results indicate increased mRNA levels of the AAM marker Arg1 under HFD conditions in 
adipose tissue macrophages (ATM) (CD11b positive fraction).  
 
To define a molecular signature for Irs2lyzM-/- BMDM, mRNA expression studies were performed in 
BMDM that were polarized into either CAM or AAM phenotype following 24 hours treatment with 
LPS and IL-4, respectively.  LPS treatment increases gene expression levels of the inflammatory 
markers Tnfα, Inos, Il-6 and Il-1β in control BMDM. Only Tnfα and Inos show a significant 
decrease in LPS-treated Irs2lyzM-/- BMDM compared to control BMDM. Taken together, the 
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reduced mRNA levels of macrophage inflammatory markers in the AT along with these in vitro 
experiments suggest that Irs2 dependent signaling mechanisms and downstream effector 
pathways drive macrophage polarization towards an inflammatory phenotype. It further indicates 
that abrogation of Irs2 signaling in macrophages, and therefore suppression of Irs2-dependant 
inflammatory signaling pathways, is at the basis of the improved energy homeostasis in Irs2lyzM-/- 
mice. 
To further characterize Irs2lyzM-/-  BMDM, we undertook unbiased approaches to look at the global 
gene expression network by sequencing the whole mRNA as well as an untargeted metabolomic 
approach to measure metabolite levels secreted by macrophages in the presence and absence of 
Irs2. 
mRNA sequencing experiments were undertaken in LPS-treated BMDM and differential gene 
expression analysis showed reduced mRNA levels of Tnfα and Inos in the absence of Irs2 
whereas Il-6 and Il-1β expression were unchanged. This is consistent with the mRNA changes 
from the RT-PCR data described above. Untargeted metabolomic analysis of LPS-treated BMDM 
CM indicated decreased citrulline levels in Irs2lyzM-/- CM compared to control CM. Reduced 
citrulline can be associated with reduction in nitric oxide production via INOS and suggest a 
reduced polarization of Irs2lyzM-/- BMDM towards a classical macrophage phenotype.  
Together these in vitro and in vivo studies indicate that Irs2 signaling in macrophages promotes 
an inflammatory profile and abrogation of Irs2 signaling in macrophages alters both their biology 
and also the systemic physiology of the mouse leading to protection from obesity-induced 
inflammation and insulin resistance. 
These findings therefore clarify a number of issues on the role of macrophage Irs2 in the 
regulation of energy homeostasis under basal and high fat diet conditions. They also give insights 
on the possible molecular mechanisms that might be altered in the absence of Irs2 and the 
underlying mechanisms that might explain these physiological changes. 
However, these findings also raise further questions, potential technical issues, alternative 
interpretations and some disagreements within the literature and various aspects of these issues 
will now be discussed.  
6.1.2 Specificity of Irs2 deletion in Irs2lyzM-/- mice 
Mouse conditional gene targeting systems in myeloid lineages have perhaps been the most 
successfully used approach to elucidate gene function in these cells since it specifically targets 
myeloid cells including monocytes, macrophages and granulocytes and also permits in vivo 
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analysis (Clausen et al., 1999). Lysozyme M Cre mice are the most widely used mice to 
manipulate specific floxed genes in myeloid lineages (reviewed in chapter 1 section 1.8). 
However, this mouse strain has some limitations.  Firstly, the gene of interest is deleted in all the 
myeloid cells and not only in macrophages. Moreover, lysozyme M may not be uniformly 
expressed in all macrophages and therefore Cre expression driven by its promoter may not result 
in the complete deletion of floxed genes in myeloid lineages. Deletion efficiency also varies 
depending on the floxed strain used with the Lysozyme M-Cre mice (Murray and Wynn, 2011). 
Nonetheless, genetic studies using the myeloid-specific lysozyme M-Cre mice have shown the 
contribution of macrophage function in the regulation of body energy metabolism (Reviewed in 
introduction table 1.3). Furthermore, in our studies we found high levels of recombination of the 
Irs2 allele and efficient deletion of this gene. There remains the need to develop genetic systems 
specific to macrophages which may also permit deletion of genes in tissue macrophages such as 
ATM. Such a model would help to further refine our understanding of the function of 
macrophages in adipose tissues in the context of regulation of whole body energy homeostasis.  
  
6.1.3 Implications of the improved glucose homeostasis and insulin sensitivity in 
the Irs2lyzM-/- mice 
6.1.3.1 Questions and findings from the literature  
The first question to ask is why abrogating Irs2 signaling in macrophages has a beneficial effect 
on whole body energy homeostasis? Macrophages do not require insulin for glucose uptake since 
they lack the insulin-dependent glucose transporter Glut4 (Fukuzumi et al., 1996). Defective 
insulin action in classical insulin target tissues and cells predisposes mice and humans to 
metabolic disorders. 
Nonetheless, macrophages respond to insulin by activating a cascade of downstream molecular 
events since they express the insulin receptor and its substrate IRS2 and all the machinery 
required for insulin signaling. Macrophages also express the IL-4 receptor and similar to IR 
signaling, the IL-4 signaling in macrophages induces IRS2 tyrosine phosphorylation. Most 
importantly, insulin signaling overlaps with many inflammatory pathways in macrophages 
because Irs2 is downstream of various inflammatory molecules including TNFα and JNK.  
Peritoneal macrophages from mice genetically deficient in leptin (ob/ob) have decreased insulin 
signaling. This is manifested by decreased protein expression levels of the IR and IRS2 as well 
as reduced IR and IRS2 tyrosine phosphorylation under basal conditions and upon insulin 
treatment. As a consequence of reduced insulin signaling, macrophages from ob/ob mice have 
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increased uptake of modified low density lipoproteins, are lipid loaded and predispose mice to 
foam cell formation and atherosclerosis. These findings are consistent with earlier studies 
showing reduced insulin affinity to monocytes from obese people and suggest reduced 
concentrations of the insulin receptor (Liang et al., 2004).  
Similarly, in macrophages from mice lacking the leptin receptor (db/db), IL-4 signaling and IRS2 
tyrosine phosphorylation are impaired and the resulting IRS2/PI3K complex formation is 
decreased. This is due to an overexpression of SOCS3 which suppresses the activity of the anti-
inflammatory cytokine IL-4 and consequently the expression and production of the IL-1 receptor 
antagonist (IL-1RA). These findings indicate that the IL-4-dependent IRS2-associated PI3K 
activity is fundamental in the upregulation of the anti-inflammatory cytokine IL-1RA, and this is 
impaired in a model of type-2 diabetes (O’Connor et al., 2007).  
These two studies imply that in mouse models of obesity and type-2 diabetes (ob/ob and db/db 
mice), the innate immune system appears to greatly impact the complications of the disease 
associated with atherosclerosis and alterations of the inflammatory status.  
Our results show that genetic ablation of Irs2 in macrophages has beneficial effects on the 
metabolic status of the mice, shown by improved glucose homeostasis on both chow diet and 
HFD.  Therefore, the phenotypic changes in these mice result from the specific ablation of Irs2 in 
macrophages which show a reduced inflammatory phenotype manifested by reduced 
inflammatory signaling pathways and reduced expression levels of inflammatory markers such as 
Tnfα and Inos upon LPS treatment.  
In type-2 diabetic ob/ob and db/db mice there is reduced insulin signaling in macrophages; 
however, insulin signaling is also reduced in other cells. In fact, ob/ob mice have a down-
regulation of IR and overexpression of SOCSs proteins in their liver and db/db mice show 
reduced levels of IL-1RA in their spleens and brains following LPS treatment. Therefore the type-
2 diabetes phenotype of these mice is associated with alteration of insulin signaling in insulin-
sensitive tissues like liver and brain and reduced insulin signaling in macrophages seems to be a 
consequence and not a cause of the metabolic phenotype observed in ob/ob and db/db mice.  
Mouse models with specific deletion of Irs2 in various tissues have highlighted that tissue-specific 
deletion has a different impact on mouse glucose homeostasis.  
Systemic deletion of Irs2 in mice (Irs2-/-) induces diabetes due to glucose intolerance, impaired 
β-cell function and insulin resistance in skeletal muscle and liver (Kubota et al., 2000; Withers et 
al., 1998). Mice with specific Irs2 deletion in β-cells and hypothalamus (RipCreIrs2KO) show 
reduced β-cell mass while mice with Irs2 deletion in all neurons (NestinCreIrs2KO) have 
increased β-cell mass due to the systemic insulin resistance associated with obesity. Fasted 
glucose and insulin levels, body weight, percentage body fat and food intake are high in both 
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models on chow diet. Irs2 deletion in the liver (LivIrs2KO) induces insulin resistance upon fasting 
only but not upon refeeding (Kubota et al., 2008). Another study in liver-specific Irs2 deletion 
(Simmgen et al., 2006) has shown no changes in insulin sensitivity on chow diet and increased 
fasted blood glucose levels on HFD. Unlike global Irs2-/- mice, LivIrs2KO and NestinCreIrs2KO, 
Irs2lyzM-/- mice have improved insulin sensitivity. Unlike RipCreIrs2KO and NestinCreIrs2KO, 
Irs2lyzM-/- mice have reduced fasted glucose and insulin levels on chow diet, no change in body 
weight and no change in percentage body fat on chow but only on HFD. Irs2LyzM-/- male mice 
show reduced percentage body fat with ageing. In contrast to LivIrs2KO mice, Irs2LyzM-/- mice 
show reduced fasted glucose levels on HFD. 
Similar to RipCreIrs2KO and NestinCreIrs2KO, Irs2lyzM-/- mice show increased food intake.  
Hypothalamic deletion of Irs2 in POMC neurons, does not lead to any metabolic abnormalities in 
these mice (Choudhury et al., 2005). Similarly, mice with Irs2 deletion in skeletal muscle 
(MCKCreIrs2KO) maintain normal glucose and insulin tolerance (Long et al., 2011). It is therefore 
clear that strong tissue specific effects of Irs2 signaling exist. 
Previous reports have directly linked insulin signaling in macrophages to metabolic disorders in 
mice, including atherosclerosis and insulin resistance associated with obesity-induced 
inflammation.  
Such studies have highlighted the role of Irs2 signaling in macrophages in a mouse model of 
atherosclerosis: the apolipoprotein-E (Apo-E) knock-out mice. These mice have high cholesterol 
levels and develop atherosclerotic lesions similar to those observed in humans and are 
considered to be the most studied model in atherosclerosis (Nakashima et al., 1994). Irs2-/- mice 
were crossed on the Apo-E knock-out background to generate double knock-out: Irs2-/-; ApoE-/- 
mice. These mice are diabetic with glucose intolerance, and have aggravated atherosclerosis 
compared to the ApoE-/- mice (Baumgartl et al., 2006).  
Additionally, transplantation of Irs2-deficient bone marrow cells from Irs2-/- mice into C57Bl/6 
mice results in the accumulation of macrophages in their vascular wall under normal conditions 
as well as upon acute LPS treatment. This seems to be dependent on insulin/Irs2 signaling and 
not IL-4/Irs2 signaling in macrophages and is accompanied with increased expression levels of 
the chemotactic protein CCL2 (Mita et al., 2011).  
These two studies suggest that Irs2 signaling in macrophages protects mice from atherosclerosis 
and type-2 diabetes under normal conditions as well as acute inflammatory and atherosclerotic 
conditions.  
Other studies contradict these findings as they show some beneficial metabolic effects upon 
reduction of Irs2 signaling in macrophages. Transplantation of Irs2-/-; ApoE-/- fetal liver 
hematopoietic stem cells into the ApoE-/- mice improves the glucose tolerance and alleviates the 
atherosclerosis phenotype observed in the ApoE-/- mice (Baumgartl et al., 2006). Additionally, 
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mice with specific deletion of the IR in myeloid lineages (IRlyzM-/- mice) are protected from 
obesity-induced inflammation and insulin resistance when challenged with HFD. In particular, 
they have reduced glucose and insulin levels, improved glucose tolerance and insulin sensitivity 
as well as reduced hepatic glucose production when challenged with HFD. This is due to reduced 
serum TNFα levels and reduced JNK activity in liver and skeletal muscle (Mauer et al., 2010). 
When crossed on an ApoE-/- background, IRlyzM-/-; ApoE-/- mice do show differences in glucose, 
insulin and cholesterol levels. However, they manifest reduced number of atherosclerotic lesions 
in their aorta compared to the ApoE-/- mice under a high-cholesterol diet (Baumgartl et al., 2006). 
These results implicate both beneficial as well as harmful effects of insulin and Irs2 signaling in 
macrophages in the development of atherosclerosis. Such differences could be attributed to the 
complexity of the disease whereby Irs2 exerts different functions during each step of its 
development or to the genetic background of the mice used in the study.  
Our results suggest that abrogation of Irs2 signaling in macrophages seems to have a beneficial 
effect on glucose homeostasis and protects mice from HFD-induced insulin resistance.  
Looking at atherosclerotic lesions in the aorta of Irs2lyzM-/- mice would be interesting and 
correlating these findings with bone-marrow transplantation experiments from donor Irs2LyzM-/- 
mice into control recipient mice would be helpful in finding molecular targets of insulin sensitizing 
pathways for the therapeutic treatment of atherosclerosis. 
The role of systemic IL-4 signaling in vivo has also been implicated in the regulation of whole 
body glucose homeostasis in mice. In fact, increasing IL-4 systemic levels by i.p injection to WT 
Balb/cJ and C57BL/6J mice on HFD improves their glucose homeostasis phenotype, via 
increased STAT6 signaling mainly in the liver. This is associated with improved insulin sensitivity 
specifically in the liver and skeletal muscle, shown by increased AKT serine phosphorylation in 
these two tissues but not in the pWAT.  Interestingly, there is also a reduction of inflammatory 
markers in the pWAT of these mice on HFD. These results suggest the beneficial effects of IL-4 
in protecting mice from HFD-induced insulin resistance (Ricardo-Gonzalez et al., 2010).  
6.1.3.2 Interpretations of the improved glucose homeostasis phenotype 
Irs2 is downstream of insulin and IL-4 and is also a target for many other inflammatory signaling 
molecules including TNFα and JNK which make Irs2 a critical node downstream of multiple 
signaling pathways. Both IL-4 and insulin induce IRS2 tyrosine phosphorylation which results in 
the activation of downstream pathways that regulate cellular function. TNFα and JNK inhibit 
insulin signaling by inducing IRS2 serine phosphorylation which impairs its tyrosine 
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phosphorylation. Additionally, citrulline levels were found to be increased in plasma of obese mice 
(Sailer et al., 2013). 
Since IRlyzM-/- mice lack any metabolic phenotype on chow diet, the improved glucose 
homeostasis phenotype in Irs2lyzM-/- mice on chow diet is most likely not due to the specific 
alteration of insulin receptor signaling in macrophages. Instead other signaling pathways that 
require Irs2 might be involved. Nonetheless, similar to Irs2lyzM-/- mice, IRlyzM-/- mice are protected 
from HFD-induced insulin resistance. This might suggest that common inflammatory signaling 
pathways are altered in both mouse models under conditions of stress and contribute to the 
improvement of insulin resistance. A candidate inflammatory pathway is the JNK signaling 
pathway. Reduced JNK activity in insulin target tissues is usually associated with improved insulin 
sensitivity. There was reduced phosphorylation of c-Jun, a JNK substrate, in liver and skeletal 
muscle of IRlyzM-/- mice on HFD. Furthermore, IRlyzM-/- mice manifest reduced macrophage 
infiltration into their AT, and reduced systemic TNFα levels upon HFD (Mauer et al., 2010). 
Deletion of Irs2 in macrophages theoretically results in a partial alteration of the IL-4 signaling 
pathway in these cells. The role of IL-4 signaling in macrophages has not yet been investigated in 
the context of glucose homeostasis in mice (Nguyen et al., 2011). Therefore the improvement in 
glucose homeostasis cannot at the moment be accredited to reduced IL-4 signaling in 
macrophages. However, increasing systemic levels of IL-4 in mice on HFD is reported to improve 
their glucose tolerance and insulin sensitivity (Ricardo-Gonzalez et al., 2010).  
mRNA expression analysis of macrophage markers including F4/80 and inflammatory markers 
including Cd11c, Ccl2 and Ccl3 were significantly reduced in the AT from Irs2lyzM-/- mice.  
Similarly, mRNA levels of some macrophage inflammatory markers were reduced in Irs2lyzM-/- 
BMDM upon LPS treatment. Among these genes, Tnfα and Inos, both targets of NF-ĸB were 
dramatically decreased. Along with the prediciting associated transcription factors from annotated 
affinities (PASTAA) analysis and mRNA sequencing co-expression network analysis, these 
results suggest that the NF-ĸB signaling is compromised in the absence of Irs2 because of the 
reduced mRNA levels of its downstream targets. 
These findings are in agreement with the literature that anti-inflammatory macrophages promote 
insulin sensitivity in mice and vice-versa (Arkan et al., 2005; Liao et al., 2011; Han et al., 2013). 
The untargeted metabolomics approach indicated reduced citrulline levels in the conditioned 
medium from Irs2lyzM-/- BMDM upon LPS treatment. Citrulline is the by-product of arginine 
following digestion with INOS, an enzymatic reaction that also produces nitric oxide. This is 
consistent with reduced Inos expression levels which are usually an indication of reduced 
enzymatic activity. 
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6.1.3.3 Future experiments in the context of glucose homeostasis 
Glucose uptake in macrophages is facilitated mainly through Glut1 (Liang et al., 2007), the only 
glucose transporter expressed in these cells (Fukuzumi M et al 1996), and can be measured 
through incorporated radioactive labelled glucose (2-[
3
H]-deoxyglucose) (Liao et al., 2011; 
Odegaard et al., 2007). Since glucose uptake in macrophages is insulin-independent, it therefore 
does not reflect the overall glucose homeostasis and insulin action in the body like other insulin-
target tissues do. However, a previous study has shown that increased glucose uptake in 
macrophages is associated with high insulin levels, insulin resistance and glucose intolerance in 
mice (Liao et al., 2011). 
Fasted blood glucose and insulin levels on chow and HFD were used to characterize the 
metabolic state of Irs2lyzM-/- mice. Glucose and insulin tolerance tests (GTT and ITT) were 
performed to measure glucose handling and insulin sensitivity. 
Other methods can be used to determine insulin action in vivo. Hyperinsulinemic euglycemic 
clamp is the gold standard method used to measure insulin sensitivity by assessing glucose 
infusion rate (GIR) and hepatic glucose production (HGP) which provides information on glucose 
handling and glucose levels, respectively (Ayala et al., 2011). This technique would permit a more 
detailed dissection of the sites of altered insulin action and the tissue basis of the improved 
glucose homeostasis phenotype seen in the Irs2lyzM-/- mice. Measuring glucose uptake in tissues 
would have shown which tissues in Irs2lyzM-/- mice have increased glucose uptake compared to 
control mice. 
The reduced insulin levels along with the improved glucose tolerance in the Irs2lyzM-/- mice might 
indicate reduced insulin secretion from the β cells of the pancreas. To assess this, histological 
and immunochemical studies in the pancreas would permit measuring insulin content, number of 
islets and their size in addition to β cell mass.  
In light of these findings discussed in section 6.1.3.2, and to further address the cellular and 
molecular mechanisms underlying the metabolic changes in these mice, it would be interesting to 
assess JNK activity in peripheral tissues such as liver, skeletal muscle and adipose tissues, count 
macrophage number in the AT and measure circulating inflammatory and anti-inflammatory 
cytokine levels in these mice.  It would also be helpful to determine mRNA and protein levels of 
inflammatory markers in ATMs. 
Additionally, as described previously on the role of proliferating AT macrophages in obesity-
induced inflammation, a determination of local proliferation of Irs2lyzM-/- ATM would be helpful. This 
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is particularly important based on the fact that Irs2 is responsible for the IL-4 proliferative 
properties in some cells including T cells (Wurster et al., 2002). 
6.1.4 Implications of the lean phenotype and increased energy expenditure 
6.1.4.1 Questions and findings from the literature  
The Irs2lyzM-/- mice are protected from HFD-induced weight gain and fat accumulation in part due 
to increased energy expenditure and thermogenesis. Molecularly, there was increased brown 
adipose tissue expression of thermogenic markers which may underpin the increased energy 
expenditure and the lean phenotype as well as the improved glucose homeostasis. On chow diet, 
Irs2lyzM-/- mice show increased energy expenditure and food intake and maintain a stable body 
weight.  
As discussed earlier, deletion of Irs2 in macrophages results in an alteration of the insulin 
signaling since Irs2 is the only insulin receptor substrate expressed in macrophages, as well as a 
partial abrogation of the IL-4 signaling through the type1 IL-4 receptor which is responsible for 
IRS2 tyrosine phosphorylation.  Therefore the lean phenotype and increased energy expenditure 
of Irs2lyzM-/- mice might be a result of the alteration of either of these upstream signaling 
pathways.  
 
However, mice with specific deletion of IR in macrophages (IRlyzM-/-) have a body weight similar 
to control mice and show no changes in fat content, energy expenditure and food intake on both 
chow and HFD (Mauer et al., 2010). Moreover, mice with specific deletion of the IL4Rα, a 
component of the type 1 IL-4 receptor in macrophages (IL4rlyzM-/-) also have similar energy 
expenditure compared to control mice. Interestingly, there were no studies relating to body 
weight, adiposity, food intake and energy expenditure in IL4rlyzM-/- mice on HFD (Nguyen et al., 
2011). These results suggest that the molecular mechanisms underlying the increased energy 
expenditure in Irs2lyzM-/- mice might be independent of insulin and IL-4 signaling. They could be a 
consequence of alterations to both signaling pathways or a result of alteration of inflammatory 
signaling pathways upstream of Irs2.  
 
Previous studies have demonstrated the beneficial effects of IL-4 signaling in ATs of mice on 
whole body energy homeostasis. In fact, increased IL-4 signaling in AT blunts the deleterious 
effects of HFD (Wu et al., 2011) and increases thermogenesis during cold stress (Nguyen et al., 
2011).  
In the lean AT, eosinophils support AAMs by secreting IL-4. Hypereosinophilic transgenic mice 
have smaller visceral fat depots and are more glucose tolerant compared to control mice on chow 
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diet.  However, unlike the Irs2lyzM-/- mice, mice lacking eosinophils have increased adiposity and 
have impaired glucose tolerance under HFD challenge. This is due to the lack of eosinophil-IL-4 
production which might contribute to sustaining AAMs in the AT (Wu et al., 2011). These results 
suggest that IL-4-dependent AAM might contribute to the lean phenotype and the improved 
glucose homeostasis in mice. They might indicate increased eosinophil number and therefore IL-
4 signaling in the AT of Irs2lyzM-/- mice on HFD. 
Upon cold exposure, IL-4 stimulates AT alternative activation of macrophages which produce 
catecholamines to sustain cold-induced thermogenesis (Nguyen et al., 2011). These 
catecholamines account for 50-60% of the total catecholamine content in BATs and WATs upon 
cold stress. The remaining 40-50% are released by the sympathetic nerves. There were no 
studies showing in vivo catecholamine release from tissue macrophages from mice on HFD. 
Therefore, further studies would be essential to determine this possibility.  
In addition to AT IL-4 signaling, systemic IL-4 contributes to the regulation of energy homeostasis 
alongside its role in maintaining glucose homeostasis, as discussed earlier.  
In fact, T helper 2 (Th2) polarization following IL-4 i.p treatment in HFD-fed mice results in a 
significant reduction in their body weight, total fat content and increased energy expenditure 
compared to control mice treated with saline (Ricardo-Gonzalez et al., 2010). These metabolic 
phenotypes are similar to those observed in HFD-fed Irs2lyzM-/- mice and might be a result of 
increased circulating levels of IL-4 and Th2 polarization.  
IL-4 treatment increases the energy expenditure in control mice on chow diet (Nguyen KD et al 
2011). The Irs2lyzM-/- mice, similar to IL-4-treated mice show increased energy expenditure on 
chow diet; However, mice with specific deletion of the IL4rα in macrophages (IL4rlyzM-/-) show 
similar energy expenditure compared to control mice but do not respond to IL-4 treatment. 
Similarly, mice depleted of macrophages following clodronate treatment do not show increased 
energy expenditure upon IL-4 injection. These results suggest that the increased energy 
expenditure upon IL-4 treatment is macrophage-dependent (Nguyen et al., 2011). In fact, 
treatment of mice with IL-4 mediates the IL-4/STAT6 signaling and increases STAT6 tyrosine 
phosphorylation through the IL4Rα in macrophages. STAT6 regulates the transcription of AAM 
markers including Arg1, Mrc1 and Clec10a  which impact AAM polarization in BAT and WAT and 
increases energy expenditure in mice upon cold exposure. The cold-induced increased energy 
expenditure is associated with increased lipolysis in WAT and release of free fatty acids in the 
serum, resulting in increased thermogenic gene expression in BAT. A direct contribution of these 
AAMs to the increased energy expenditure was investigated. In fact,  IL-4-/-/IL-13-/- mice, IL4rlyzM-
/- and Stat6-/- display a defect in alternative macrophage activation, show reduced levels of 
serum free fatty acids and decreased expression of thermogenic markers in BAT, mainly Ucp1 
and Pgc1α. Therefore, AAM were required in the mobilization of WAT free fatty acids and the 
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induction of thermogenesis program in BAT. Moreover, the expression of tyrosine hydroxylase, 
the key enzyme in the synthesis of catecholamines, was increased in peritoneal macrophages of 
mice treated with IL-4 and in alternatively activated BAT and WAT macrophages upon cold 
exposure. Consequently, BMDM treated with IL-4 showed increased secretion of epinephrine and 
norepinephrine in their culture media in a STAT6-dependent manner. Similarly, levels of both 
catecholamines are significantly low in IL4rlyzM-/- and Stat6-/- BAT and WAT macrophages upon 
cold exposure (Nguyen et al., 2011). The role of Irs2 in IL-4/STAT6 signaling transduction 
pathway in BAT and WAT upon cold exposure is unknown. Since AAM play a major role in the 
induction of thermogenesis upon cold exposure by producing catecholamines, it would be 
interesting to check mRNA levels of AAM markers in BAT and WAT from Irs2lyzM-/- mice and their 
catecholamines content upon cold exposure. Nonetheless, our results have indicated no changes 
in STAT6 tyrosine phosphorylation in control and Irs2lyzM-/- BMDM under basal conditions and 
upon IL-4 treatment. 
Altogether, these findings suggest the in vivo requirement for IL-4-induced AT AAMs in the 
maintenance of a lean phenotype and the regulation of non-shivering thermogenesis.   
6.1.4.2 Interpretations of the energy homeostasis phenotype in Irs2lyzM-/- mice 
 
As a summary of the above, deletion of Irs2 in macrophages results in the alteration of the insulin 
and the IL-4 signaling pathways since both molecules signal via their receptors to induce IRS2 
tyrosine phosphorylation. Unlike Irs2lyzM-/- mice, IRlyzM-/- mice have similar body weight, total fat 
and energy expenditure phenotypes on chow and HFD compared to control mice. IL4RlyzM-/- 
mice fail to increase their energy expenditure due to lack of STAT6 activity and show a defect in 
thermogenesis upon cold exposure. The metabolic phenotypes of these mice upon HFD 
challenge were not addressed.  
Irs2lyzM-/- mice have increased energy expenditure under basal conditions when housed at normal 
temperature (24ºC). This is true despite the partial abrogation of the IL-4 signaling in 
macrophages upon Irs2 deletion which should theoretically lead to no differences in energy 
expenditure. However, the fact that Irs2 captures many upstream signaling pathways other than 
IL-4 pathway might explain this increased energy expenditure. Since STAT6 tyrosine 
phosphorylation is not changed in Irs2lyzM-/- BMDM compared to control BMDM upon IL-4 
treatment, this indicates that IL-4 signals through Irs2 in macrophages independently of STAT6. It 
might indicate that other signaling pathways that contribute to increased thermogenesis are up-
regulated in macrophages upon Irs2 deletion.  
The increased energy expenditure in Irs2lyzM-/- mice is accompanied with increased 
catecholamine levels in the urine suggesting increased levels of this hormonal signal. 
159 
 
Additionally, Irs2lyzM-/- macrophages manifest a trend towards increased catecholamine secretion 
in their cell culture media upon IL-4 treatment compared to control macrophages. Th mRNA 
levels and thermogenic gene expression program were also increased in the BAT of these mice. 
Increased catecholamine levels in the urine may suggest increased activity of the sympathetic 
nervous system (SNS). In combination with increased AAM catecholamine production this might 
explain the increased thermogenesis of HFD-fed Irs2lyzM-/- mice. Further studies are required to 
dissect the contribution of each of the SNS and AAMs in the regulation of diet-induced 
thermogenesis.  
The mechanisms by which the IR and IL-4 signal in macrophages through Irs2 to regulate mRNA 
expression of AAM markers are poorly characterized. Previous reports have indicated that 
enhanced IRS2 tyrosine phosphorylation observed for the IL-4 type I receptor was responsible for 
the enhanced gene induction in macrophages. In fact, IL-4 induced gene expression is STAT6 
and PI3K dependent; PI3K is typically downstream of Irs2 (Heller et al., 2009). Based on our 
analysis of the STAT6 pathway in Irs2lyzM-/-  macrophages, we confirm previous reports (Heller et 
al., 2009) that the initial activation of STAT6, as detected by tyrosine phosphorylation, is 
completely independent of Irs2. However, this does not mean other modifications of STAT6 or 
other pathways downstream of Irs2 do not modify the functional activity of STAT6. Further 
experiments would be helpful such as determining PI3K activity in the absence of Irs2 in 
macrophages.  
 
This paradox of the role of Irs2 in the regulation of gene expression in macrophages is 
unresolved. Our studies using BMDM from Irs2lyzM-/- mice have shown that macrophage gene 
expression (Arg1) is not dependent upon Irs2 expression (24 hours treatment with IL-4) and 
mRNA levels of Arg1 are unchanged upon IL-4 treatment despite the reduced IRS2 tyrosine 
phosphorylation resulting from the absence of Irs2 in macrophages. However, upon LPS 
treatment, Arg1 mRNA levels are increased in Irs2lyzM-/- BMDM. Similarly, Arg1 mRNA levels were 
increased in the ATM isolated from pWAT from HFD-fed Irs2lyzM-/- mice. Since STAT6 tyrosine 
phosphorylation is unchanged between control and Irs2lyzM-/- BMDM, these results might suggest 
that other signaling pathways downstream of Irs2 and/or transcription factors other than STAT6 
are altered to induce an increase in alternatively activated macrophage gene expression. In fact, 
PASTAA analysis revealed up-regulation of KLF4 targets upon LPS treatment in Irs2lyzM-/- BMDM. 
KLF4 is induced by IL-4 in a STAT6-dependent manner and directly binds the Arg1 promoter 
(Liao et al., 2011). This finding might suggest up-regulation of IL-4 signaling in LPS-treated 
Irs2lyzM-/- BMDM.   
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6.2 Future perspectives 
6.2.1 Beige adipocytes in thermogenesis 
6.2.1.1 Overview 
Brown adipocytes express high levels of mitochondrial Ucp1 content and transform chemical 
energy into heat, a property that counteracts hypothermia and obesity. Activation of BAT confers 
beneficial effects on adiposity and insulin resistance and variations in its function can greatly 
affect energy balance and body weight as well as glucose homeostasis (Fisher et al., 2012; Wu et 
al., 2012). Recent studies have identified brown-like fat depots in the white adipose tissues of 
mice. These were termed beige or brite adipocytes. They are most abundant in the subcutaneous 
adipose tissue and are seldom observed in the perigonadal adipose tissue upon cold exposure or 
in response to treatment with β3-adrenergic agonists. These beige adipocytes, unlike classical 
brown adipocytes, do not appear to arise from the myogenic factor 5 (myf-5)-positive muscle-like 
cells but from endothelial and perivascular cells within the WAT (Lidell et al., 2013). They may 
also arise from transdifferentiation of white adipocytes present in the WAT (Bartelt and Heeren, 
2014). 
 Despite their multiple origins, beige and brown adipocytes share similar features as they both 
express Ucp1 and the transcriptional co-regulator Pr domain containing 16 (Prdm16). Prdm16, 
which controls the development of brown adipocytes during days 9 and 12 of gestation in mice, 
was also shown to be expressed at high levels in beige adipocytes (Cohen et al., 2014; Seale et 
al., 2011).  
It was always thought that the brown adipose tissue in rodents was the equivalent to that in adult 
humans. However, this concept has been questioned recently. In adult humans, the brown fat 
depots located at the supraclavicular area share more molecular properties with murine beige 
adipocytes than with classical brown adipocytes. The brown fat depots, most abundant at 
interscapular area of the mouse, are undistinguishable from interscapular BAT present in human 
infants (Lidell et al., 2013). 
6.2.1.2 Mouse models of increased thermogenesis 
The concept of brown adipocytes occurring into white fat depots emerged when UCP1 protein 
levels were detected in white fat cells under stress conditions (such as cold or exercise) as well 
as in genetically engineered mice (Cannon and Nedergaard, 2004). As discussed previously, the 
concept of beige adipocytes was later established in both mice and humans because these cells 
manifest differences with the classical brown adipocytes in many aspects.  
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Genetic manipulations and pharmacological interventions in mice have revealed a direct 
contribution of these beige adipocytes in the regulation of energy homeostasis. The release of 
catecholamines from the SNS and possibly from AAMs activates energy-sensing pathways in the 
WATs and promotes the differentiation of beige adipocytes from their precursors. This 
differentiation into beige adipocytes requires the induction of several transcription factors, 
including PGC1α. PGC1α up-regulates the expression of thermogenic genes such as Ucp1 in the 
WAT, therefore, generating the beige phenotype and as a result increasing energy expenditure 
(Bartelt and Heeren, 2014). 
Pharmacological induction of PPARγ by the anti-diabetic drug thiazolidinedione in obese mice 
causes browning of the WAT and increases Ucp1 expression (Fukui et al., 2000). Treatment of 
mice with fibroblast growth factor 21 (Fgf21), a regulator of fatty-acid oxidation in liver, induces 
thermogenic gene expression and browning of the subcutaneous inguinal WAT and to a lesser 
extent the perigonadal WAT (Fisher et al., 2012). 
Transgenic expression of Prdm16 in adipose tissues of mice using the adipocyte protein 2 (aP2) 
promoter (aP2-Prdm16) stimulates the expression of several brown fat markers mostly in the 
inguinal WAT (iWAT). Morphologically, this was accompanied by the formation of clusters of cells 
expressing high levels of UCP1 and TH in these iWAT under basal conditions. aP2-Prdm16 mice 
are protected from HFD-induced weight gain, with decreased adiposity and increased energy 
expenditure. They show improved glucose homeostasis manifested by improved glucose 
tolerance and insulin sensitivity under HFD conditions (Seale et al., 2011). 
On the other hand, mice with specific deletion of Prdm16 in adipocytes (Adipo-Prdm16) show the 
opposite phenotype to aP2-Prdm16 mice. They displayed greater weight gain on HFD than 
control mice with increased total adiposity and increased inguinal fat mass with no change in 
perigonadal fat mass. The increased iWAT mass was accompanied by increased accumulation of 
F4/80/CD11b positive macrophages forming crown-like structures in the iWAT of Adipo-Prdm16 
mice compared to control mice. Hyperinsulinemic-euglycemic clamps indicated increased fasting 
insulin levels and reduced whole body glucose uptake (Cohen et al., 2014). 
Transgenic expression of cyclooxygenase-2 (Cox-2) in mice, a rate limiting enzyme in the 
synthesis of prostaglandins (PG), results in increased BAT-like cells in the intra-abdominal fat, 
accompanied by an induction of thermogenic gene expression program. These mice displayed 
reduced body weight and total adiposity with increased food intake and energy expenditure on 
chow diet. Moreover, these mice were protected from HFD-induced obesity, hyperinsulinemia and 
hyperglycemia as well as glucose intolerance. These results suggest that the COX-2-PG pathway 
confers protection against metabolic complexities observed during obesity, through increased 
circulating PG levels and energy expenditure (Vegiopoulos et al., 2010). 
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These studies suggest that induction of browning in white adipose tissue depots is one approach 
to treat obesity and insulin resistance in humans. However, at the moment, studies in mice have 
only shown the beneficial effects of inguinal WAT transplantation on metabolic parameters, such 
as adiposity and insulin resistance. These effects are similar to those observed in BAT-
transplantation experiments. Nonetheless, the anatomical locations of these inguinal WAT depots 
have been characterized in humans and therefore future therapeutic interventions could be 
helpful to develop strategies for weight loss and insulin resistance (Bartelt and Heeren, 2014). 
6.2.1.3 Macrophages in the browning process? 
The release of catecholamines at the end of the sympathetic nerves in WAT and BAT is 
associated with increased BAT activity and the formation of beige adipocytes in white adipose 
depots (Cannon and Nedergaard, 2004).  
As discussed earlier, the secretion of catecholamines by AAM has been associated with 
increased energy expenditure and increased thermogenic gene expression program in BAT upon 
cold exposure or β3 adrenergic stimulation in mice (Nguyen et al., 2011). However, whether 
AAM-catecholamines play a role in the browning process has not been resolved.  
Obesity induces a switch of macrophage phenotype from AAMs to CAMs and therefore might 
impair the browning process by promoting inflammation in the WAT (Bartelt and Heeren, 2014). 
White to brite transformation in WAT depots of obese individuals could offer therapeutic 
perspectives to treat obesity-induced inflammation and related disorders. Such therapies might 
include pharmacological interventions aimed at promoting the trans-differentiation process by 
acting on β-adrenergic receptors or on transcription factors involved in this process (Frontini and 
Cinti, 2010). Therapeutic strategies to switch macrophage phenotype from inflammatory to anti-
inflammatory might also be helpful in treating obesity by increasing catecholamine secretion and 
as a result the browning process is activated and energy expenditure increased.  In fact, the 
inflammatory phenotype induced by CAM in the adipose tissue of obese mice results in reduced 
energy expenditure (Cohen et al., 2014). Future studies would reveal whether CAMs have an 
anti-browning effect by counteracting catecholamine production by AAM (Bartelt and Heeren, 
2014).  
6.2.1.4 Future experiments in the context of energy expenditure and browning 
Increased energy expenditure along with elevated thermogenic gene expression program have 
implicated the role of many tissues and organs in AT browning. In fact, increased energy 
expenditure in mice could be the consequence of metabolic adaptations of other organs.  
Metabolically active organs like liver, skeletal muscle and heart, under stress conditions, secrete 
paracrine and endocrine factors that activate energy-sensing pathways in adipocytes to increase 
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thermogenesis. For instance, irisin, a newly identified hormone secreted by skeletal muscle 
during exercise stimulates expression of thermogenic program in BAT and increases energy 
expenditure (Boström et al., 2012).  Acute administration of FGF21 lowers circulating insulin 
levels and increases hepatic mRNA levels of Irs2 (Fisher et al., 2011). Therefore, an estimation of 
the involvement of each tissue which might have an adaptive role in thermogenesis observed in 
Irs2lyzM-/- mice could be important.  
To address the role of WAT macrophages in the browning process, WAT macrophages can be 
depleted through the pharmacological use of clodronate and mice challenged with cold or treated 
with β-adrenergic agonists. Clodronate belongs to the “bisphosphonates” family of drugs and 
targets all tissue macrophages in the body including osteoclasts of the bone and kupffer cells of 
the liver. Therefore, the contribution of multiple tissues in WAT browning cannot be excluded.   
Another way of addressing the role of macrophages in browning is through inflammatory 
macrophages that counteract AAMs and therefore might impair browning. The use of mouse 
models to specifically knockout inflammatory genes in macrophages could be helpful in 
addressing this question.  
Several mechanisms could be responsible for the increased energy expenditure in the Irs2lyzM-/- 
mice upon HFD challenge. The increased urinary catecholamine levels in Irs2lyzM-/- mice might 
imply that this is in part due to increased activation of the sympathetic nervous system. Therefore, 
the involvement of the SNS in increased EE  in Irs2lyzM-/- mice cannot be excluded and could be 
assessed by performing tyrosine hydroxylase staining on adipose tissue sections.  
Moreover, non-shivering thermogenesis could be a result of increased activity of the thyroid 
gland. Therefore, measuring levels of T3, which is produced by the thyroid gland and is an 
indication of thermogenesis, may add to the role of macrophages and the SNS. 
Unlike HFD-induced obesity that causes a switch of macrophages towards CAM phenotype, cold 
exposure activates IL-4 signaling and promotes AAM polarization. Consequently, the role of 
macrophage Irs2 signaling in the regulation of obesity-induced inflammation might be different 
from its role upon cold challenge.  Therefore, it would also be interesting to address its role in 
cold-induced thermogenesis by acclimatizing mice to low temperatures and determining their BAT 
function. 
Additionally, the role of BAT in thermogenesis can be assessed through in vivo measurement of 
glucose uptake by BAT using positron emission tomography (PET). Increased glucose uptake by 
BAT could also implicate improved glucose homeostasis.  
The underlying mechanisms which contribute to increased energy expenditure and macrophage 
catecholamine secretion in Irs2lyzM-/- mice are therefore complex and could be attributed to 
several tissues. Further experiments could be undertaken to answer such questions.  
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Tissue macrophages cross-talk with other cells in the tissue, for exemple, Kupffer cells crosstalk 
with hepatocytes in the liver (Huang et al., 2010) and therefore Irs2 deletion in macrophages 
might regulate signaling pathways in the liver. IL-4 signaling could be assessed in the liver of 
HFD-fed mice by measuring STAT6 tyrosine phosphorylation. If a reduction of STAT6 
phosphorylation is detected, it might be responsible for the increased energy expenditure upon 
HFD challenge in the Irs2lyzM-/- mice (Ricardo-Gonzalez et al., 2010). 
Additionally, increased IL-4 signaling can be determined in WAT by counting eosinophils since 
these are the main cells producing IL-4 in the AT and there is a positive correlation between the 
number of eosinophils and the number of AAM expressing Arg1 (Wu et al., 2011). 
Since Fgf21 is an upstream regulator of Irs2 (Fisher et al., 2011), and its production by both liver 
and WAT induces WAT browning, Fgf21 mRNA levels could be determined as well as their 
circulating levels in Irs2lyzM-/- mice. 
6.2.2 Obesity-associated hypothalamic inflammation 
In addition to the role of WAT and BAT macrophages in the regulation of energy homeostasis, 
microglial cells which are the resident macrophages of the brain play a significant role in this 
process. There is no evidence of Irs2 deletion in the hypotahalmus of Irs2lyzM-/- mice under 
normal conditions (chow diet); However, Irs2 deletion under HFD conditions still need to be 
investigated. 
In fact, consumption of a HFD in rodents induces neuronal injury mainly in the arcuate nucleus of 
the mediobasal hypothalamus. This is associated with recruitment of microglia cells into the site 
of injury. Unlike inflammation in peripheral tissues that develops after a chronic exposure to HFD 
(weeks to months), hypothalamic inflammation is detected as early as one day of HFD exposure 
and contributes to central leptin and insulin resistance (Thaler et al., 2012). 
The mechanisms linking hypothalamic inflammation to HFD-induced obesity have implicated the 
role of leptin and insulin signaling in this process. In fact, inflammatory signals in the 
hypothalamus influence both insulin and leptin signaling through common downstream pathways 
that activate IRS proteins and subsequently the PI3K and MAPK pathways. Likewise, leptin 
signals through the JAK/STAT3 pathway to regulate gene expression (Thaler and Schwartz, 
2010). 
Hypothalamic over-expression of the IKK isoform reduces leptin and insulin signaling through 
serine phosphorylation of IRS molecules, similar to its function in peripheral tissues.  Similarly, 
over-expression of SOCS3, which can be induced by the leptin-JAK/STAT or the IKK/NF-B 
pathway, in the arcuate nucleus upon high fat feeding inhibits insulin and leptin signaling (Thaler 
and Schwartz, 2010). 
The mechanisms linking hypothalamic inflammation to insulin signaling are under investigation, it 
would be interesting to determine the role of Irs2 in microglia in hypothalamic inflammation upon 
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high fat feeding or sepsis conditions. This is particularly important based on the direct contribution 
of Irs2 in the regulation of inflammatory signaling pathways including the JNK and the NF-B 
pathway. 
These findings in rodents when extended to humans using MRI scanning revealed gliosis in the 
hypothalamus of obese human patients (Thaler et al., 2012). 
The above studies implicate hypothalamic inflammation as a cause and not a consequence of 
obesity, unlike peripheral tissue inflammation. It therefore represents a potential target for anti-
inflammatory therapies to treat obesity of both rodents and humans. Understanding the molecular 
mechanisms that link central inflammation to leptin and insulin resistance as well as activation of 
inflammatory signaling pathways is of crucial importance to find therapeutic approaches to treat 
obesity. 
6.2.3 The gut microbiota in obesity- induced insulin resistance 
Another metabolic system in the human body that influences energy homeostasis is the gut 
microbiota and this is a developing area in the metabolic research. Studies from mice indicate 
that unlike mice with a gut microbiota, germ-free mice are resistant to diet-induced obesity after 
consumption of a HFD. This is due to an interaction between HFD and gut microbiota which alters 
bacterial function and predisposes to metabolic diseases. 
In fact, in addition to AT inflammation that induces insulin resistance, an overproduction of TNFα 
in the intestine results in intestinal inflammation and might contribute to the development of 
insulin resistance during obesity.  However these inflammatory changes occur in various cells of 
the intestine but not macrophages (Ding et al., 2010). Therefore the role of gut macrophages in 
obesity-induced inflammation has not been confirmed. 
Another mechanism by which gut microbiota initiate the inflammatory state of obesity and insulin 
resistance is through the gram-negative bacterial component LPS. LPS is continually produced 
within the gut following death of gram–negative bacteria and a HFD decreases the numbers of 
some bacteria, including gram-negative and gram-positive bacteria in the gut. Since Irs2 signaling 
in macrophages upon LPS treatment has been shown to regulate inflammatory signaling 
pathways, it would be interesting to know whether the metabolic changes in Irs2lyzM-/- mice on 
HFD are a result of alteration of gut microbiota. 
As a result of HFD, the number of bifidobacteria decreases as well, resulting in increased 
intestinal LPS levels and disruption of the mucosal barrier function. LPS is then absorbed into 
intestinal capillaries through a TLR4-dependent mechanism and transported to target tissues 
though lipoproteins. This results in increased plasma LPS levels and implies that the food fat 
content is an important regulator of plasma LPS levels. This so called “metabolic endotoxemia” is 
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accompanied by increased fasting glucose and insulin levels as well as increased body weight 
and accumulation of F4/80-positive cells in the adipose tissue. There is increased mRNA 
expression of inflammatory markers including Tnf, Il-6 and Il-1 in liver, muscle, visceral and 
subcutaneous adipose depots (Cani et al., 2007). 
Therefore, reducing gut microbiota through antibiotics for example can be used as a therapy to 
treat obesity and insulin resistance through reduction of circulating LPS levels.  
6.3 Role of macrophage Irs2 in the regulation of energy homeostasis 
Findings in this thesis have confirmed a critical role of Irs2 signaling in macrophages in the 
regulation of glucose homeostasis, adiposity and energy expenditure under normal and high fat 
feeding conditions. Irs2 expression has been consistently shown to alter energy homeostasis in 
mice by regulating various signaling pathways, depending on the cell or tissue where it resides. 
By inactivating Irs2, the sole insulin receptor substrate that mediates insulin signaling in 
macrophages, we were able to show that Irs2 signaling in macrophages possesses pleotropic 
functions. 
Irs2 signaling overlaps with multiple inflammatory and anti-inflammatory pathways that are critical 
for determining macrophage molecular signature, and therefore biological function. Such 
inflammatory pathways include the NOD-like receptor and the Toll-like receptor signaling 
pathways which are decreased upon Irs2 inactivation in LPS-treated BMDM. Since Irs2 is a 
downstream target of IL-4 signaling, we have shown that Arg1 expression is affected upon Irs2 
deletion but independently of STAT6. The transcription factor KLF4 might be of particular interest, 
since its downstream target, Arg1, was shown to be up-regulated in LPS-treated Irs2lyzM-/- 
BMDM.  
In addition to the role of adipose tissue macrophages in the development of insulin resistance and 
obesity, studies have implied the role of microglial cells (Thaler et al., 2012) and Kuppfer cells 
(Huang et al., 2010) in the regulation of energy homeostasis.  
The generation of a mouse model whereby Irs2 function in specific tissue macrophages could be 
altered is of particular interest. This will allow the dissection of the role of Irs2 signaling in 
macrophages in various compartments of the body and their implication for energy homeostasis. 
Understanding the mechanisms of insulin signaling in ATMs and their contribution to the browning 
process should also be considered. This is particularly important because reduced BAT activity, 
associated with systemic insulin resistance has been correlated with ageing in humans (Bartelt 
and Heeren, 2014). Therefore, increased browning could offer therapeutic strategies for the 
treatment of obesity and insulin resistance, and might contribute to increased healthy life span.  
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Appendix 1: List of pathogens where the mice studies were conducted. 
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Appendix 2: Characterization of adipose tissue macrophages from control 
and Irs2lyzM-/- mice by flow cytometry staining 
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Appendix 3: Schematic representation of the experimental design of 
physiological and metabolic studies in female and male mice. 
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Numbers in brackets (1), (2) and (3) beside each test indicate the different cohorts on which the 
experiments were performed.  
Cum. FI: Cumulative food intake; EE: energy expenditure. 
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